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Abstract 
Adipose tissue engineering holds promise for the development of therapeutic strategies for 
subcutaneous adipose tissue regeneration to treat defects resulting from congenital birth 
defects, invasive surgical procedures and traumatic injuries. Decellularized adipose tissue 
(DAT) scaffolds represent a potential off-the-shelf tissue substitute for volume augmentation. 
Seeding the DAT with adipose-derived stromal cells (ASCs) has been shown to enhance 
adipose tissue regeneration in immunocompetent animals in vivo. Although promising, this 
strategy is limited by low cell attachment on the DAT. As such, this thesis focused on the 
development of bioreactor strategies to enhance the capacity of human ASCs to stimulate 
angiogenesis and adipogenesis within the DAT.  
Culturing human ASCs on the DAT scaffolds within a perfusion bioreactor under hypoxia 
(2% O2) promoted ASC expansion, and altered cell phenotype, upregulating the expression 
of hypoxia inducible factor 1-alpha (HIF-1), inducible nitric oxide synthase (iNOS) and 
tumour necrosis factor-alpha (TNF-) in the ASCs in the peripheral regions of the DAT. 
Further, bioreactor culture modulated the expression of pro-angiogenic and 
immunomodulatory paracrine factors, suggesting that the capacity of the ASCs to stimulate 
regeneration may have been altered by shear stress stimulation. In vivo testing in athymic 
nude mice demonstrated that angiogenesis and adipogenesis within the DAT were markedly 
enhanced when the ASCs were cultured for 14 days within the perfusion bioreactor under 2% 
O2 prior to implantation as compared to bioreactor culture under 20% O2, as well as static-
cultured, freshly-seeded and unseeded controls. Analysis of host cell infiltration indicated 
that there was increased CD31+ endothelial cell recruitment and potentially adipogenic 
progenitor cell recruitment into the DAT implants, as well as a shift towards a more pro-
regenerative macrophage response, in the 2% O2 bioreactor group relative to static cultured 
controls.  
Building from this work, a novel scalable rocking bioreactor platform was explored as an 
expansion and preconditioning system for ASCs. Preliminary studies indicated that culturing 
ASCs on DAT coatings within the rocking bioreactor enhanced the expression of the pro-
angiogenic and immunomodulatory markers CD146 and iNOS. Collectively, this work 
 
iii 
 
supports that dynamic culture systems can be applied to enhance the pro-regenerative 
potential of ASC-seeded DAT bioscaffolds. 
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Summary for Lay Audience 
The adipose (fat) tissue layer underneath the skin has limited ability for self-healing. Damage 
or loss of these tissues resulting from conditions including trauma, cancer, burns, or 
congenital birth defects can cause functional impairment and affect self-image, potentially 
causing anxiety and post-traumatic stress disorder (PTSD). Current therapeutic strategies 
have numerous limitations and there is a clear need for new approaches that promote the 
stable regeneration of adipose tissue for volume augmentation applications in plastic and 
reconstructive surgery.  
To address this challenge, human adipose tissue discarded as surgical waste was processed to 
extract cellular components that would cause an immune response and produce protein-based 
decellularized adipose tissue (DAT) scaffolds. In combination with adipose-derived stromal 
cells (ASCs), a population of regenerative cells found in fat, the DAT was previously shown 
to promote the regeneration of fat tissues in pre-clinical models. Building from this work, the 
current thesis primarily focused on investigating whether culturing the ASCs on the DAT 
within a custom perfusion bioreactor system could enhance their capacity to stimulate blood 
vessel formation and adipose tissue regeneration. Using this perfusion bioreactor system, 
conditions were identified that promoted human ASC proliferation and infiltration on the 
DAT. Further, in-depth biological characterization indicated that human ASC function was 
altered by culturing within the bioreactor under low oxygen tension. More specifically, these 
cells were shown to produce higher levels of a range of proteins that could stimulate tissue 
regeneration. Testing in a pre-clinical mouse model demonstrated that culturing the ASCs on 
the DAT scaffolds for 14 days using the established perfusion bioreactor strategy was 
effective at promoting adipose tissue regeneration within the DAT. Characterization studies 
suggested that these effects were mediated by enhancing the infiltration of cells from the host 
tissues that contributed to the formation of new blood vessels and fat cells,  as well as by 
promoting a more pro-regenerative host immune response. 
Although promising, it may be challenging to scale up the perfusion bioreactor for clinical 
applications in humans where a large number of cells are needed, particularly in cases where 
a large volume of fat tissue regeneration is required. As such, the development of a more 
scalable rocking bioreactor was explored as an alternative to the perfusion bioreactor. Initial 
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results showed that this system could also promote the expression of proteins that have been 
identified as positive markers of the regenerative capacity of ASCs. Overall, the work in this 
thesis represents an advancement towards a clinically translatable strategy to support the 
stable and predictable regeneration of the fat tissue layer below the skin.  
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Chapter 1  
1 Literature review 
1.1 Overview of the integumentary system  
The integumentary system, comprised of the skin and its appendage structures, along 
with the subcutaneous adipose tissue layer, is one of the largest organ systems in the body 
(Figure 1.1)1. The skin consists of two distinct layers, termed the epidermis and dermis. 
The epidermis is composed of a thin layer of keratinized squamous epithelium, which is 
largely made up of keratinocytes, but also contains melanocytes, Langerhans cells and 
Merkel cells2. The epidermis is avascular and dependent on the dermal layer for 
oxygenation and nutrients2. The epidermal layer is organized into several sub-layers, 
from the deep stratum basale, also referred to as the stratum germinativum, to the apical 
stratum corneum.  
The dermal layer is located between the epidermis and the subcutaneous tissues. The 
dermis is enriched in lymphatic vessels, blood vessels, and nerve endings necessary for 
the physiological function of the skin3. Further, the dermis also contains hair follicles, as 
well as apocrine, sebaceous and eccrine glands4. In addition, the dermal layer contains a 
high density of collagen and elastin, which are essential for maintaining the structural 
integrity and elasticity of the skin. Notably, collagen accounts for approximately 70% of 
the dry mass of the skin2.  
The hypodermis, also known as subcutaneous tissue, is a part of the integumentary 
system that is located below the dermis4. The subcutaneous tissue layer is predominantly 
composed of adipose tissue that can be anatomically divided into two layers: the 
superficial adipose tissue layer and the deep adipose tissue layer5.  While the superficial 
layer can be variable in depth depending on the fat depot, it averages around 1 cm in 
thickness6. In addition to being rich in adipocytes, this layer contains a dense network of 
blood and lymphatic vessels. Adipose tissue in this layer is organized into lobules that are 
separated by connective tissue6. The deep adipose tissue layer is separated from its 
superficial counterpart by a thin layer of highly fibrous fascia, known as the fascia 
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superficialis5. While the superficial fat layer is relatively resistant to hypertrophic and 
hyperplastic expansion in adult humans, the deep fat layer accounts for the majority of 
overall adipose tissue growth in instances of increased fat accumulation6. Additionally, 
fat tissue in this layer is also more sensitive to glucose, which could explain its 
susceptibility for expansion compared to the superficial adipose tissue depots6. 
Functionally, the subcutaneous adipose tissue layer is an important endocrine organ, and 
has been shown to regulate metabolism7–10. Additionally, subcutaneous adipose tissue is 
involved in thermoregulation, and also provides structural support to the dermis and 
epidermis4.  
 
Figure 1.1 Overview of the structure of the integumentary system showing the 
anatomy of the epidermis, dermis and hypodermis (subcutaneous tissue). Image re-
printed with permission from publisher1.  
 
1.2 Clinical need for soft tissue augmentation strategies 
Subcutaneous adipose tissue damage or loss are prevalent issues that can be caused by 
trauma, birth defects, aging and surgical procedures, such as oncologic resection 
surgeries11. It was estimated that over 5.8 million reconstructive procedures were 
performed in the U.S. in 2018 alone to address these issues, including more than 480,000 
scar, burn or laceration repairs, 101,000 breast reconstructions, and 4.4 million tumour 
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removals12. Existing clinical interventions and therapeutic strategies generally aim to 
augment the volume of the damaged or missing tissues.  
The current gold standard to correct large-volume defects is the transfer of vascularized 
flaps of skin, fat and muscle from a distant depot on the patient’s body12. For example, 
deep inferior epigastric perforator flaps are common procedures where subcutaneous 
tissues and a small portion of the muscle tissue from the abdominal region of the patient 
are directly grafted to augment the breast13. However, these types of surgical 
interventions are associated with serious complications including tissue necrosis, 
weakening of the abdominal wall, and abdominal hernia14–16.  
Common clinical interventions for medium-volume defects (50 – 150 cc) include 
autologous fat grafting, where subcutaneous adipose tissue from a distal fat depot is 
extracted, processed and injected into the target site17,18. This strategy requires a high 
degree of surgical precision, and the grafted tissue may be quickly resorbed following 
implantation due to a lack of supporting vascularization19. In addition, poorly 
vascularized fat grafts can lead to complications such as the formation of oil cysts and 
calcification13.  
For small-volume augmentations, such as the treatment of wrinkles, dermal fillers are the 
primary treatment strategies. These dermal fillers are typically composed of injectable 
hyaluronic acid (HA) formulations20–22. However, the augmentation effects of these 
fillers are transient, typically lasting 3-6 months19. Inappropriate techniques can lead to 
swelling, pain, infections and tissue necrosis19. Additionally, these materials do not 
support the natural regeneration of host adipose tissue23.  
While existing clinical interventions can address soft tissue damage or loss to varying 
degrees, these treatment strategies are associated with risks and complications as outlined 
above. In addition, these strategies have not demonstrated the capacity to support tissue 
regeneration, which often leads to transient and/or unpredictable augmentation22. The 
lack of intervention strategies to address soft tissue damage that are effective in the long-
term can lead to anxiety and depression24. For patients with injuries caused by trauma or 
cancer, an inability to address these issues can also precipitate post-traumatic stress 
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disorder (PTSD)25. As such, there is a critical need for alternative clinical treatment 
strategies that can provide long-term augmentation and support the stable and predictable 
regeneration of damaged or deficient subcutaneous adipose tissue.  
1.3 Adipose tissue engineering 
Adipose tissue engineering has generated promising advances toward strategies that can 
promote subcutaneous adipose regeneration. A common approach involves a combination 
of pro-regenerative cell populations and biocompatible scaffolds26–28. The scaffolds can 
provide immediate volume augmentation and serve as a delivery vehicle for the 
regenerative cell populations. In addition, depending on the properties of the 
biomaterials, they can also provide the necessary biomechanical and biochemical support 
to promote host-derived regenerative processes29–31. Existing biomaterials that have been 
investigated for adipose tissue engineering applications can be categorized as either 
synthetic polymers, such as poly(lactic-co-glycolic) acid (PLGA), polyglycolic acid  
(PGA) and polyethylene glycol (PEG)32–34, or naturally-derived biomaterials, which 
include extracellular matrix (ECM) components such as collagen, HA, or decellularized 
ECM bioscaffolds35–37. Key studies involving a variety of scaffolds will be described in 
more detail in Section 1.6. 
Pro-regenerative cell populations are often delivered within the bioscaffolds to help 
stimulate regeneration. To date, the majority of studies have incorporated either mature 
adipocytes38 or adult mesenchymal stromal cell (MSC) populations39–41. The specifics of 
these cell populations will be discussed in detail in the next section.      
1.4 Cell sources for adipose tissue engineering 
To develop a therapeutic strategy for adipose tissue regeneration, potential cell sources 
should be readily available and accessible, and ideally provide a high density of pro-
regenerative cells to support clinical translation in humans42.  A range of cell sources 
such as adipocytes, embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) 
and MSC populations, such as bone marrow-derived MSCs and adipose-derived stromal 
cells (ASCs) have been examined for this application43–46. This section will discuss the 
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specifics of these cell populations and how they can contribute to the processes involved 
in adipose tissue regeneration, with a particular focus on MSCs as the most predominant 
cell source studied to date. 
Among cell types investigated for adipose tissue regeneration, mature adipocytes have 
been used to provide immediate tissue augmentation to the target site, similar to 
autologous fat grafting47. While studies have demonstrated that this cell population could 
be promising, it is unclear if adipocytes can survive long-term and maintain volume over 
time. A recent study by Eto et al. demonstrated that human adipocytes that were 
delivered in vivo into mice did not survive under hypoxia48. In particular, the lack of 
vascularization near the newly grafted tissue led to the loss of ~80% of the delivered 
adipocytes within 3 days48. Additionally, mature adipocytes can be fragile to handle, 
which could add further challenges for clinical translation49,50. In light of these findings, 
studies have largely shifted away from delivering mature adipocytes. 
In addition to mature adipocytes, ESCs, a population of pluripotent cells derived from the 
inner cell mass of blastocysts51, have also been studied as a potential cell source for 
adipose tissue engineering52. This cell population has the capacity to differentiate into 
mature cells derived from the endoderm53,54, mesoderm55,56 and ectoderm57,58 layers, 
which makes them promising for a wide range of therapeutic applications. However, 
grafting ESCs into patients had led to the formation of teratomas59. This, in addition to 
their embryonic sourcing, raises ethical concerns associated with their use60. Similarly, 
iPSCs generated from reprogrammed adult somatic cells have also been considered for 
the regeneration of adipose tissue61. However, the process involved in reprogramming 
has the potential to be tumorigenic and delivery of these cells into patients can also lead 
to teratoma formation61. Overall, while ESCs and iPSCs have demonstrated promise for 
adipose tissue regeneration, their associated safety and ethical concerns represent barriers 
to clinical translation that currently limit their investigation for this application.  
1.4.1 Mesenchymal stromal cells 
MSCs are a heterogenous cell population that was first identified within the bone 
marrow62. Since then, MSCs have also been isolated from numerous other sources 
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including adipose tissue63, synovial fluid64, umbilical cords65 and peripheral blood66. To 
address their diverse sourcing and heterogenous nature, MSCs were broadly defined as a 
cell population that is adherent to tissue culture plastic, expresses the cell surface markers 
CD73, CD90 and CD105, and lacks expression of CD14, CD31 and CD4567. 
Additionally, MSCs also have the capacity to undergo adipogenic, chondrogenic and 
osteogenic differentiation when cultured in vitro under inductive conditions67. 
1.4.2 Adipose-derived stromal cells 
The stromal vascular fraction (SVF) of adipose tissue contains fibroblasts, committed 
adipogenic progenitors, endothelial cells, hematopoietic cell populations and a small 
subpopulation of MSC-like cells called ASCs 68. The SVF can be isolated from adipose 
tissue through enzymatic digestion with collagenase, followed by centrifugal separation 
and filtration techniques69. The ASCs are broadly classified as the population within the 
SVF that adheres to tissue culture polystyrene (TCPS)69. It is estimated that between 5 x 
105 to 2 x 106 nucleated cells can be isolated per gram of fat, and ASCs account for 20% 
of this population70,71. As such, ASCs are considerably more abundant than MSCs within 
the bone marrow, which are estimated to represent only 0.04% of the nucleated cell 
population71. Additionally, ASCs can be isolated from surgically discarded fat, which is a 
highly abundant and readily available source material, making them a particularly 
promising source of regenerative cells for adipose tissue engineering strategies. 
In addition to being plastic-adherent, ASCs are also defined by the expression of selected 
cell surface markers and their potential to undergo tri-lineage differentiation into 
adipocytes, chondrocytes and osteoblasts when induced in culture72. 
Immunophenotypically, ASCs are characterized by their positive expression of CD29, 
CD44, CD73, CD90 and CD105 and their lack of expression of CD31 and CD45. 
Additionally, ASCs may also have variable expression of CD26, CD34 and CD14670. A 
comprehensive list of ASC surface markers and their associated functions is shown in 
Table 1.1.  
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Table 1.1 Key positive, negative and variable ASC surface markers. 
Positive Surface Markers 
Surface 
Marker 
Protein  Function(s) 
CD29 Integrin β1 Component of cell surface integrins, which can 
mediate cell adhesion and a diverse range of functions 
including tissue regeneration and immunoregulation73 
CD44 Homing cell 
adhesion molecule 
Cell surface glycoprotein, receptor for hyaluronic 
acid74,75 
CD73 Ecto-5'-
nucleotidase 
Catalyzes the production of ECM adenosine, 
modulates transforming growth factor beta 1 
(TGF-β1) expression76 
CD90 Thymocyte 
differentiation 
antigen 1 
Maintenance of progenitor-like phenotype77 
CD105 Endoglin Surface glycoprotein, component of the TGF-β1 
receptor complex78 
Negative Surface Markers 
Surface 
Marker 
Protein Function(s) 
CD31 Platelet endothelial 
cell adhesion 
molecule 1 
Endothelial cell marker. Attenuates VEGFA-mediated 
angiogenesis79 
CD45 Protein tyrosine 
phosphatase 
receptor type C 
Hematopoietic marker. Membrane glycoprotein 
involved in cell activation and differentiation80 
Variable Surface Markers 
Surface 
Marker  
Protein Function(s) 
CD26 Dipeptidyl 
peptidase 4 
Modulates macrophage recruitment by degrading key 
cytokines and paracrine factors81,82 
 
Associated with a pro-fibrotic phenotype in dermal 
fibroblast populations83 
CD34 Transmembrane 
glycoprotein 
Associated with maintenance of clonogenicity84 and 
pro-angiogenic functionality85. 
CD146 melanoma cell 
adhesion molecule 
Expressed in vascular endothelial cells, smooth 
muscle cells and pericytes. Cell surface receptor for 
laminin, mediates blood vessel maturation86,87 
As mentioned, in addition to their characteristic cell surface marker expression profile, 
ASCs also have the capacity to differentiate into adipocytes, chondrocytes and 
osteoblasts in culture using differentiation media formulations incorporating lineage-
specific supplements and factors88. For example, human ASCs can be induced to undergo 
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adipogenic differentiation in culture by administering adipo-inductive hormones and 
glucocorticoids, such as hydrocortisone, dexamethasone and insulin89. The sequential 
addition of these factors can lead to growth arrest, and activation of the transcription 
factors CCAAT/enhancer binding protein alpha (CEBP-α) and peroxisome proliferator-
activated receptor gamma (PPAR-γ)90,91. Activation of these two master regulators of 
adipogenesis causes upregulation of a range of genes that are associated with intracellular 
lipid accumulation and adipogenic differentiation92. Similarly, ASCs can be induced to 
undergo chondrogenic differentiation by administering cytokines and growth factors such 
as transforming growth factor-beta (TGF-β1) and bone morphogenetic protein-2 (BMP-
2), to cells cultured in 3-D aggregates89. These culture conditions induce the ASCs to 
undergo cellular condensation and commit towards chondrogenic differentiation93. ASCs 
can also be induced to undergo osteogenic differentiation using a combination of 
dexamethasone, ascorbic acid and β-glycerophosphate94. These factors activate the 
transcriptional factor, Runt-related transcription factor 2 (RUNX-2), which commits 
ASCs towards the osteogenic lineage94. 
ASC isolation protocols were initially developed using lipoaspirated fat from rats95. Since 
then, the isolation protocols have been adapted for numerous tissue sources including 
human adipose tissue96. Advances in this field have led to an increasingly diverse range 
of isolation methodologies69. One recent study compared several common isolation 
protocols, including methods with collagenase digestion, trypsin digestion, red blood cell 
lysis buffer solution-based isolation and a centrifugation-based protocol for lipoaspirated 
human fat tissue97. This study demonstrated that while ASC yield was higher with the 
collagenase digestion method, there was no difference in cell viability and key cell 
surface marker expression between the protocols97. Recently, a study by Priya et al. 
showed that outgrowth cultures from extracted adipose tissue could yield ASCs with 
similar cell surface marker expression patterns and tri-lineage differentiation potential as 
compared to cells extracted through traditional enzymatic isolation methods98. 
Additionally, magnetic bead purification methods have also been developed, where cells 
with negative markers of ASCs, such as CD31 and CD45, were removed from the SVF 
using antibodies conjugated to magnetic beads99,100. While this was effective at obtaining 
a more homogenous starting cell population, it did not significantly impact the expression 
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of positive ASC cell surface markers or the capacity of the cells for tri-lineage 
differentiation.  
1.5 Mechanisms of ASC-mediated tissue regeneration 
While past studies have attempted to harness the differentiation potential of ASCs for 
adipose tissue engineering, recent work has suggested that transplanted ASCs primarily 
stimulate regeneration by remodeling the cellular microenvironment and secreting 
paracrine factors that promote host-derived angiogenesis, macrophage recruitment and 
adipogenesis101–103.  
ASCs are highly metabolically active and secrete a range of ECM components, growth 
factors and cytokines104–106. A recent study comparing the results from 5 independent 
studies on the ASC secretome showed 68 proteins that were expressed in common107. 
Interestingly, ASCs were shown to secrete a range of ECM-associated proteins, most 
notably, collagen I, II, III, IV, V, VI, XII, fibronectin, laminin, heparan sulfate (HS), 
matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases-1 
(TIMP-1)105, which suggests an active role in both the degradation and deposition of 
ECM components. Their capacity for ECM remodeling is supported by a previous in 
vitro study that demonstrated that ASCs seeded in a fibrin-based matrix could degrade 
the hydrogel via matrix metalloproteinase 14 (MMP-14) activity and deposit collagen 
type IV, which led to an increased invasion and tubule formation by seeded human 
umbilical vein endothelial cells (HUVECs)108. In addition to supporting angiogenesis, 
ASCs can also participate in remodeling the ECM to establish a more pro-adipogenic 
microenvironment. Previously, ASCs were found to degrade a collagen-based matrix in 
vitro and deposit collagen type IV109. In particular, the deposition of collagen VI has been 
shown to play an important role in adipogenesis110. Collectively, ECM remodeling is a 
mechanism for ASCs to mediate both angiogenesis and adipogenesis to support adipose 
tissue regeneration. 
ASCs are well recognized for their capacity to support regeneration through the secretion 
of paracrine factors and cytokines that mediate angiogenesis and modulate the immune 
response101,107,111. Previous studies have shown that ASCs can be stimulated to produce 
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pro-angiogenic factors such as basic fibroblast growth factor (bFGF), hepatocyte growth 
factor (HGF), TGF-β1, and vascular endothelial growth factor (VEGFA)112–115. For 
example, a previous study showed that HGF can increase the diameter of endothelial 
tubules in vitro, whereas VEGFA resulted in an increased branching of tubules115, 
suggesting that these two pro-angiogenic factors that can be secreted by ASCs can play 
distinct and complementary roles during neovascularization. Additional details of the 
functions of key angiogenic factors secreted by ASCs are outlined in Table 1.2.  
Table 1.2 Key pro-angiogenic factors secreted by human ASCs and their functions 
Pro-angiogenic Factors Function(s) 
Basic fibroblast growth factor 
(bFGF) 
Promotes endothelial cell survival, proliferation, 
migration and differentiation112  
  
Binds and activates fibroblast growth factor 
receptor 1 on endothelial cells, and activates MAPK 
to promote angiogenesis116  
Granulocyte colony stimulating 
factor (G-CSF) 
Stimulates the proliferation, survival and 
recruitment of innate immune cells113 
    
  
Chemoattractant for endothelial progenitor cells; 
promotes the differentiation of endothelial cells117  
Hepatocyte growth factor (HGF) Promotes endothelial cell survival, proliferation and 
mobilization114 
  
 
  
Creates an autocrine loop that drives 
angiogenesis118 
    
  
Works synergistically with VEGFA to increase 
vessel diameter115  
Vascular endothelial growth 
factor A (VEGFA) 
Potent driver of vessel sprouting and 
neovascularization115 
Platelet-derived growth factor 
(PDGF-B) 
Promotes endothelial cell proliferation119  
 
Chemoattractant for pericytes and promotes blood 
vessel stabilization120,121 
Angiopoietin 1 (Ang-1) Promotes endothelial cell survival, proliferation and 
motility122 
 
Supports blood vessel maturation and 
stabilization122 
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In addition to angiogenesis, ASCs can promote tissue regeneration by mediating both 
pro-inflammatory and anti-inflammatory immune responses123,124. ASCs can be induced 
towards a pro-inflammatory phenotype by treatment with lipopolysaccharide (LPS)125,126. 
Upon induction, ASCs can produce an array of pro-inflammatory cytokines, including 
tumor necrosis factor alpha (TNF-α)127. At the molecular level, TNF-α can not only lead 
to an increased expression of pro-inflammatory cytokines by effector cells, such as 
monocytes, it can also act in an autocrine loop on ASCs, which leads to the increased 
expression of additional pro-inflammatory mediators, such as interleukin 6 (IL-6), 
interleukin 8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and interferon gamma 
(IFN-γ)128,129. Interestingly, TNF-α also plays an important role in angiogenesis130,131. An 
in vitro study by Yuan et al. demonstrated that TNF-α can increase the expression of 
VEGFA and promote tube formation in human omental tissue microvascular endothelial 
cells127.  
While the transient exposure of MSCs to these factors could be pro-angiogenic, chronic 
exposure to TNF-α and the pro-inflammatory mediator interferon gamma (IFN-γ) have 
been shown to impair the proliferation and differentiation capacity of MSCs in vitro and 
in athymic nude mice in vivo129. IFN-γ can also increase the expression of inducible nitric 
oxide synthase (iNOS) and the production of nitric oxide (NO)132. In an inflamed 
microenvironment, NO can mediate tissue regeneration and inhibit fibrotic pathways133. 
Moreover, interferon gamma (IFN-γ), along with prostaglandin E2 (PGE-2) can also 
promote the expression of the anti-inflammatory cytokine interleukin-10 (IL-10), which 
subsequently downregulates the expression of pro-inflammatory cytokines in ASCs as 
well as immune cell populations134,135. Additionally, IL-10 can promote the polarization 
of macrophages towards a more pro-regenerative phenotype136. A detailed discussion of 
the roles of IL-10 and pro-regenerative macrophage populations in tissue regeneration is 
provided in Section 1.9.2. A list of key immunomodulatory cytokines secreted by ASCs 
is summarized in Table 1.3.  
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Table 1.3 Key pro- and anti-inflammatory cytokines expressed by ASCs.  
Cytokines Function(s) 
Tumor necrosis factor-
alpha (TNF-α) 
Binds to surface receptors on monocytes, T cells, 
endothelial cells and fibroblasts, activates IKK/NFκB 
signaling cascade137 to modulate cell survival138 and 
mobilization139 
  
  
Promotes the release of pro-inflammatory mediators140, 
such as IL-6141 and IFN-γ142  
Interleukin-6 (IL-6) Binds to surface receptors on monocytes and endothelial 
cells, leading to survival, proliferation and differentiation 
of monocytes143,144  
Interleukin-10 (IL-10) Expression in ASCs induced by IFN-γ and PGE-2145 
    
  
Downregulates the expression of pro-inflammatory 
factors (e.g. TNF-α)146 
    
  
Promotes the polarization of monocytes towards a 
pro-regenerative phenotype and inhibits the maturation 
of dendritic and pro-inflammatory macrophages147  
Interferon gamma (IFN-γ) Activates pro-inflammatory immune cells such as T 
cells, natural killer cells148 
    
  Upregulates iNOS expression in ASCs132  
Nitric oxide (NO) 
Inhibits fibrotic pathways by inhibiting the TGF-β1 
signaling pathway133 
    
  
Inhibits T-cell activation by inhibiting STAT5 and the 
expression of pro-inflammatory cytokines149  
 
1.6 Biomaterials for adipose tissue engineering 
Both synthetic and naturally-derived biomaterials have been explored for adipose tissue 
engineering. Scaffolds that are fabricated from synthetic materials can offer advantages in 
terms of their tunability, as they typically have more highly adjustable mechanical and 
chemical properties150. Biodegradable polymers such as poly-lactic acid (PLA) and PGA 
have been investigated for adipose tissue engineering44,151–153. For example, PLA-based 
scaffolds, when seeded with human ASCs and implanted into the muscularis layer of the 
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subcutaneous tissue of nude rats, promoted adipose tissue formation after 4 weeks44. 
Furthermore, this study demonstrated that seeding the PLA scaffold with the ASCs 
promoted the degradation of the polymer and supported adipogenesis in vivo44. Similarly, 
Weiser et al. investigated the adipogenic and angiogenic potential of PGA-based 
scaffolds151. When these scaffolds were seeded with 3T3-L1 preadipocytes exposed to 
adipogenic induction media and implanted subcutaneously into athymic nude mice, blood 
vessels and adipose tissue were observed within the scaffolds at 12 weeks151. 
PLGA, a co-polymer of PLA and PGA, has also been investigated for adipose tissue 
engineering, and has been shown to support adipogenesis in animal models with 
moderate success154–157. For example, Patrick et al. demonstrated that PLGA, when 
seeded with rat ASCs, can support the formation of adipocytes at 2 weeks following 
implantation in an immunocompetent rat model158. Similarly, when PLGA spheres were 
seeded with rabbit bone marrow-derived MSCs that were transfected to express green 
fluorescence protein (GFP), exposed to a short-period of adipogenic induction, and 
implanted in nude mice for 2 weeks, GFP+ cells with lipid accumulation were observed in 
the implanted scaffold159. Moreover, a study by Cho et al. showed that PLGA scaffolds 
seeded with human ASCs and loaded with bFGF can also support adipose tissue 
formation in nude mice at 6 weeks157. 
Overall, while biodegradable synthetic materials have shown promise in supporting 
adipose tissue formation in rodent models, these effects are largely transient, and the 
scaffolds are unable to maintain long-term volumetric augmentation following 
degradation of the polymer44. Further, while providing a supporting structure, synthetic 
polymers typically lack the innate bioactivity of naturally-derived biomaterials, which 
have greater potential to have intrinsic pro-angiogenic and/or pro-adipogenic properties 
that may be favorable for adipose tissue regeneration160–162.  
1.6.1 Naturally-derived biomaterials 
In addition to synthetic polymers, naturally-derived biomaterials have also been 
investigated for adipose tissue engineering. Broadly, these biomaterials can be 
categorized based on their compositional complexity. For example, purified structural 
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components of the ECM, such as HA and collagen, have been fabricated into bioscaffolds 
for adipose tissue engineering163–165. In addition, more highly complex biomaterials 
derived from decellularized tissues have also been explored, which contain a diverse 
range of ECM components166–170. 
HA is a naturally-derived biomaterial found within the ECM of connective, epithelial and 
neural tissues171. HA is a non-sulfated glycosaminoglycan (GAG) that plays an important 
role in tissue hydration, nutrient diffusion and proteoglycan organization172–174. HA has 
been studied for adipose tissue regeneration because its mechanical properties can mimic 
native soft tissues, and it has the potential to be fabricated into an injectable material163.  
In addition, studies have shown that HA scaffolds can support the attachment, 
proliferation and adipogenic differentiation of seeded ASCs in culture175. The adipose 
tissue regenerative effects of HA have also been examined in animal models. 
Borzacchiello et al. designed HA-based scaffolds that maintained mechanical and 
viscoelastic properties similar to that of adipose tissue when implanted into rats for up to 
12 weeks164. When seeded with human ASCs and implanted into athymic nude mice for 
3, 5 and 8 weeks, HA-based scaffolds demonstrated increased cell infiltration and blood 
vessel formation compared to unseeded control scaffolds, as well as hydrogels without 
HA176. Moreover, ASC-seeded HA-based scaffolds were shown to support blood vessel 
and adipose tissue formation when delivered into the subcutaneous tissue of pigs for 6 
weeks, although the implants were highly degraded at this timepoint36. Collectively, these 
studies demonstrated that HA-based scaffolds have the potential to support adipose tissue 
regeneration, but have been unable to maintain long-term volume augmentation when 
tested in animal models due to rapid scaffold degradation.  
HA-based composite materials have also been explored with the goal of improving 
handleability, as well as enhancing the stability and tuning the mechanical properties of 
the scaffolds177–181. For example, composite HA-g-poly(N-isopropylacrylamide) scaffolds 
have been developed, which can function as thermo-responsive injectable biomaterials177. 
Furthermore, these composite hydrogels could be crosslinked in situ, supported cell 
infiltration and were stable when delivered subcutaneously in athymic nude mice over 5 
days177. In another study, HA was incorporated with gelatin to form naturally-derived 
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composite hydrogels165. This study showed that porcine ASCs encapsulated in the HA-
gelatin composites could survive and undergo adipogenic differentiation in vitro, as well 
as promote adipose tissue remodeling in vivo when implanted in athymic nude mice and 
pigs for 8 weeks165. 
In addition to GAGs such as HA, collagen has also been used to fabricate bioscaffolds for 
adipose tissue engineering160–162,182–185. Collagen is a highly abundant and essential 
structural component of the ECM that is highly conserved between species186–188. Culture 
studies have confirmed that collagen-based scaffolds can support the attachment of 
MSCs126 and ASCs138. Further, previous animal studies have demonstrated that collagen 
scaffolds have the potential to both augment volume and act as a carrier for growth 
factors and/or regenerative cell populations183,184,189. For example, increased blood vessel 
formation and adipose tissue remodeling were observed at 6 weeks in collagen-based 
microspheres loaded with bFGF that were implanted into C57BL/6 mice compared to 
control scaffolds without bFGF190. This observation was further supported by a study by 
Hiraoka et al., who demonstrated that composite collagen and gelatin bioscaffolds that 
were loaded with bFGF could support angiogenesis and adipogenesis when delivered into 
the inguinal tissues in Wistar rats at 6 weeks191. In addition, a study by von Heimberg et 
al. demonstrated that seeding human ASCs on collagen sponge bioscaffolds better 
supported angiogenesis than unseeded controls when implanted subcutaneously in 
athymic nude mice for 12 weeks162. Collectively, these studies indicate that collagen-
based bioscaffolds alone may not adequately support adipose tissue regeneration, and 
often require additional cellular components or growth factors to enhance their pro-
regenerative capacity.  
Collagen scaffolds can also be combined with other naturally-derived or synthetic 
materials to form composite scaffolds that may have enhanced properties for adipose 
tissue engineering182,185,189,192,193. For example, composite chitosan/collagen scaffolds 
seeded with rat ASCs were found to better support adipogenesis and angiogenesis as 
compared to unseeded control scaffolds when implanted in Lewis rats as early as 14 
days184. In another study, collagen scaffolds combined with alginate microspheres seeded 
with both adipogenic-induced human ASCs and HUVECs were shown to better support 
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adipogenesis and angiogenesis than acellular controls when implanted into athymic nude 
mice at 12 weeks185. Additionally, this study also demonstrated that composite collagen 
scaffolds with human ASCs and HUVEC showed greater volume retention than the 
acellular controls at 12 weeks185. As another example, Zhang et al. demonstrated that 
composite chitosan-collagen scaffolds incorporating PEG/PLGA microspheres loaded 
with VEGFA and seeded with human ASCs showed enhanced adipose tissue remodeling, 
as well as infiltration of CD31+ endothelial cells and CD163+ pro-regenerative 
macrophages when compared to control scaffolds without PEG/PLGA microspheres or 
human ASCs193.  
Collectively, prior studies have demonstrated that naturally-derived bioscaffolds such as 
HA and collagen can act as supportive cell and/or growth factor delivery platforms for 
adipose tissue engineering. However, these materials often degrade rapidly and are 
unable to provide long term volumetric augmentation required to be clinically 
translatable.  
1.6.2 Extracellular matrix-derived bioscaffolds 
The ECM is the non-cellular structural and functional network of proteins, proteoglycans, 
and glycoproteins that surrounds cells within tissues31,194,195. Together, these components 
provide biochemical, structural and biomechanical cues that regulate cell 
behaviour31,194,195. ECM proteins such as collagen, laminin and fibronectin not only 
provide important structural support for cells, but they also contain binding sites for cell 
surface receptors such as integrins, which can guide cell attachment and function31,196–198. 
Collagen is the most abundant structural protein in the ECM. To date, 29 types of 
collagen have been identified, with collagen I, II, III, IV and V being the most abundant 
within human tissues31. A characteristic feature of collagens is their triple helical 
structure comprised of three alpha chains186. However, there can be interruptions within 
the helical structures that enable interactions with other matrix proteins31. Many types of 
collagens can form fibrils, such as I, II, III, V, IX, XIV, XVII186 . Collagen IV is a 
network-type collagen that forms the structural meshwork of the basement membrane, 
which is present in high abundance around adipocytes199. Collagens contain multiple 
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receptor-binding sites that facilitate cell attachment. For example, a well-studied 
specialized collagen binding site is the GFOGER motif that binds with α1β1 and α2β1 
integrins with high affinity186,200 and also bind to integrins with a β2 component, such as 
αmβ2 and αxβ2 integrins201.  
In addition to collagen, fibronectin is also highly abundant in the adipose tissue ECM199. 
This cell-adhesive glycoprotein associates with collagen and can also form fibrillar 
structures. While fibronectin can exist in a soluble form in plasma, it is insoluble in the 
ECM202,203. Functionally, fibronectin can bind with integrin receptors on the cell surface 
and mediate cell adhesion. For example, one of the most well studied adhesion motifs is 
the tripeptide Arg-Gly-Asp (RGD) sequence, which enables cell adhesion through 
integrins such as α4β131, αvβ3 and α5β1204. In addition, fibronectin can also bind to 
heparan sulfate, which acts as a reservoir for growth factors in the ECM205,206. In adipose 
tissue, fibronectin is associated with the pro-inflammatory cytokine, TNF-α, and the cell 
surface receptor preadipocyte factor-1 (Pref-1), which play important roles in mediating 
angiogenesis and adipogenesis, respectively207,208.  
Laminin is another important structural and bioactive component of the adipose tissue 
ECM. Laminins are a family of heterotrimeric glycoproteins that are composed of an α-, 
β- and γ- chain and are a key component within all basement membranes209. Functionally, 
laminin binds to cell surface integrins, as well as glycoproteins, dystroglycan and 
syndecan within the ECM209,210. The interaction of laminin with these extracellular 
components is crucial for cell adhesion, morphogenesis and differentiation, as well as 
tissue integrity211–213. 
Functioning in concert with the structural proteins within the ECM, proteoglycans can 
influence the cellular response via biochemical cues214,215. Additionally, with their high 
capacity to hold water, proteoglycans can also be important in maintaining the structural 
integrity and mechanical properties of the ECM. Proteoglycans are composed of a core 
protein and one or more GAG chains210. GAGs are linear polysaccharides that are 
negatively charged, which enables them to sequester growth factors, cytokines and 
chemokines214,216. As such, GAGs often serve as a reservoir for growth factors. One such 
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GAG that is present in adipose tissue is HA217. As discussed in the previous section, HA 
has been used as an injectable dermal filler due to its high abundance and compatibility 
with adipose tissue. In addition to contributing to the structural integrity of the adipose 
tissue ECM, HA has also been implicated in adipose tissue metabolism, as recent studies 
have shown that it can mediate insulin sensitivity218,219 and lipid biogenesis220.  
The combination of structural proteins and proteoglycans can guide cell behavior via 
biomechanical and biochemical cues211. Cells can also remodel the ECM by degrading 
existing components and depositing new matrices. The degradation of the existing ECM 
is achieved via the secretion of extracellular proteases221. To date, over 569 matrix-
associated proteases have been identified221. These proteins can be classified based on 
their roles and properties in protein hydrolysis and can be categorized as MMPs, serine 
proteases, cysteine proteases, aspartic acid proteases and threonine proteases222. 
By far the most well characterized ECM proteases are the MMPs, which are secreted by 
the cells as inactive pro-enzymes, and can be converted into an active form by pro-
protein convertases194,223,224. Once activated, MMPs can degrade structural proteins in the 
ECM. Moreover, the enzymatic activities of MMPs can be regulated by glycoproteins 
such as TIMPs210. In addition, studies have shown that ECM-bound growth factors and 
cytokines liberated through matrix degradation can act on cell surface receptors, such as 
epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor (IGFR) 
to downregulate the production of MMPs57.  
Recognizing the innate capacity of the ECM to direct cell function, there has been 
growing interest in the development of ECM-derived bioscaffolds for a broad range of 
applications in tissue engineering37,166,169,226–232. One of the earliest forms of ECM-
derived biomaterials is Matrigel®, which is comprised of purified basement membrane 
components secreted by Engelbreth-Holm-Swarm mouse sarcoma cells233. While the 
precise composition of Matrigel® is not fully defined, it contains structural proteins, such 
as collagen IV and laminin, as well as heparan sulfate233. In previous studies, Matrigel® 
was shown to support angiogenesis and adipogenesis when injected with bFGF in 
athymic nude mice for 6 weeks190. Furthermore, seeding the bFGF-loaded Matrigel® with 
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human ASCs was shown to further promote host-derived angiogenesis and adipogenesis 
in the same animal model for up to 9 weeks234. While Matrigel® has shown promise in 
promoting tissue regeneration, its tumour cell origin represents a significant barrier to 
clinical translation235.  
Tissue decellularization is another approach that has been applied to generate a broad 
range of tissue-specific ECM-derived bioscaffolds195,236,237. In general, the goal of 
decellularization is to remove antigenic cellular components, including cellular proteins, 
lipids and nucleic acids, while preserving the structure and composition of the native 
ECM as much as possible228,236. Decellularization is typically accomplished by subjecting 
tissues to a combination of mechanical, chemical and biological treatment steps that lyse 
cells and extract cellular debris236.  Mechanical and physical treatments are applied to 
breakdown cellular structures and expose the intracellular antigens236. These methods are 
often supplemented with chemical treatments, such as acid, base and/or detergent 
extractions, to degrade and extract cellular components236. Furthermore, biological 
treatments in the form of enzymes such as trypsin can further facilitate cell disruption, 
and the addition of DNase and RNase can cleave residual nucleic acids236. It is inevitable 
that the decellularization processes will alter the native ECM composition to some extent, 
as well as causing some structural changes. However, the degree of disruption is highly 
dependent on the nature of the tissues being processed and the protocols used for 
decellularization. To date, several types of decellularized ECM scaffolds have been 
investigated for applications in adipose tissue regeneration, as discussed below. 
Decellularized placental matrix (DPM) has been studied for adipose tissue 
engineering26,238,239. The placenta is rich in ECM and is composed of structural proteins 
including collagen I, III, IV, V, VI and laminin, many of which are present in adipose 
tissue238. In addition, it is a reservoir for growth factors and has a rich vascular network 
that may provide structural cues that are conducive for angiogenesis240. The DPM was 
demonstrated to support the attachment and adipogenic differentiation of human ASCs239. 
In a subsequent study, the DPM was combined with crosslinkable HA hydrogels as a 
possible strategy to enhance volume augmentation and modulate the cellular response to 
promote adipose tissue regeneration239. Subsequently, ASCs were seeded in the DPM-HA 
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composite scaffolds or DPM alone and implanted subcutaneously in athymic nude mice 
for up to 8 weeks26. Results from this study showed that both types of scaffolds 
macroscopically retained their volume and were able to promote blood vessel formation 
and adipose tissue remodeling within the implants, with mouse-to-mouse variability 
observed in the response26.  
In addition to DPM, decellularized dermal matrix (DDM) has also been explored for 
adipose tissue engineering241–243. Decellularized dermal tissue has been used clinically in 
plastic surgery because of its low immunogenicity and robust mechanical properties242. In 
a previous study, human ASCs were found to attach, survive, proliferate and remodel 
DDM in vitro241. Subsequently, when the ASC-seeded DDM was implanted in vivo in 
nude mice, angiogenesis was observed in the bioscaffolds as early as 2 weeks243.   
Collectively, ECM-derived bioscaffolds such as Matrigel®, DPM and DDM have shown 
promise in supporting angiogenesis and to a certain degree, adipogenesis238,243,244. 
However, it is possible that the regenerative effects could be further enhanced by 
applying a tissue-specific approach to designing ECM-derived bioscaffolds. For example, 
adipose ECM-derived bioscaffolds can be fabricated to possess biomechanical properties 
that closely mimic the native tissues, which could be favourable for adipose tissue 
regeneration245–247. Additionally, the composition of the ECM is also tissue-specific, 
containing a unique array of bioactive factors that can influence cell behaviour. Together, 
this provides a strong rationale for exploring a tissue-specific approach to designing 
ECM-derived bioscaffolds for adipose tissue regeneration.  
1.6.3 Adipose tissue-derived bioscaffolds  
Adipose tissue is important for maintaining energy homeostasis and also supports many 
of the endocrine functions of the body248. This organ is composed largely of adipocytes, 
with preadipocytes, endothelial cells, fibroblasts, immune cells and ASCs also found 
within the SVF70. The mature adipocytes are encased in a meshwork of collagen type 
IV187. Previous studies have demonstrated that the adipose tissue ECM plays a crucial 
role in regulating the metabolic function of this organ199,249–252. For example, Khan et al. 
demonstrated that an imbalance in collagen type IV and collagen type VI in the ECM of 
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adipose tissue in collagen type VI knockout mice leads to uninhibited hypertrophic 
expansion of adipocytes and decreased sensitivity to insulin109. These findings support 
that the composition of adipose tissue-derived bioscaffolds could be important for 
promoting adipose tissue regeneration and function.  
In the past, the Flynn lab group and others have made significant advances in developing 
decellularized adipose tissue (DAT) as a bioscaffold to support adipose tissue 
regeneration169,227,253–255. In the Flynn lab, DAT scaffolds are fabricated from surgically 
discarded human fat by first lysing cells through repeated freeze-thaw cycles. Cell-cell 
interactions are then disrupted via enzymatic digestion with trypsin, and the lipids are 
extracted through repeated rinsing in isopropanol253. Finally, residual lipids and nucleic 
acids are digested with a combination of lipase, DNase and RNase253. Notably, this 
decellularization process is entirely detergent-free, which avoids potential cytotoxicity 
concerns associated with residual detergents in the matrix199,249–252. Moreover, a 
detergent-free process may also be favorable for preserving GAGs and sequestered 
growth factors in the adipose tissue ECM253. DAT bioscaffolds processed using these 
methods have been shown to retain similar structural ECM components and architecture 
as the native adipose tissue ECM, including collagen IV, fibronectin, and laminin253. 
Using high-throughput mass spectrometry techniques, over 1000 proteins were detected 
in the DAT, including a diverse array of glycoproteins, proteoglycans, ECM-affiliated 
proteins and secreted factors256. Additionally, the DAT bioscaffolds were also shown to 
have similar viscoelastic properties as native adipose tissue246,247, which may be favorable  
for promoting adipogenic differentiation245.  
Previously, culturing human ASCs on DAT scaffolds has been shown to upregulate genes 
associated with adipogenesis, including the master regulators PPAR-γ and CEBP-α, 
enhance activity of glycerol-3-phosphate dehydrogenase (GPDH), an enzyme associated 
with lipid biosynthesis relative to TCPS controls, and induce low levels of intracellular 
lipid accumulation, under proliferation conditions that would normally suppress 
adipogenesis227,253–255. More recently, unseeded DAT scaffolds were demonstrated to 
support adipose tissue and blood vessel formation in Wistar rats at 8 weeks227. These 
findings suggest that the DAT exhibits pro-adipogenic properties and may provide an 
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inductive microenvironment for adipose tissue regeneration. In addition, when allogeneic 
rat ASCs were seeded on the DAT bioscaffolds prior to subcutaneous implantation in the 
Wistar rat model, significant increases in angiogenesis and adipogenesis were observed at 
both 8 and 12 weeks169. In addition, the allogeneic ASCs were shown to promote a more 
pro-regenerative macrophage response, which may have contributed to the enhanced 
adipose tissue regeneration observed169. Together, these studies provide a strong case for 
applying the DAT as a tissue-specific bioscaffold for adipose tissue regeneration.  
The DAT can also be fabricated into other forms of bioscaffolds, such as microcarriers, 
gels and composite hydrogels, which have also shown similar pro-adipogenic effects on 
human ASCs in culture as the intact DAT scaffolds254,255. Microcarriers can be produced 
by first digesting the DAT with enzymes to create an ECM suspension, which can be 
electrosprayed into liquid nitrogen to form microcarriers257. Previous in vitro studies have 
shown that human ASCs expanded on these DAT microcarriers showed enhanced 
adipogenic capacity relative to ASCs expanded on TCPS, with elevated adipogenic gene 
expression and intracellular lipid accumulation after 2 weeks in culture in adipogenic 
differentiation medium257.  
In addition to microcarriers, adipose tissue can also be decellularized and fabricated into 
injectable gels258,259. Previous work by Wang et al. demonstrated that the solubilized 
human adipose tissue matrix stimulated host cell infiltration when injected 
subcutaneously in Fischer rats for 30 days181. Additionally, when this scaffold was seeded 
with human ASCs and injected into nude rats, blood vessel formation and adipose tissue 
remodeling were observed in the scaffolds as early as 2 weeks and continued to be 
present at 8 weeks258. In a similar study, adipose tissue matrix hydrogels fabricated from 
lipoaspirates that were seeded with human ASCs and injected subcutaneously in nude 
mice showed an increase in macrophage infiltration as early as 1 week and an increase in 
blood vessel and adipose tissue formation at 4 weeks when compared to unseeded 
hydrogels259.  
DAT can also be fabricated into composite hydrogels for adipose tissue engineering 
applications255. For example, previous work from the Flynn lab investigated DAT 
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particles encapsulated with human ASCs within methacrylated chondroitin sulfate (MCS) 
hydrogels255. Adipogenic differentiation in vitro was enhanced in the hydrogel 
composites at 7 and 14 days relative to ASCs encapsulated in the MCS alone260. In 
addition, when similar composite hydrogels were delivered subcutaneously into Wistar 
rats, blood vessel formation and adipose tissue remodeling were observed within the 
implanted hydrogels at 12 weeks255.  
Collectively, these studies demonstrate that DAT scaffolds hold promise as pro-
adipogenic scaffolds for adipose tissue engineering, and that in vivo regeneration can be 
enhanced by combining them with ASCs. 
1.7 Cell preconditioning strategies  
ASCs have shown promise for a broad range of cell therapy applications and there has 
been emerging interest in the development of in vitro preconditioning strategies to 
enhance their pro-regenerative functionality prior to in vivo delivery261–267. More 
specifically, preconditioning strategies can involve culturing the cells within a controlled 
environment that provides specific biochemical and/or biomechanical cues that can help 
guide the cells to respond in a desired manner261. For example, preconditioning strategies 
may involve treatment with specific factors to promote lineage-specific differentiation 
towards the goal of replacing cell populations within damaged tissues268. Alternatively, 
ASCs can also be preconditioned to enhance their expression of paracrine factors and 
cytokines that can promote angiogenesis and modulate the immune response, to indirectly 
support tissue regeneration269. Given that there is a growing body of evidence to support 
that this is the primary mechanism for ASC-mediated regeneration, this section will focus 
on preconditioning approaches that harness bioactive factors, oxygen tension and/or 
mechanical stimulation to enhance the pro-regenerative paracrine functionality of ASCs.  
1.7.1 Application of bioactive factors to precondition ASCs 
Treatment with bioactive factors can be a powerful approach to stimulate MSC 
populations including ASCs to express higher levels of various pro-regenerative growth 
factors and cytokines261,262,268. For example, MSCs that were cultured in medium 
supplemented with TGF-β1 for 24 h produced higher levels of VEGFA compared to 
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controls and increased vessel formation when delivered into isolated rat cardiac tissue ex 
vivo262. In another culture study, the pro-inflammatory cytokine TNF-α was used to 
precondition ASCs for 3 days, which resulted in increased cell migration, proliferation 
and expression of BMP-2268. A study by Baer et al. compared the paracrine effects of 
preconditioning mouse ASCs in either TNF-α or epidermal growth factor (EGF) for 48 h 
and demonstrated that each upregulated the secretion of different paracrine factors and 
cytokines261. Preconditioning mouse ASCs with TNF-α upregulated the expression of IL-
10 and interleukin 11 (IL-11), whereas EGF preconditioning upregulated the expression 
of HGF and bFGF261. While these approaches have shown promise, these bioactive 
factors can be costly, which could limit the scalability of these strategies for clinical 
applications.  
1.7.2 Effects of hypoxic preconditioning on ASCs 
Oxygen tension can also regulate the paracrine response of pro-regenerative cell 
populations111,262,265,270,271. Cells that are grown in culture under atmospheric conditions 
are generally exposed to a hyperoxic environment, as the oxygen tension in most tissues 
in the human body is significantly lower than 21%272. Within adipose tissue, the normal 
oxygen tension typically ranges between 7 – 9%, with an oxygen tension less than 5% 
considered to be hypoxic273,274.   
At the molecular level, the intracellular protein hypoxia inducible factor 1-alpha (HIF-1α) 
is degraded following the hydroxylation of oxygen-dependent prolyl hydroxylase under 
physiological normoxic states275–277 (Figure 1.2). Under hypoxia, this degradation 
pathway is inhibited, leading to the stabilization of HIF-1α and the activation of the Akt 
and P38 mitogen-activated protein kinase (MAPK) pathways that drive cell proliferation 
and paracrine factor secretion278,279.  
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Figure 1.2 Normoxic oxygen tension leads to the degradation of HIF-1α, whereas 
hypoxia leads to the stabilization and nuclear translocation of this transcription 
factor, leading to the expression of pro-angiogenic factors and immunomodulatory 
cytokines.  
In MSCs, hypoxia (1-3% O2) has been shown to increase cell proliferation263. More 
specifically, a previous study demonstrated that when mouse bone marrow-derived MSCs 
were cultured at 3% O2, they entered the exponential expansion phase earlier than 
controls cultured under 21% O2280. Similarly, when human ASCs were cultured at 2% O2, 
the cells exhibited greater gene expression of the stem cell markers REX14, SOX2, OCT4, 
NANOG, and were more proliferative, with the effects mediated through HIF-1α 
activation281. Moreover, the modulation of cell proliferation through HIF-1α-dependent 
mechanisms was further supported by a study by Kakudo et al., who demonstrated that 
HIF-1α expression led to increased bFGF expression in human ASCs, which accelerated 
cell proliferation282.  
In addition to proliferation, HIF-1α activation can also enhance the secretion of pro-
angiogenic factors in cultured MSC populations263,283. For example, a study by Chen et 
al. showed that culturing human bone marrow-derived MSCs at 2% O2 increased VEGFA 
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secretion through a HIF-1α dependent mechanism283. Additionally, when human 
placenta-derived MSCs were preconditioned under 2% O2 for 3 days, the conditioned 
media from these cell cultures was found to contain elevated levels of TGF-β1, insulin-
like growth factor 1 (IGF-1), HGF, VEGFA and bFGF269. This study also demonstrated 
when these preconditioned cells were delivered into cutaneous wounds in Goto-Kakizaki 
rats, the rate of wound closure was enhanced, with a 90% decrease in wound area as 
compared to only 40% in the control group at 15 days269. In addition, studies have shown 
that culturing rat bone marrow-derived MSCs at 5% O2 increased the expression of HGF, 
bFGF and PDGF-B through a HIF-1α mediated mechanism also involving the activation 
of Akt284,285. 
In addition to pro-angiogenic growth factors, hypoxia can also upregulate 
immunomodulatory cytokine expression in MSC populations including ASCs261. 
Previous studies have shown that when human bone marrow-derived MSCs were 
cultured in 2% O2 for 3 days, the cells expressed higher levels of the pro-angiogenic 
factors VEGFA and bFGF as well as the pro-inflammatory cytokines IL-6 and IL-8283.  
Furthermore, studies have also shown that culturing fetal human astrocytes under 2% O2 
can increase the expression of pro-inflammatory cytokines such as IL-8 and MCP-1 
through a HIF-1α-mediated mechanism286.   
The increased secretion of pro-angiogenic factors and immunomodulatory cytokines as a 
result of hypoxic preconditioning has been harnessed to promote adipose tissue 
regeneration265,287. For example, a study by Hsiao et al. showed that the conditioned 
media from human ASCs cultured under 0.1% O2 for 3 days had a greater effect on 
stimulating angiogenesis at 2 weeks following subcutaneous delivery in C57BL/6 mice 
relative to control media prepared with ASCs cultured under 21% O2111. In another study, 
rat ASCs that were cultured under 0.5% O2 for 2 days were found to be better than 
control cells cultured under 21% O2 at supporting the vascularization of fat flap grafts in 
Lewis rats over 7 days288.  
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1.7.3 ASC response to mechanical stimulation 
Mechanical stimulation, including shearing forces from fluid flow, can provide important 
biomechanical cues that guide the secretory behaviour of ASCs289–291. These cues can 
activate mechanosignalling pathways through tensegrity, integrin-mediated 
mechanotransduction and membrane fluidity292. Tensegrity-mediated mechanosensing 
takes place when a mechanical force applied on the cell leads to changes in the 
cytoskeleton, which transmits the signal to the nucleus293. Integrin-mediated signaling 
generally involves the activation of the extracellular domains of integrins, which triggers 
the phosphorylation and activation of focal adhesion kinase (FAK)-mediated intracellular 
pathways294. Membrane fluidity is a mechanosensing mechanism by which shearing 
forces can induce a change in membrane viscosity, which also leads to the activation of 
mechanotransduction pathways294.  
Mechanical stimulation often results in the activation of the MAPK and c-Jun N-terminal 
kinase (JNK) pathways295,296, which can trigger a range of cellular responses including 
migration, differentiation and paracrine factor secretion138,297,298. A study from Yuan et 
al. showed that inhibiting JNK and p38 inhibited the migration of human bone marrow-
derived MSCs that is typically induced by fluid flow296. In the context of biomaterials, 
the application of shearing forces was shown to enhance the mobilization of human ASCs 
on acellular blood vessel grafts299. More specifically, when the human ASCs were seeded 
and perfused through the lumen of the vessel graft, migration was enhanced and the cells 
aligned in the direction of the fluid flow299.  
The application of shearing forces can also promote paracrine factor secretion in MSC 
populations. A previous study demonstrated that when human bone marrow-derived 
MSCs were cultured under fluid flow at 2 Pa, increased VEGFA expression was observed 
relative to static culture controls290. Additionally, studies have shown that shearing forces 
can stimulate the production of NO, which can act in an autocrine loop to increase the  
expression of VEGFA289. A recent study by Becquart et al. further supported this 
observation and showed that the NO production during shearing stress was mediated 
through the extracellular signal-regulated kinase 1/2 (ERK1/2) intracellular signaling 
28 
 
pathway291. Collectively, these studies support that shearing forces can be applied to 
precondition ASCs to enhance their expression of pro-angiogenic factors.  
1.8 3-D bioreactor systems for tissue engineering 
Bioreactors are systems that allow for the close monitoring and control of biological 
processes. Parameters that can be regulated within these systems include pH, 
temperature, pressure and oxygenation, which generates a highly controlled environment 
for cell growth300. A range of bioreactors have been explored for both MSC expansion 
and tissue engineering applications including spinner flask systems, rotating wall 
bioreactors, and perfusion bioreactor systems.  
1.8.1 Spinner flask systems 
Spinner flask systems allow for the culturing of cell-seeded bioscaffolds in suspension or 
fixed within a holding device, with stirring of the culture media controlled through an 
impellor (Figure 1.3A)300. Spinner flask bioreactors can increase the efficiency and 
uniformity of cell seeding on scaffolds, which may be favorable for tissue 
regeneration301–303. For example, previous studies have shown that the seeding efficiency 
of chondrocytes on PGA scaffolds was 70% greater when a spinner flask system was 
used as compared to static culturing304. Spinner flasks have also been successfully 
applied for human bone marrow-derived MSC expansion on 3-D polymer microcarriers, 
while maintaining their immunophenotype and capacity for tri-lineage differentiation 
potential305. Additionally, previous work from the Flynn lab also showed that spinner 
flask bioreactor systems could be used to culture and expand human ASCs on DAT 
microcarriers, while maintaining their potential for adipogenic differentiation in vitro254. 
More recently, the spinner flask system were also demonstrated to better support ASC 
expansion on the DAT than commercially available Cultispher-S microcarriers following 
28 days of culture257. Together, spinner flask bioreactors have been shown to be an 
effective 3-D culture system for MSC expansion. However, studies to date have not yet 
explored whether spinner flasks could also be applied as preconditioning systems to 
increase the pro-regenerative functionality of cultured cell populations. One potential 
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limitation is that the stirring motion in spinner flask bioreactor systems can result in 
heterogenous shear stresses being applied, which may lead to variable cell properties306. 
1.8.2 Rotating wall bioreactor systems 
Rotating wall bioreactor systems can also be used to expand regenerative cell 
populations. Within rotating wall vessels,  the culture media, cells and scaffolds are 
placed in between two concentric cylinders (Figure 1.3B)300. The vessel is then placed 
horizontally, and the cells and scaffolds are maintained in a constant state of suspension 
by the competing forces of gravity and the stirring caused by the rotation of the outer 
cylindrical wall307. The rotation of the outer wall can generate a low amount of shear 
forces, which can modulate cell functions including proliferation and differentiation308. 
For example, one previous study showed that epithelial cells cultured on synthetic ECM-
coated beads in a rotating wall vessel proliferated well and formed multi-layer cell 
aggregates307. Furthermore, cells cultured on these synthetic beads could be digested and 
dynamically cultured under a bead-free environment within the rotating wall vessel307. 
Rotating wall bioreactors have also been used to expand MSCs309. Nishi et al. showed 
that rabbit bone marrow-derived MSCs seeded on a porous PLA bead scaffold cultured 
within a rotating wall bioreactor proliferated and showed evidence of being primed for 
osteogenic differentiation309. Moreover, a study by Chen et al. showed that human bone 
marrow-derived MSCs cultured in a rotating wall vessel bioreactor expanded 
significantly faster than statically cultured controls after 16 days in vitro306. Additionally, 
a study by Ben-David et al. demonstrated that human bone marrow-derived MSCs could 
be cultured on gelatin microspheres within a rotating wall bioreactor, and when 
implanted subcutaneously in athymic nude mice could support in vivo osteogenesis at 8 
weeks88. Overall, while rotating wall vessel bioreactors are a promising expansion 
platform for pro-regenerative cell populations, to date these systems have been primarily 
applied for bone tissue engineering applications.  
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Figure 1.3 Schematic of A) spinner flask and B) rotating wall vessel bioreactor 
systems. Image re-printed with permission from publisher300. 
1.8.3 Perfusion bioreactor systems 
Perfusion bioreactors are systems that circulate media via pumps through porous 
scaffolds housed within customized chambers, with the goal of enhancing nutrient 
delivery and waste removal throughout the 3-D constructs300. Relative to static cultures, 
perfusion bioreactors can offer greater control over the media conditions and oxygen 
tension experienced by cells within scaffolds300,310. Perfusion of the media also applies 
shear stress, which can modulate cell function311–313.  
Perfusion bioreactor systems have been investigated for a range of applications in tissue 
engineering to support the proliferation of pro-regenerative cell populations within 
scaffolds310,312,314–317. While media perfusion can potentially enhance proliferation, the 
fluid flow rate must be carefully refined to prevent newly secreted factors and ECM 
components from being rapidly removed310. In previous studies, perfusion bioreactors 
have been shown to maintain a constant oxygen tension within the perfused regions of 
scaffolds, and increase the uniformity of attached cells318. Another study using a two-
stage perfusion bioreactor optimized for nutrient delivery and waste removal showed that 
human ESCs seeded on polyethylene-terephthalate (PET) scaffolds and cultured in this 
system maintained their stem cell phenotype and also expanded significantly faster than 
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cells grown in spinner flask systems314. Moreover, a recent study by Papadimitropoulos et 
al. showed that human bone marrow-derived MSCs seeded on ceramic-based 
bioscaffolds in an oscillating perfusion bioreactor system attached and proliferated under 
perfusion, while maintaining their immunophenotype and trilineage differentiation 
capacity312. Further, the cells that were cultured in the perfusion bioreactor were 
demonstrated to express more immunomodulatory cytokines including IL-8, C-X-C motif 
chemokine 5 (CXCL-5) and C-X-C motif chemokine 6 (CXCL-6) than 2-D and static 
culture controls312.  
Perfusion bioreactor systems have also been explored as a strategy to enhance the 
differentiation of MSC populations313,319–323. More specifically, the shearing forces 
applied to cells within these systems can potentially be harnessed to help direct MSCs 
towards the osteogenic lineage319,323–325. A previous study demonstrated that when PLGA 
scaffolds seeded with MSCs were perfused in an oscillating bioreactor for 21 days, the 
cells exhibited greater mRNA expression of key osteogenic genes relative to static culture 
controls326. This observation was supported by the work of Alvarez-Barreto et al., who 
showed intracellular calcium accumulation in rat bone marrow-derived MSCs that were 
seeded on an RGD-conjugated PLA scaffold and perfused in a bioreactor at a rate of 1 
mL/min for 8 days313. Interestingly, a study conducted with a hollow-fibre bioreactor 
showed that when ASCs were perfused within this system, they could be induced to 
differentiate towards the adipogenic lineage over 3 weeks of culture327.  
1.9 In vivo adipose tissue regeneration 
Adipose tissue regeneration within engineered bioscaffolds in vivo is a multistep process 
that involves the interaction of diverse cell populations. One of the first key stages is an 
angiogenic response that results in the development of a vascular network to support 
seeded and infiltrating cell populations328. These newly-established vessels can facilitate 
the recruitment of immune cells and other pro-regenerative cell populations that 
contribute to scaffold remodeling and tissue regeneration329. The next sections will 
discuss current understanding of angiogenesis, macrophages and adipogenesis in the 
context of adipose tissue regeneration.  
32 
 
1.9.1 Angiogenesis in soft tissue regeneration  
Angiogenesis is a key step in achieving soft tissue regeneration. The development of a 
vascular network is required for the delivery of oxygen and nutrients, and enables the 
recruitment of pro-regenerative host cell populations328,330. When tissue-engineered 
implants remain poorly vascularized, it can lead to the death of delivered cell populations 
and tissue necrosis, impeding regeneration48.  
Broadly, sprouting angiogenesis is a multistep process that includes vessel sprouting, 
lumen formation and finally anastomosis331. More specifically, vessel sprouting involves 
outgrowth of endothelial cells from the existing vasculature in response to biochemical 
cues within the local microenvironment332–334. Subsequently, lumen formation and 
extension takes place, where endothelial cells proliferate and migrate as the length of the 
newly-formed vessels increases335. These new extensions also form lumens that resemble 
endothelial tubes. Finally, anastomosis leads to the fusion of existing sprouts, and allows 
vascularization and blood flow to be fully established in these newly-built blood 
vessels331.  
Vessel sprouting typically begins with existing blood vessels within the target site. 
Endothelial cells from these existing vessels send out extensions known as filopodia336, 
which are crucial in sensing and responding to biochemical cues within the 
microenvironment332. The filopodia on these leading endothelial cells, termed tip cells, 
can respond and extend to the presence of pro-angiogenic growth factors, such as bFGF 
and VEGFA332,337, and can be repelled by angiogenic inhibitory proteins, such as 
semaphorin338. The combination of these biochemical attractants and repellents guides 
the direction of the sprouting. Endothelial cell proliferation occurs, with stalk cells 
trailing the endothelial tip cell, resulting in extension of the sprouts and ultimately lumen 
formation339.  
As endothelial sprouts continue to extend, the stalk cells will begin the process of 
forming a unicellular lumen339. These unicellular lumens will eventually become a 
multicellular vessel, as the sprouts continue to extend in length. Although the precise 
mechanisms of lumen formation have not been clearly delineated, it is possible that 
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lumen formation can be achieved through an intracellular hollowing process, where 
endothelial cells generate a hollow vacuole, and eventually fuse with the hollow vacuoles 
in neighbouring endothelial cells to form an extended hollow lumen340.  
Anastomosis is a multistep process where connections are built between the developing 
vessels resulting in the formation of functional vasculature331. During anastomosis, the 
filopodia from neighbouring tip cells interact to establish a stable connection via cell 
junctions331. Once connected, these tip cells deposit basement membrane to support and 
guide lumen connection341.  
During soft tissue regeneration, newly-formed capillaries will continue to expand in 
length and diameter. Stabilization is required for the long-term viability of these newly-
formed and growing vessels333. Endothelial tube stabilization is achieved, primarily, by 
pericytes. Pericytes are recruited to endothelial tubes by pro-angiogenic factors, such as 
angiopoietin 1 (Ang-1), VEGFA and PDGF-BB342–345. Among these factors, PDGF-BB 
can lead to an increased expression of stromal cell-derived factor 1 (SDF-1) from 
endothelial cells, which is a potent chemoattractant for pericytes344. Studies have shown 
that when platelet-derived growth factor receptor beta (PDGFR-β) that is specific for 
PDGF-BB is inhibited, vessel growth and stabilization are stalled346. Moreover, when 
both vascular endothelial growth factor receptor 1 (VEGFR-1) and PDGFR-β are 
inhibited, the ability of pericytes to stabilize vessels is also blocked347. Collectively, this 
supports the importance of VEGFA and PDGF-BB signaling in initiating and supporting 
vessel stabilization. Once the connection between endothelial cells and pericytes is 
established, remodeling of the basement membrane occurs through the action of secreted 
MMPs and TIMPs to support the stabilized vessel348,349.  
ASCs can play a critical role in mediating angiogenesis by secreting key paracrine 
factors. As previously discussed in Section 1.4.2, ASCs can secrete HGF, VEGFA and 
bFGF under hypoxia269,284,285, which can guide vessel sprouting and promote endothelial 
tube extension. SDF-1 with Ang-1 and PDGF-B secreted from ASCs leads to the 
recruitment of pericytes to stabilize the extending endothelial tubes269,284,285 (Figure 1.4).  
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Figure 1.4 Schematic showing the role of paracrine factors secreted by ASCs in 
mediating endothelial tube elongation and the recruitment of supporting pericytes 
to stabilize blood vessels. (1) ASCs initiate vessel sprouting by first secreting paracrine 
factors such as VEGFA, HGF and bFGF, which drive endothelial cell proliferation and 
tube elongation. (2)  Endothelial cells can secrete SDF-1, in combination with PDGF and 
Ang-1 from ASCs, to recruit pericytes to stabilize the newly formed endothelial tube.  
1.9.2 Role of macrophages in mediating soft tissue regeneration  
Although early work considered macrophages as a phagocytic cell population that was a 
barrier to regeneration, recent studies have shown that this diverse cell population plays 
essential roles in mediating soft tissue repair and regeneration350. In particular, 
macrophages can modulate regenerative responses through the secretion of cytokines, 
angiogenic growth factors and MMPs351. The macrophage secretion profile is highly 
dependent on the stage of the inflammatory/regenerative response352.  
Macrophages are highly plastic cells that historically have been classified as having the 
capacity to be polarized towards either a pro-inflammatory M1-subtype or a pro-
regenerative M2-subtype351. However, recent evidence supports that there are a wide 
range of macrophage subpopulations that exist on a spectrum between these two 
extremes, and can often exhibit characteristics of both the M1-subtype and 
M2-subtype353,354. To better categorize the diversity of macrophages involved in tissue 
regeneration, a new classification system has been proposed, which is based on the factor 
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that activates the macrophages355. For example, M(IFN-γ) denotes pro-inflammatory 
macrophages that are activated by IFN-γ. This macrophage population can also be 
identified by the co-stimulatory molecule CD80356,357. M(IL-4) denotes pro-regenerative 
macrophages activated by interleukin 4 (IL-4), and finally M(IL-10) denotes pro-
regenerative macrophages that are activated by IL-10355. The M(IL-10) macrophage 
population can be identified by the hemoglobin scavenger receptor CD163358. 
Monocytes and tissue-resident macrophages that are initially recruited to the target tissue 
site are typically polarized towards a more pro-inflammatory macrophage phenotype359. 
These populations are crucial in initiating tissue repair and regeneration359. For example, 
previous studies suggest that depleting monocytes and dendritic cells immediately 
following renal injury delays tissue regeneration360. These infiltrating monocytes are 
activated by IFN-γ, which can be secreted by ASCs128,129 and innate immune cells, such 
as natural killer cells361, to polarize toward a M(IFN-γ) phenotype355,362 (Figure 1.5). 
These pro-inflammatory macrophages can subsequently release cytokines such as TNF-α, 
interleukin 1 beta (IL-1β), IL-6 and interleukin-12 (IL-12), which promotes the 
recruitment of further immune cells, such as neutrophils and eosinophils363. Moreover, 
these cytokines can act in an autocrine fashion to polarize more infiltrating monocytes 
toward a pro-inflammatory phenotype364. A previous study in a hindlimb injury model in 
rabbits suggested these pro-inflammatory macrophages are important in stimulating 
vascularization, as the infiltrating macrophages were shown to express TNF-α and bFGF, 
suggesting they were both pro-inflammatory and pro-angiogenic365.  
Pro-inflammatory M(IFN-γ) macrophages can promote an increase in M(IL-4) 
macrophages, as IL-6 secreted by M(IFN-γ) macrophages can upregulate the expression 
of interleukin 4 receptor (IL-4R)366. These M(IL-4) macrophages can often exhibit both 
pro-inflammatory and pro-regenerative characteristics and can mediate pro-regenerative 
processes (Figure 1.5). More specifically, this macrophage subpopulation was shown to 
secrete VEGFA and PDGF-B to support angiogenesis351. Further, these cells also secrete 
TGF-β1, which can act on fibroblasts to stimulate matrix deposition367. In addition, these 
M(IL-4) macrophages are also capable of remodeling the matrix through the secretion of 
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MMP-2, matrix metalloproteinase 9 (MMP-9) and matrix metalloproteinase 13 
(MMP-13)368.  
Following the initial inflammatory response, macrophages can be polarized toward a 
more pro-regenerative phenotype through the secretion of IL-10 by Th2 and Treg cells359. 
Moreover, M(IL-10) macrophages can further secrete IL-10, which generates an 
autocrine loop that further promotes a more anti-inflammatory response (Figure 1.5). 
Overall, the increased expression of IL-10 contributes to the resolution of tissue 
inflammation and establishes a microenvironment that is more conducive for tissue repair 
and regeneration369.  
 
Figure 1.5. Schematic highlighting the roles of pro-inflammatory and pro-
regenerative macrophages in mediating tissue regeneration. Inflammatory mediators, 
such as IFN-γ, present at the target site polarize infiltrating monocytes and tissue resident 
macrophages towards a pro-inflammatory phenotype. These pro-inflammatory 
macrophages secrete additional chemokines and cytokines to further increase the 
accumulation of pro-inflammatory cells. The increase in pro-inflammatory mediators 
promotes an increase in pro-regenerative macrophage populations that can secrete growth 
factors and cytokines to increase angiogenesis and ECM remodeling. Once the early 
inflammatory response subsides, IL-10 secreted from T cells mediates an anti-
inflammatory response from the macrophages. Image re-printed with permission from the 
publisher362.  
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1.9.3 Adipogenesis in soft tissue regeneration  
Adipose tissue formation and expansion under physiological states can be achieved 
through hyperplasia and hypertrophy370–372. Hyperplastic expansion involves increasing 
the number of adipocytes in response to a need to store lipid, whereas hypertrophic 
expansion refers to an increase in the size of existing adipocytes373. It is important to note 
that both mechanisms of adipose tissue expansion require existing adipocytes. In the 
context of adipose tissue engineering, fat tissue formation is often required in target sites 
without existing adipocytes. As such, different mechanisms of adipogenesis are involved 
during adipose tissue remodeling and regeneration within engineered scaffolds, at least 
during the early stages of the process.  
As previously discussed, while delivering mature adipocytes and adipogenic-induced 
ASCs have been investigated as a way to provide immediate adipocytes to the target 
tissue, it is unclear if these exogenous cells are maintained or form stable adipocytes over 
the long-term190,234,244. Alternatively, de novo adipose tissue formation in the context of 
adipose tissue engineering has been speculated to be initiated by the recruitment of host-
derived cells. One interesting study by Stillaert et al. delivered human fat grafts that were 
embedded in Matrigel® into the groin of severe combined immunodeficient (SCID) 
mice234. At 6 weeks post implantation, host-derived adipose tissue formation was 
observed, whereas limited adipogenesis was observed in control implants without the 
human fat graft. Moreover, host-derived blood vessels were observed in the SVF of the 
implanted fat234. These observations support that cell populations in the SVF are 
pro-angiogenic, and may be responsible for the recruitment of host cells that formed the 
adipocytes. Interestingly, a study by Rodeheffer et al. showed that a CD29+CD34+ cell 
population present in the SVF that were also stem cell antigen 1 (Sca-1)+ and CD24+ 
possesses the capacity to support adipogenesis in vivo, and therefore, could be an 
adipocyte precursor population374. Additionally, Shook et al. demonstrated that this 
adipocyte precursor population are also CD26+, and can be recruited to wounded dermal 
tissue to facilitate tissue repair375. Given its proximity to dermal tissue, it is plausible that 
this adipocyte precursor population could also play a role in subcutaneous adipose tissue 
regeneration.    
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Finally, there is some evidence that macrophages could also be a potential source of 
adipocytes during tissue regeneration. Previous in vitro studies showed that when 
macrophages were co-cultured with human adipocytes and ASCs, the macrophages 
accumulated intracellular lipid droplets102. This study provided initial evidence that 
macrophages could be directly involved in de novo adipogenesis. More recently, work 
from the Flynn lab group showed that infiltrating CD163+ host macrophages expressed 
the adipogenic markers perilipin and adiponectin  in ASC-seeded DAT implants in an 
immunocompetent rat model169. While these studies provide evidence for a possible 
direct role of macrophages in adipose tissue formation, additional studies are required to 
more fully understand the involvement of these cell populations in adipose tissue 
regeneration.  
1.10 Project overview 
DAT is a promising adipo-inductive biomaterial for applications in adipose tissue 
engineering that can support regenerative processes such as angiogenesis and 
adipogenesis227. Further, previous studies indicate that combining DAT scaffolds with 
allogeneic ASCs can augment adipose tissue regeneration in an immunocompetent Wistar 
rat model by enhancing angiogenesis, adipogenesis, and modulating the host macrophage 
response169,255.  
While the delivery of ASCs on DAT bioscaffolds has shown potential for stimulating 
tissue regeneration, limitations of previous work include the static seeding and culture 
methods employed that result in a heterogenous distribution of ASCs predominantly on 
the surface of the scaffolds. Perfusion bioreactor systems represent a promising approach 
to promote cell expansion and infiltration on 3-D scaffolds. In the second chapter of this 
doctoral thesis, a perfusion bioreactor strategy for culturing human ASCs on DAT 
scaffolds was developed. Using this system, the effects of both shear stress stimulation 
and hypoxic preconditioning were explored both in vitro and in vivo, with the goal of 
enhancing angiogenesis and adipose tissue regeneration within the DAT. In the third 
chapter, the effects of dynamic culturing of the human ASCs on the DAT scaffolds under 
hypoxic conditions (2% O2) within the perfusion bioreactor system were assessed 
through comparison to static culture controls. In particular, these studies focused on 
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exploring the impact of shear stress stimulation induced by bioreactor culture on the ASC 
phenotype and paracrine function through in vitro culture studies. Further, in vivo 
characterization was performed to probe whether dynamic culture of the ASCs on the 
DAT altered host cell recruitment into the implants, with a focus on angiogenesis and the 
host macrophage response. Finally, in the fourth chapter, the development of an 
alternative and more scalable rocking bioreactor platform was explored as a possible 
strategy to precondition the ASCs to enhance their pro-regenerative paracrine 
functionality. More specifically, the effects of dynamic culture on the rocking platform in 
combination with DAT coatings on human ASC phenotype and pro-regenerative marker 
expression were assessed as a first step to assess the potential of this new approach.  
1.11 Hypothesis and specific aims 
The underlying hypothesis for this work is that dynamic culture of human ASCs on DAT-
based biomaterials can enhance their capacity to stimulate regeneration by altering their 
paracrine factor expression profile, which will contribute to enhanced host-derived 
angiogenesis and adipogenesis within DAT implants. 
To test this hypothesis, three specific aims have been formulated: 
1. To apply dynamic culture of human ASCs on DAT bioscaffolds within a 3-D 
perfusion bioreactor system to enhance ASC expansion in vitro and angiogenesis and 
adipogenesis within DAT implants in vivo.  
2. To characterize how dynamic culture of human ASCs on the DAT bioscaffolds within 
the perfusion bioreactor system enhances the capacity of the ASCs to stimulate soft 
tissue regeneration via paracrine-mediated mechanisms. 
3. To develop a novel rocking bioreactor platform to dynamically culture ASCs on 
DAT-based coatings to promote a more pro-regenerative ASC phenotype. 
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Chapter 2  
2 Perfusion bioreactor culture of adipose-derived stromal 
cells on decellularized adipose tissue scaffolds 
enhances in vivo regeneration 
2.1 Abstract 
Adipose tissue engineering holds promise to address the unmet need in plastic and 
reconstructive surgery for strategies that promote the stable and predictable regeneration 
of adipose tissue for volume augmentation applications. Previous studies have 
demonstrated that decellularized adipose tissue (DAT) scaffolds can provide a pro-
adipogenic microenvironment, and that seeding with adipose-derived stromal cells 
(ASCs) can enhance in vivo angiogenesis and adipogenesis within DAT implants. 
Recognizing that bioreactor systems can promote cell expansion and infiltration on 
tissue-engineered scaffolds, this study evaluated the effects of culturing human ASCs on 
DAT scaffolds within a perfusion bioreactor. Using this system, the impact of both shear 
stress stimulation and hypoxic preconditioning were explored in vitro and in vivo.  Initial 
studies compared the effects of 14 days of culture within the perfusion bioreactor under 
2% O2 or ~20% O2 on human ASC expansion and hypoxia inducible factor 1 alpha 
(HIF-1α) expression in vitro relative to static cultured controls. The findings indicated 
that culturing within the bioreactor under 2% O2 significantly increased ASC 
proliferation on the DAT, with a higher cell density observed in the scaffold periphery. 
HIF-1α expression was significantly higher when the scaffolds were cultured under 2% 
O2. Subsequent characterization in a subcutaneous implant model in athymic nude mice 
revealed that in vivo angiogenesis and adipogenesis were markedly enhanced when the 
ASCs were cultured on the DAT within the perfusion bioreactor under 2% O2 for 14 days 
prior to implantation relative to the other culture conditions, as well as additional freshly-
seeded and unseeded DAT control groups.  Overall, culture within the perfusion 
bioreactor system under hypoxia represents a promising approach for preconditioning 
ASCs on DAT scaffolds to enhance their capacity to stimulate blood vessel formation 
and infiltration, as well as host-derived adipose tissue regeneration. 
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2.2 Introduction 
The subcutaneous adipose tissue layer plays important structural and functional roles 
within the integumentary system1. Due to the limited capacity of adipose tissue for self-
repair, damage or loss resulting from trauma, burns, tumour resections, disease or aging 
can alter the normal body contours and result in scarring, deformities and loss of 
function376. While reconstruction can have a major positive impact on self-image and 
quality of life, there are numerous limitations to the existing clinical interventions that 
rely on tissue transfer from other sites on the body or on current implants used for volume 
augmentation18,377.  
Adipose tissue engineering represents a promising approach to address the unmet clinical 
need in plastic and reconstructive surgery for strategies that can promote the stable 
regeneration of healthy host-derived soft tissues27,378. Towards this goal, our lab has 
pioneered the development of off-the-shelf bioscaffolds derived from human 
decellularized adipose tissue (DAT), demonstrating that they provide a pro-adipogenic 
microenvironment both in vitro and in vivo227,253. DAT contains a diverse array of 
extracellular matrix (ECM) components, including a variety of matricellular proteins, 
small leucine-rich proteoglycans (SLRPs), growth factors and chemokines256 that may 
have bioactive effects on seeded and infiltrating host cell populations. Moreover, the 
DAT has similar biomechanical properties to native human fat246,247, which may be 
favorable for both implant integration and adipogenic differentiation245,253.  
Previously, seeding the DAT with allogeneic adipose-derived stromal cells (ASCs) 
enhanced angiogenesis and adipogenesis within the implants in an immunocompetent 
Wistar rat model169. More specifically, our study suggested that the ASCs indirectly 
contributed to host-derived adipose tissue regeneration through paracrine mechanisms, 
rather than through long-term engraftment and differentiation. It is well-established that 
ASCs secrete a variety of pro-regenerative growth factors and cytokines that can promote 
the recruitment of host progenitor cells, stimulate angiogenesis, and modulate the 
response of infiltrating immune cell populations, to help coordinate tissue 
regeneration106,146,379.  
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A key limitation to the previous approach was that the static seeding and culture methods 
employed resulted in low cellular infiltration and a heterogeneous distribution of the 
ASCs within the dense ECM of the DAT, which may have limited their long-term 
survival and functionality following in vivo implantation. As such, the primary goal of 
this study was to explore the potential of dynamic culture as a strategy to enhance human 
ASC expansion, infiltration and pro-regenerative function on the DAT bioscaffolds. In 
particular, perfusion bioreactors represent a promising approach for promoting cell 
growth on 3-D bioscaffolds by enhancing nutrient delivery and waste removal380,381. 
Further, the shear forces applied by these systems can modulate cell phenotype and 
function290,291,296,382, which may alter their capacity to stimulate regeneration. 
In the current experimental design, human ASCs were pre-seeded on the DAT under 
dynamic conditions on an orbital shaker and then transferred into a custom-designed 
perfusion bioreactor system and cultured for 14 days. As oxygen tension has been shown 
to modulate ASC survival287, proliferation282, differentiation271,281, and pro-angiogenic 
factor production106,111,283 through the regulation of hypoxia inducible factor-1 alpha 
(HIF-1α)282,284,285, the effects of culturing the cells under both normoxic (~20% O2) and 
hypoxic (2% O2) conditions were explored. The selection of 2% O2 was based on studies 
showing enhanced ASC expansion in vitro at this level271,383. Initial studies focused on 
characterizing human ASC distribution, proliferation, and HIF-1α expression in vitro 
relative to control scaffold groups cultured under static conditions. Subsequently, in vivo 
testing was performed to probe the effects of dynamic culture within the perfusion 
bioreactor on human ASC retention, angiogenesis and adipogenesis within a 
subcutaneous implant model in athymic nude (nu/nu) mice relative to static cultured, 
freshly-seeded and unseeded DAT scaffold controls.  
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2.3 Methods 
2.3.1 Materials 
Unless otherwise stated, all chemicals and reagents were purchased from Sigma Aldrich 
Canada Ltd. (Oakville, Canada), and all antibodies were purchased from Abcam 
(Cambridge, USA).  
2.3.2 Adipose tissue processing  
Subcutaneous adipose tissue was collected with informed consent from elective breast 
reduction or abdominoplasty surgeries at the University Hospital and St. Joseph’s 
Hospital in London, Canada. All studies were approved by the Human Research Ethics 
Board at Western University (HREB# 105426). The tissues were transported on ice in 
sterile phosphate buffered saline (PBS) with 2% bovine serum albumin (BSA) and 
processed within 2 h of collection for ASC isolation238 or DAT scaffold fabrication253 
using published protocols. Processed DAT was pooled from multiple tissue donors for all 
subsequent experiments. 
ASCs were cultured in proliferation medium comprised of DMEM:Ham’s F12 
supplemented with 10% fetal bovine serum (FBS) (Wisent, St. Bruno, Canada) and 100 
U/mL penicillin/0.1 mg/mL streptomycin (1% pen-strep) (ThermoFisher, Waltham, 
USA) at 37°C with 5% CO2 and ~20% O2. Freshly isolated cells were passaged at 80% 
confluence, and passage 3 (P3) cells were used in all studies. 
Following decellularization, the DAT was lyophilized and cut into scaffolds with a mass 
of 8 ± 1 mg. In preparation for seeding, the DAT scaffolds were rehydrated in deionized 
water for 24 h and then decontaminated by repeated rinsing in 70% ethanol. Next, the 
scaffolds were rinsed in sterile PBS and incubated in proliferation medium for 24 h.   
2.3.3 Scaffold seeding and bioreactor setup  
To seed the scaffolds, 1 x 106 P3 human ASCs were combined with individual DAT 
scaffolds in 3 mL of proliferation medium within 15 mL vented cap conical tubes 
(CellTreat Scientific Products, Pepperell, USA). The tubes were transferred into an 
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incubator and agitated on an orbital shaker at a 15° incline and 100 RPM for 24 h (37°C, 
5% CO2). Following seeding, the scaffolds were transferred into culture inserts that could 
be positioned within the individual sample chambers of the customized perfusion 
bioreactor system (Tissue Growth Technologies, Instron) (Appendix Figure A.1). The 
cell-seeded scaffolds were cultured under a flow rate of 0.5 mL/min for 14 days in 
proliferation medium under either normoxic (~20% O2: 5% CO2/95% air) or hypoxic 
(5% CO2/93% N2/2% O2) conditions, controlled through the use of a tri-gas incubator 
(ThermoFisher Forma Series II 3130), at 37°C. Static control scaffolds were included by 
culturing within the inserts under static conditions within vented cap conical tubes. 
2.3.4 Assessment of ASC density and distribution 
After 14 days of culture, scaffold samples were collected (n=4 replicate scaffolds/trial, 
N=3 trials with different ASC donors) for analysis of total cell density using the Quant-
iT® PicoGreen® dsDNA Assay Kit (ThermoFisher, Waltham, USA). For all trials, control 
groups were included of freshly-seeded (collected after the 24 h dynamic seeding phase) 
and unseeded DAT scaffolds. The scaffolds were finely minced with surgical scissors and 
digested in 1 mL of 4 mg/mL collagenase (Worthington Type I) in Kreb’s Ringer Buffer 
supplemented with 1% BSA, 2 mM glucose, and 25 mM HEPES under agitation at 100 
RPM on an orbital shaker for 1 h at 37°C. The digested scaffolds were then centrifuged 
for 10 min at 1200 xg at room temperature, resuspended in Tris-EDTA buffer (10 mM 
Tris base, 1 mM EDTA, pH 8), and briefly sonicated using an ultrasonic dismembrator 
(ThermoFisher Model 100). The samples were then centrifuged at 5000 xg for 10 min at 
room temperature to remove debris, and the supernatant was analyzed using the 
PicoGreen® Assay kit according to the manufacturer’s instructions using a CLARIOstar® 
microplate reader (BMG Labtech, Guelph, Canada). All plates included a standard curve 
generated with known numbers of ASCs to estimate the total number of ASCs per 
scaffold.  
To corroborate the PicoGreen® data, the density of ASCs on the scaffolds was also 
assessed after 14 days of culture through quantification of DAPI staining (n=3, N=3). 
Scaffold samples were fixed in 4% paraformaldehyde for 24 h at 4°C before being 
embedded in paraffin and cut into 7 µm sections. Three non-adjacent cross-sections 
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100 µm apart were stained with DAPI, mounted and imaged with an EVOS® FL Cell 
Imaging System (ThermoFisher) under the 20X objective. DAPI+ cells from 10 randomly 
selected non-adjacent fields from each scaffold cross-section were quantified using 
ImageJ software.   
Hematoxylin & eosin (H&E) staining was also performed on scaffold cross-sections 
following standard procedures to assess the cell distribution within the DAT scaffolds 
after 14 days of culture. The samples were visualized using an EVOS® XL Cell Imaging 
System (ThermoFisher). 
2.3.5 Immunohistochemical analysis of Ki-67 and HIF-1α 
expression 
Immunohistochemical staining was performed on additional scaffold sections (3 non-
adjacent sections at least 100 µm apart/scaffold; n=3, N=4) to examine the expression of 
Ki-67 as a proliferation marker and HIF-1α to probe potential changes under hypoxia. 
Heat-mediated antigen retrieval was performed in target antigen retrieval solution 
(pH=6.0) (Agilent, Santa Clara, USA) for 25 min. The slides were allowed to cool for 25 
min and then washed in PBS and blocked in PBS-T (0.1% Tween-20) supplemented with 
10% goat serum for 1 h at room temperature. Sections were then incubated with rabbit 
anti-Ki-67 antibody (1:100 dilution) or mouse anti-HIF-1α antibody (Novus Biologicals, 
Oakville, Canada; 1:100 dilution) overnight at 4°C. Alexa Fluor® 594 conjugated goat 
anti-rabbit (1:100 dilution) or Alexa Fluor® 680 conjugated goat anti-mouse (1:100 
dilution) secondary antibody was subsequently applied for 1 h at room temperature and 
the samples were mounted in Fluoroshield Mounting Medium with DAPI (Abcam, 
Cambridge, USA). Mouse skin tissues and hypoxically cultured human ASCs were used 
as positive controls for Ki-67 and HIF-1α, respectively, and no primary antibody controls 
were included in all trials. Stained sections were visualized with the EVOS® FL Cell 
Imaging System, and 10 randomly selected non-adjacent fields of view from both the 
peripheral (< 200 µm from the scaffold edge) and central (>200 µm from the scaffold 
edge) regions of the scaffolds were imaged under the 20X objective. The number of 
Ki-67+DAPI+ cells and HIF-1α+DAPI+ within each region were quantified using ImageJ 
Software. 
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2.3.6 Subcutaneous implantation surgeries  
Following the in vitro testing, studies were performed to assess the effects of bioreactor 
culture on the capacity of the human ASCs to stimulate in vivo angiogenesis and 
adipogenesis within the DAT scaffolds. More specifically, these studies compared 6 
scaffold groups including the ASC-seeded scaffolds that had been cultured for 14 days 
within the perfusion bioreactor or under static conditions at both 20% and 2% O2 (i.e. (i) 
20% O2 static, (ii) 20% O2 dynamic, (iii) 2% O2 static, (iv) 2% O2 dynamic) to (v) 
freshly-seeded (after the 24 h seeding phase) and (vi) unseeded DAT scaffold controls. 
For each scaffold group, duplicate samples were implanted for each trial and a total of 3 
trials were performed using ASCs isolated from 3 different donors. All studies followed 
the Canadian Council on Animal Care (CCAC) guidelines and the protocols were 
approved by the Animal Care Committee at Western University (Protocol # 2015-049).  
The scaffolds were implanted subcutaneously in female Nu-Foxn1nu mice (Charles River 
Laboratories, Sherbrooke, Canada) that were 10-13 weeks of age for 4 and 8 weeks. A 
total of 36 mice were used for this study (N=6 mice per scaffold group at each timepoint). 
The mice were anaesthetized with isoflurane and given pre-operative analgesics via 
subcutaneous injections of meloxicam (2 mg/kg loading dose; 1 mg/kg follow up dose at 
24 h) and bupivacaine (2 mg/kg). Two small incisions (~7 mm) were made on the dorsa 
of each mouse below each scapula, and pockets were created using blunt-ended forceps. 
One scaffold was then carefully positioned within each pocket and the incisions were 
closed with surgical staples. At each timepoint, the mice were euthanized by CO2 
overdose and the scaffolds were excised within their surrounding tissues. The samples 
were fixed in 4% paraformaldehyde overnight at 4°C, prior to paraffin embedding and 
sectioning (7 µm thick) in preparation for histological and immunohistochemical 
analyses. For all staining analyses, 3 cross-sections per implant (N=6 per time point) 
were analyzed that were a minimum of 100 µm apart. 
2.3.7 Masson’s trichrome staining 
Masson’s trichrome staining was performed using standard procedures to assess implant 
integration and remodeling, as well as the density of erythrocyte-containing blood vessels 
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within the scaffolds. The entire scaffold cross-section in each sample was imaged using 
the EVOS® XL Cell Imaging System at 20X magnification and combined into a single 
cross-sectional image using Adobe® Photoshop® CS6 Software. Within each complete 
cross-section, the number of erythrocyte-containing blood vessels was quantified within 
the DAT implant to determine the overall blood vessel density. Further, the distance to 
the closest scaffold edge and diameter were measured for each vessel using ImageJ 
Software. Vessel infiltration within 500 µm of the scaffold surface was analyzed using 
frequency distribution graphs with a bin size of 25 µm. 
2.3.8 Immunohistochemical analysis of perilipin expression 
At both timepoints, immunohistochemical staining was performed to assess perilipin 
expression as a marker of adipocyte formation within the DAT implants. The sections 
were prepared as described in section 2.3.5 and incubated overnight in rabbit anti-
perilipin A antibody (1:200 dilution) at 4°C, followed by a goat anti-rabbit HRP-
conjugated secondary antibody (1:500 dilution) for 1 h at room temperature. The samples 
were then processed with a DAB peroxidase (HRP) substrate kit (Vector Labs, 
Burlington, Canada), followed by counterstaining with hematoxylin and mounting with 
Permount® Mounting Medium (ThermoFisher, Waltham, USA). Mouse adipose tissues 
were used as a positive control, and no primary antibody controls were included in all 
trials. The entire scaffold region was imaged at 10X magnification and stitched into a 
single cross-sectional image as previously described. Positive pixel counting was 
performed to analyze the relative perilipin expression levels between the implant groups, 
with the values normalized to the total scaffold area within each cross-section measured 
using ImageJ Software. 
2.3.9 Immunohistochemical analysis of human ASC engraftment 
and differentiation  
To detect the human ASCs within the DAT implants, cross-sections were stained for 
human-specific Ku80384 using a rabbit anti-Ku80 antibody (Cedarlane, Burlington, 
Canada; 1:100 dilution) followed by Alexa Fluor® 594 conjugated goat anti-rabbit (1:200 
dilution) secondary antibody using methods described in section 2.3.5. Tissue positive 
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and no primary antibody controls were included in all trials. The stained cross-sections 
were imaged using the EVOS® FL Cell Imaging System. Quantification of Ku80+DAPI+ 
cells was performed on 10 randomly selected non-overlapping fields of view taken at 
20X magnification using ImageJ analysis software.   
To probe whether the human ASCs were differentiating into adipocytes within the DAT 
implant region, co-staining was performed using rabbit anti-perilipin A antibody as an 
adipocyte marker in combination with a mouse anti-human mitochondria (hMito) 
antibody conjugated with Cy3 (EMD Millipore, Burlington, USA; 1:100 dilution). hMito 
was used as an alternative to Ku80 based on the availability of antibodies compatible for 
co-staining. The samples were incubated overnight at 4°C and then incubated for 1 h at 
room temperature with a goat anti-rabbit secondary antibody conjugated with Alexa 
Fluor® 680 (1:100 dilution). The stained sections were visualized with the EVOS® FL 
Cell Imaging System and imaged under 20X magnification.  
2.3.10 Statistical analysis 
All numerical values are represented as the mean ± standard deviation. Statistical 
analyses were performed using GraphPad Prism® version 6 by one way or two-way 
ANOVA and followed by a Tukey’s post-hoc test. Differences were considered 
statistically significant at p<0.05. 
2.4 Results 
2.4.1 Dynamic culturing in the bioreactor under hypoxic conditions 
for 14 days enhanced ASC density on the DAT bioscaffolds 
To quantitatively assess cell density on the DAT, the scaffolds were digested and 
analyzed with the PicoGreen® dsDNA Assay. Freshly-seeded scaffolds had an average of 
1.49 ± 0.19 x 105 cells per scaffold following the 24 h seeding period. After 14 days of 
culture, the total cell density was significantly higher in the 2% O2 dynamic group as 
compared to the freshly-seeded scaffolds and the 20% O2 static and 2% O2 static groups 
(Figure 2.1A). DAPI staining showed similar patterns in terms of the ASC density on the 
DAT scaffolds, corroborating the PicoGreen® results (Figure 2.1B).  
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To complement the quantitative findings, H&E staining was performed to assess the ASC 
distribution within the DAT scaffolds following the 14-day culture period. The ASCs 
were predominantly localized to the surface of the DAT scaffolds in the samples that 
were cultured under static conditions at both 20% and 2% O2 (Figure 2.1C). A higher 
density of ASCs was observed in the scaffolds cultured for 14 days within the bioreactor, 
with a dense cell layer observed along the surface of the scaffolds. Consistent with the 
PicoGreen® results, the 2% O2 dynamic group appeared to have a qualitatively higher 
density of cells, with greater infiltration into the central scaffold regions.  
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Figure 2.1 ASC density was enhanced on the DAT scaffolds following 14 days of 
culture within the perfusion bioreactor under 2% O2. A) Average number of 
ASCs/scaffold based on total dsDNA content following 14 days of culture. Dashed line 
represents the average cell density in the freshly-seeded group. Error bars represent 
standard deviation (n=4 replicate scaffolds, N=3 trials with different ASC donors). B) 
The average number of ASCs per mm2 of the DAT bioscaffold as measured by DAPI 
quantification following 14 days of culture. Error bars represent standard deviation (n=3 
cross-sections/scaffold, N=3 trials with different ASC donors). * = 2% O2 dynamic is 
significantly different than 20% O2 static and 2% O2 static group (p<0.05). C) 
Representative H&E staining showing the distribution of ASCs on the DAT scaffolds 
following 14 days of culture. Scale bars represent 100 µm.   
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2.4.2 Dynamic culturing in the bioreactor under hypoxic conditions 
for 14 days enhanced Ki-67 expression in the scaffold 
periphery 
Immunostaining identified a low density of Ki-67+DAPI+ cells distributed throughout the 
scaffolds at 14 days. Qualitatively, there appeared to be more Ki-67+DAPI+ cells in the 
2% O2 dynamic group, with a higher density in the scaffold periphery (Figure 2.2A). 
Representative images of the central scaffold regions are shown in Appendix Figure A.2. 
These observations were confirmed by quantification of the number of Ki-67+DAPI+ cells 
within the peripheral (< 200 µm from edge) and central  (> 200 µm from edge) regions of 
the scaffolds, which revealed that there was a significantly higher density of 
Ki-67+DAPI+ cells in the periphery in the 2% O2 dynamic group as compared to both the 
peripheral and central regions of all other culture conditions. Additionally, a greater 
density of Ki-67+DAPI+ cells was measured in the central region of 2% O2 dynamic 
group as compared to the central region of 2% O2 static group (Figure 2.2B).   
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Figure 2.2 Ki-67 expression at 14 days was enhanced in the ASCs dynamically 
cultured on the DAT scaffolds within the perfusion bioreactor under 2% O2. A) 
Representative images showing Ki-67+ cells (red) counterstained with DAPI (blue) in the 
peripheral regions of the scaffolds after 14 days of culture. White arrowheads denote 
positively labelled cells and dashed lines represents the edge of the bioscaffolds. Scale 
bars represent 100 µm. B) The average number of Ki-67+DAPI+ cells in the peripheral 
and central regions of the scaffolds at 14 days. Error bars represent standard deviation 
(n=3 cross-sections/scaffold, N=4 trials with different ASC donors). * = significant 
difference between 2% O2 dynamic group and all other groups, # = significant difference 
between the central region of 2% O2 dynamic and 2% O2 static groups (p<0.05).  
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2.4.3 Culturing under hypoxia increased the number of HIF-1α+ 
cells within the scaffolds at 14 days  
Immunohistochemical staining revealed that there were very few HIF-1α+DAPI+ cells in 
both the peripheral (< 200 µm from edge) and central (> 200 µm from edge) regions of 
the scaffolds cultured either dynamically or statically for 14 days under 20% O2 (Figure 
2.3A). In contrast, HIF-1α expression was observed in the majority of the cells in the 
2% O2 static and dynamic groups. Representative images of the central scaffold regions 
are shown in Appendix Figure A.3. Quantification of the staining indicated that the 
density of HIF-α+DAPI+ cells was significantly higher in the 2% O2 dynamic group as 
compared to all other groups within both the peripheral and central scaffold regions 
(Figure 2.3B). In addition, the density of HIF-1α+ DAPI+ cells was also significantly 
greater in the 2% O2 static group as compared to the 20% O2 static and dynamic groups 
within both the peripheral and central scaffold regions (Figure 2.3B). 
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Figure 2.3 HIF-1α expression was enhanced at 14 days in the ASCs cultured on the 
DAT scaffolds under 2% O2. A) Representative immunostaining showing HIF-1α+ 
ASCs (green) counterstained with DAPI (blue) in the peripheral (< 200 µm from the 
edge) regions of the scaffolds following 14 days of culture. Scale bars represent 100 µm. 
Dashed lines represent the border of the bioscaffolds. B) The average number of HIF-
1α+DAPI+ cells in the peripheral and central regions of the scaffolds at 14 days. Error 
bars represent standard deviation (n=3 cross-sections/scaffold, N=4 trials with different 
ASC donors). * = significant difference between the peripheral region of the 2% O2 
dynamic group and both the central and peripheral regions of all other groups , # = 
significant difference between the central region of the 2% O2 dynamic group and the 
central region of all other conditions, Δ = significant difference between the 2% O2 static 
group as compared to the 20% O2 static and 20% O2 dynamic groups in both regions 
(p<0.05).   
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2.4.4 DAT scaffolds cultured within the bioreactor for 14 days 
under hypoxic conditions showed enhanced blood vessel 
formation at 4 and 8 weeks following subcutaneous 
implantation 
In vivo studies were subsequently performed using a subcutaneous implantation model in 
nu/nu mice to compare angiogenesis and adipogenesis in the scaffolds that had been 
cultured for 14 days within the bioreactor or statically (20% O2 static, 20% O2 dynamic, 
2% O2 static, 2% O2 dynamic) to freshly-seeded and unseeded controls. Masson’s 
trichrome staining at 4 and 8 weeks revealed that the scaffolds were well integrated into 
the host tissues and showed evidence of implant remodeling (Figure 2.4A). Small blood 
vessels and adipocytes were observed in the peripheral regions of the DAT implants 
starting at 4 weeks. At 8 weeks, more vessels were observed in the 2% O2 dynamic group 
as compared to all other conditions, along with a greater number of adipocytes extending 
into the more central scaffold regions (Figure 2.4A).    
Quantification of the number of erythrocyte-containing blood vessels in the scaffolds 
revealed that there was a significantly higher vessel density in the 2% O2 dynamic group 
as compared to all other conditions at 8 weeks (Figure 2.4B), with a significant difference 
between the two timepoints for this group. The diameter of the erythrocyte-containing 
blood vessels was also measured, with results indicating that there were no significant 
differences in the average diameter between the groups at both 4 and 8 weeks, with an 
average diameter in the range of ~25 - 35 µm (Appendix Figure A.4A). 
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Figure 2.4 The density of erythrocyte-containing blood vessels was enhanced at 4 
and 8 weeks in the DAT scaffolds that were cultured in the bioreactor under 2% O2 
for 14 days prior to subcutaneous implantation in nu/nu mice. A) Representative 
Masson’s trichrome staining of the DAT implants at 8 weeks, with black arrowheads 
highlighting erythrocyte-containing blood vessels within the scaffolds. Scale bars 
represent 100 µm. B) Density of erythrocyte-containing blood vessels within the 
scaffolds at 4 and 8 weeks. Error bars represent standard deviation (n=3 cross-
sections/implant, N=6 implants/group). * = 2% O2 dynamic group at 8 weeks is 
significantly different compared to all other groups at 8 weeks (p<0.05).  
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Blood vessel infiltration was also probed by measuring the shortest distance from each 
vessel to the scaffold periphery. No significant difference in the average distance of blood 
vessel infiltration was measured between the groups at 4 weeks, with the average values 
ranging from ~70 - 125 µm and a high degree of variability observed (Appendix Figure 
A.4B). At 8 weeks, the average distance of vessel infiltration was significantly higher in 
the 2% O2 dynamic group (198.8 ± 32.1 µm) as compared to all other groups with the 
exception of the 20% O2 static (100.7 ± 38.3 µm) and 20% O2 dynamic (125.1 ± 46.6 
µm) groups.  
Vessel infiltration within 500 µm of the scaffold surface was further analyzed by 
frequency distribution plots with pooled counts of the total number of vessels within 
25 µm intervals for each of the scaffold groups (Figure 2.5). Based on this analysis, an 
increase in the number of vessels within the first 100 µm of the scaffolds was observed in 
the 2% O2 dynamic and static groups at 4 weeks, suggesting that hypoxic culture 
promoted vessel formation in the scaffold periphery. At 8 weeks, a shift towards greater 
infiltration (i.e. rightwards) was observed for both the 2% O2 dynamic and 20% O2 
dynamic groups, suggesting that dynamic culture enhanced the number of vessels 
infiltrating into the 100 – 200 µm depth range, with a higher number of vessels in the 2% 
O2 dynamic group in this range, as well as farther into the scaffolds. Interestingly, the 
distributions for the freshly-seeded and unseeded groups were similar at both timepoints, 
indicating that the ASCs had little impact on vessel formation within the DAT under the 
conditions in this study. While the distribution for the 20% O2 static group was similar to 
these groups at 4 weeks, an increase in the number of vessels within the first 50 µm was 
observed in this group at 8 weeks, suggesting that there was some benefit of culturing the 
ASCs on the scaffolds prior to implantation in terms of vessel formation within the most 
peripheral regions of the DAT scaffolds (Figure 2.5).   
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Figure 2.5 Frequency distribution plots showing the total number of erythrocyte-
containing blood vessels at increasing depths from the scaffold periphery within the 
DAT implants. Coloured lines represent non-linear Gaussian fits of the data sets. Pooled 
data is shown representing the combined counts from 3 cross-sections at varying depths 
from 6 implants per condition at both 4 and 8 weeks.   
 
2.4.5 DAT scaffolds cultured within the bioreactor for 14 days 
under hypoxic conditions showed enhanced adipose tissue 
remodeling at 8 weeks following subcutaneous implantation 
Immunohistochemical staining for perilipin was performed to identify adipocytes 
containing intracellular lipid as a measure of adipose tissue formation within the 
implanted scaffolds at 4 (Appendix Figure A.5) and 8 weeks (Figure 2.6A). At 4 weeks, a 
small number of adipocytes were observed within the peripheral regions of the scaffolds 
in all of the groups. At 8 weeks, there were qualitatively more adipocytes in the scaffolds 
that incorporated ASCs as compared to the earlier timepoint, with more perilipin+ cells 
observed in the 2% O2 dynamic group as compared to all other conditions.  
Semi-quantitative image analysis confirmed that the relative levels of perilipin expression 
within the implant region were similar between the groups at 4 weeks (Figure 2.6B). In 
contrast, at 8 weeks, the 2% O2 dynamic group showed significantly greater perilipin 
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expression levels as compared to all other groups at both 4 and 8 weeks, with a 
significant increase observed within this group from 4 to 8 weeks. Collectively, these 
findings are indicative of enhanced remodeling of the DAT implant into adipose tissue in 
the 2% O2 dynamic condition. (Figure 2.6B).  
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Figure 2.6 Remodeling of the DAT into adipose tissue was enhanced in the 2% O2 
dynamic group at 8 weeks following subcutaneous implantation in the nu/nu mouse 
model. A) Representative immunostaining showing regions of perilipin+ adipocytes 
(brown) within the implanted scaffolds at 8 weeks. Scale bars represent 100 µm. B) The 
expression of perilipin relative to the unseeded group at 4 weeks. Error bars represent 
standard deviation (n=3 cross-sections/implant, N=6 implants/group). * = significant 
difference between the 2% O2 dynamic group at 8 weeks and all other groups at both 4 
and 8 weeks, as well as the 2% O2 dynamic group at 4 weeks (p<0.05).   
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2.4.6 Human ASCs were detected in the DAT implants at similar 
levels at both 4 and 8 weeks  
Immunohistochemical staining was performed for human-specific Ku80 to identify 
human ASCs within the DAT implants at both 4 (Appendix Figure A.6) and 8 weeks 
(Figure 2.7A). Ku80+ cells were visualized throughout the seeded scaffolds at both 
timepoints. Quantification of the number of Ku80+DAPI+ cells within the scaffold 
regions revealed that there were no significant differences in the density of human ASCs 
detected between the seeded implant groups at both 4 and 8 weeks (Figure 2.7B).  
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Figure 2.7 Ku80+ cell density was similar between all seeded groups at both 4 and 8 
weeks post-implantation. A) Representative immunostaining showing Ku80 labelled 
cells (red) counterstained with DAPI (blue). Scale bars represent 100 µm. B) Bar graph 
showing the density of Ku80+DAPI+ ASCs in the implants at 4 and 8 weeks. Data was 
compiled from 6 implants per group (N=6), with 3 cross-sections per scaffold taken from 
varying depths and 10 random fields analyzed per cross-section. Error bars represent 
standard deviation. 
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2.4.7 No evidence of human ASC differentiation into adipocytes in 
vivo  
Co-staining with a human anti-mitochondrial (hMito) antibody in combination with 
perilipin was performed to probe human ASC differentiation into adipocytes within the 
DAT implants. No perilipin+hMito+ cells were identified, indicating that the 
newly-forming adipocytes within the DAT implants were predominantly host-derived 
(Figure 2.8).  
 
Figure 2.8  Staining patterns suggest that the human ASCs did not differentiate into 
adipocytes within the DAT implants over 8 weeks. Representative image showing 
distinct hMito+ (red) and perilipin+ (green) cell populations with DAPI (blue) 
counterstaining. White arrowheads indicate human ASCs in close proximity to perilipin+ 
cells. Scale bars represent 50 µm. 
2.5 Discussion 
New strategies that can promote the regeneration of healthy host-derived adipose tissue 
and enable stable and predictable volume augmentation would be of great value for a 
broad range of applications in plastic and reconstructive surgery. With the long-term goal 
of advancing towards clinical translation, the Flynn lab has been developing a broad 
range of off-the-shelf bioscaffolds derived from the ECM of human adipose 
tissue227,229,253,255,385. Previous in vivo study exploring DAT scaffolds in a subcutaneous 
implant model in immunocompetent rats indicated that seeding the DAT with allogeneic 
rat ASCs significantly enhanced blood vessel formation and remodeling of the DAT into 
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host-derived adipose tissue169. In that study, the DAT scaffolds were seeded with the 
ASCs within tissue culture inserts and then cultured statically for 72 h to promote cell 
attachment. However, these static seeding and culture methods result in a heterogeneous 
and sparse distribution of ASCs on the relatively dense intact DAT scaffolds, with limited 
cell infiltration into the central scaffold regions. Therefore, a higher density and more 
even distribution of cells throughout the scaffold may be favorable for enhancing the rate 
and extent of adipose tissue regeneration within the DAT. Further, in the current study, 
human ASCs were used as a more clinically relevant cell population.  
Dynamic culture methods can enhance cell proliferation and infiltration into 3-D porous 
scaffolds by promoting the exchange of nutrients and waste, as well as by providing 
mechanical stimulation that can modulate cell function300,386,387. Stirred culture systems, 
such as spinner flasks, have been most extensively explored for the expansion of 
mesenchymal stromal cell (MSC) populations including ASCs, incorporating a range of 
microcarrier types to support cell attachment and growth257,301,388–392. Using an alternative 
design, Papadimitropoulos et al. investigated the use of a ceramic scaffold-based 
perfusion bioreactor for human bone marrow-derived MSC expansion312, and Kim and 
Ma applied a perfusion bioreactor system for the expansion of human MSCs from bone 
marrow on polyethylene terephthalate (PET) scaffolds319. In general, the overall goal in 
these strategies was to harness the benefits of dynamic culture within a 3-D system to 
better preserve MSC function in terms of their capacity to proliferate and differentiate 
towards the adipogenic, osteogenic and/or chondrogenic lineages, as compared to the 
progressive functional decline that is observed when the cells are expanded on 2-D tissue 
culture polystyrene under static conditions257,393. The cells expanded within these systems 
can typically be released, such as through enzymatic digestion, and subsequently 
incorporated within a range of delivery platforms depending on the application of 
interest303,394. 
In the current study, an integrated approach was applied using a custom 3-D perfusion 
bioreactor to expand the human ASCs on the same DAT scaffold on which they would be 
delivered. While similar perfusion bioreactor strategies have been explored for bone 
tissue engineering applications using biomaterials with properties that mimic bone303,394, 
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to the best of our knowledge this is the first study to investigate the use of a scaffold-
based perfusion bioreactor for adipose tissue regeneration. Culturing within the perfusion 
bioreactor system was shown to enhance the cell density within the peripheral regions of 
the DAT scaffolds, with a more marked effect in the samples that were cultured under 2% 
O2. These findings supporting the benefits of perfusion culture are similar to a previous 
study using a double chamber perfusion bioreactor that demonstrated that media 
perfusion enhanced bone marrow-derived MSC homogeneity within decellularized 
porcine tracheal scaffolds395. Additionally, a study by Sailon et al. showed that that the 
density of MC3T3-E1 murine pre-osteoblastic cells was enhanced on porous 
polyurethane scaffolds when cultured within a perfusion bioreactor system as compared 
to static controls, with the cells typically localized in the more porous regions of the 
scaffolds316. The enhanced cell density within the peripheral regions of the DAT suggests 
that there may have been limited media perfusion into the central regions of the scaffolds 
over time, which is a potential limitation. Regardless, the in vivo findings clearly support 
that culturing the ASCs on the DAT within the perfusion bioreactor under 2% O2 
significantly augmented angiogenesis and adipogenesis within the implants, supporting 
the benefits of the approach.  
Based on the PicoGreen® and Ki-67 staining results, culturing under dynamic conditions 
within the bioreactor stimulated ASC proliferation on the DAT. Interestingly, there was 
no benefit of culturing the scaffolds under static conditions for 14 days in terms of the 
total cell number per scaffold relative to the freshly-seeded group. In addition to 
promoting ASC proliferation, bioreactor culture may have enhanced long-term cell 
survival387,396, contributing to the higher cell density observed. Further, the media used in 
this study contains both mitotic factors as well as potent chemotactic factors397,398 that 
may have promoted cell migration from the scaffold interior to the more highly perfused 
periphery.  
The ASCs cultured both statically and dynamically under 2% O2 were also shown to 
express HIF-1α, consistent with hypoxia in adipose tissue being < 5% O2273,274. HIF-1α 
activation is associated with MSC proliferation279,399, which may have contributed to the 
enhanced Ki-67 expression in the hypoxic dynamic group. A previous study by Choi et 
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al. demonstrated that culturing human ASCs under 2% O2 increased proliferation relative 
to culture under ~21% O2 through HIF-1α-mediated mechanisms281. In a more recent 
study, human ASCs  were found to be more proliferative when cultured under 1% O2 as 
compared to 2% O2 for 7 days282. Moreover, the increased proliferation was shown to be 
mediated through the HIF-1α-dependent upregulation of bFGF282. In addition to 
stimulating proliferation, HIF-1α is an important transcription factor that regulates the 
expression of a range of angiogenic growth factors400. As such, it is possible that 
culturing under 2% O2 may have modulated the paracrine factor secretion profile of the 
ASCs within the DAT, which would be interesting to explore in future work.  
Following in vitro characterization, in vivo testing was performed to assess the effects of 
bioreactor culture on the capacity of the ASCs to promote angiogenesis and adipogenesis 
within the DAT. Athymic nude mice, which have been used in a number of adipose tissue 
engineering studies159,165,176,189,259,401–403, were applied to enable the investigation of 
human ASCs. Angiogenesis was probed by quantifying the number of erythrocyte-
containing blood vessels within the implants, indicative of functional vasculature.  
Previously in the rat model, seeding the DAT with allogeneic rat ASCs resulted in an 
increase in the number and diameter of erythrocyte-containing blood vessels within the 
implants starting at 8 weeks169. In the current study, the vessel density was significantly 
higher in the 2% O2 dynamic group at 8 weeks as compared to all other conditions. Since 
the ASC density at 14 days was significantly higher in this group, it is possible that 
enhanced cell delivery may have contributed to increased angiogenesis. A study by Al-
Khaldi et al. demonstrated there was a dose-dependent increase in in vivo blood vessel 
formation at 28 days when varying densities of mouse MSCs (up to 2 x 106 cells/mL) 
were delivered subcutaneously in Matrigel in C57BL/6 mice404. In addition to vessel 
density, the increased blood vessel infiltration observed in the hypoxic bioreactor group 
could be an indicator of an enhanced vessel sprouting effect. Previous studies have shown 
that vascular endothelial growth factor A (VEGFA) and bFGF are key paracrine factors 
that are crucial in driving vessel sprouting283, which are secreted by ASCs at enhanced 
levels under hypoxia284,285. Moreover, there is also evidence to support that MSCs 
subjected to shear stress induced by dynamic culturing systems can show enhanced 
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VEGFA secretion290,296. As discussed, it would be worthwhile to explore the effects of 
dynamic culture on the DAT on ASC phenotype and paracrine function in future studies.  
In addition to enhanced angiogenesis, culturing the ASCs on the DAT within the 
bioreactor under 2% O2 for 14 days prior to implantation resulted in a significant increase 
in the number of perilipin+ adipocytes within the implants at 8 weeks as compared to all 
other groups, consistent with enhanced remodeling of the DAT into adipose tissue. 
Adipose tissue regeneration is typically a gradual process that is coupled with 
angiogenesis, as a rich vascular supply is required to support mature adipocytes405,406. In 
previous rat study, seeding the DAT with allogeneic rat ASCs enhanced adipogenesis 
within the implants at both 8 and 12 weeks169. However, the response at 8 weeks was 
quite variable, with 20.1 ± 15.3% of the seeded DAT having remodeled into mature fat, 
as compared to 3.9 ± 5.7% in the unseeded group, based on area analysis of Masson’s 
trichrome stained cross-sections169. The lack of difference observed between the other 
ASC-seeded groups in the current study relative to the unseeded controls may be related 
to species variability in terms of both the ASC source and animal model employed, as 
well as to differences in the ASC dose delivered. In addition, it is possible that further 
differences would be observed between the groups at later timepoints. Regardless, the 
present findings clearly demonstrate that dynamic culture of human ASCs on the DAT 
within the perfusion bioreactor under 2% O2 significantly augmented both angiogenesis 
and adipogenesis within the implants at 8 weeks, supporting the use of this new strategy 
for adipose tissue regeneration. 
While the density of ASCs was higher on the 2% O2 dynamic scaffolds at the time of 
implantation, there were no significant differences between the groups in terms of the 
number of human ASCs detected within the implants at both 4 and 8 weeks. It is possible 
that the enhanced vascularization observed in the bioreactor-cultured samples may have 
contributed to this decline by promoting the recruitment of immune cell populations such 
as monocytes/macrophages that may recognize the human ASCs as being foreign. In 
previous rat study, using fluorescence in situ hybridization (FISH) to track the allogeneic 
ASCs sourced from male donors via the Y-chromosome, a progressive reduction in the 
number of donor cells within the DAT implants was observed over time, with only a 
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small number of donor ASCs visualized at 8 weeks and no positive cells detected at 12 
weeks, indicating that the newly-formed adipose tissues were predominantly host-
derived169. Similarly, Parisi-Amon et al. showed that mouse ASCs delivered 
subcutaneously in nude mice within a peptide-based hydrogel showed an 80% reduction 
in exogenous cells after 7 days in vivo based on bioluminescence imaging407. 
Additionally, a more recent study using a poly(N-isopropylacrylamide)-polyethylene 
glycol co-polymer to encapsulate human ASCs demonstrated ~13% retention at 14 days 
following subcutaneous delivery in athymic nude mice408. The persistence of a relatively 
high density of human ASCs in the current study at 8 weeks in all of the seeded groups 
suggests that the DAT may provide a supportive platform for their delivery. The 
functional role of these cells remains unclear, but the staining patterns suggest that there 
was limited differentiation into adipocytes. It would be interesting to explore how long 
these cells persist in future studies, as well as probing differences in possible paracrine-
mediated effects at later timepoints including host adipogenic progenitor cell recruitment. 
2.6 Conclusions 
The perfusion bioreactor system represents a novel and promising platform for the 
dynamic expansion of pro-regenerative cell populations on 3-D bioscaffolds for adipose 
tissue engineering, and also an advancement towards a clinically viable strategy to 
support adipose tissue regeneration. The findings in this study demonstrated that the 
perfusion bioreactor system is effective at increasing the density of ASCs on the DAT, 
which suggests that it could address the previous limitations of the ASC-seeded DAT 
bioscaffolds. Increasing the ASC density on the DAT bioscaffolds via culturing within 
the perfusion bioreactor system under hypoxia subsequently translated into an enhanced 
capacity to support blood vessel formation and adipose tissue remodeling in vivo. 
Collectively, the body of work in the present study provided support for the use of a 
perfusion bioreactor system to increase the pro-regenerative potential of the ASC-seeded 
bioscaffolds. Moving forward, future studies should explore the mechanisms through 
which the ASC-seeded DAT supports angiogenesis and adipogenesis in vivo as the next 
step towards developing a clinically translatable subcutaneous adipose tissue regeneration 
strategy.      
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Chapter 3  
3 Dynamic culture of human adipose-derived stromal 
cells on decellularized adipose tissue scaffolds 
modulates ASC paracrine factor expression and 
promotes a robust pro-regenerative host response 
3.1 Abstract 
Adipose-derived stromal cells (ASCs) have shown great promise as a pro-regenerative 
cell population that can be combined with decellularized adipose tissue (DAT) scaffolds 
to promote adipose tissue regeneration. Previous studies have shown that culturing 
human ASCs on DAT scaffolds within a perfusion bioreactor under 2% O2 can 
significantly enhance in vivo angiogenesis and adipogenesis within the DAT. The focus 
of the current study was on exploring how dynamic culture within the bioreactor over 14 
days modulated the phenotype and paracrine function of the ASCs on the DAT relative to 
controls cultured under static conditions. Multi-colour flow cytometry analysis of 
enzymatically-digested scaffolds indicated that there were no significant differences in 
the ASC immunophenotype between the groups. Immunohistochemical analyses 
suggested that shear stress stimulation induced by dynamic culture modulated the ASC 
response within the peripheral regions of the DAT, promoting the expression of inducible 
nitric oxide synthase (iNOS) and tumour necrosis factor alpha (TNF-α). Moreover, a 
greater fraction of the ASCs within this region co-expressed iNOS and arginase-1 
(Arg-1), as well as TNF-α and interleukin 10 (IL-10). Gene and protein expression 
analyses indicated that dynamic culturing modulated the expression of a range of pro-
angiogenic and immunomodulatory factors in the ASCs on the DAT, suggesting that their 
capacity to stimulate regeneration via paracrine mechanisms may be altered. In vivo 
studies comparing the response of the two groups in a subcutaneous implant model in 
athymic nude mice showed that culturing the ASCs on the DAT within the perfusion 
bioreactor prior to implantation enhanced the infiltration of CD31+ endothelial cells and 
CD26+ host cells into the DAT. While no significant difference was observed in total 
macrophage recruitment between the groups, there was increased infiltration of CD163+ 
macrophages in the dynamic group at 8 weeks, suggesting there was a shift towards a 
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more pro-regenerative macrophage response. Overall, this work supports that dynamic 
culturing of human ASCs on DAT scaffolds in the perfusion bioreactor can alter the ASC 
phenotype in addition to promoting cell expansion, which may have contributed to the 
enhanced host-derived adipose tissue regeneration observed in this group.   
3.2 Introduction 
Tissue engineering strategies represent a promising approach for the long-term 
augmentation and regeneration of damaged or deficient subcutaneous adipose tissue for 
applications in plastic and reconstructive surgery. Recent advances in the field have 
focused on using a combined approach involving cell-seeded scaffolds as a means to 
provide both immediate volumetric augmentation and promote the stable regeneration of 
host-derived soft tissues27,150,409. In particular, decellularized adipose tissue (DAT) has 
emerged as a promising pro-adipogenic platform for this application229,253. DAT scaffolds 
can be fabricated from human adipose tissue that is abundantly discarded as surgical 
waste, and have been shown to retain biochemical and biophysical properties that mimic 
the native tissue source, which may be favorable for adipose tissue regeneration246,256.  
While applying DAT as an off-the-shelf scaffold is appealing, studies have suggested that 
the rate and extent of adipose tissue regeneration can be enhanced by seeding the 
scaffolds with regenerative cells169,255,258,259,410, which may be critical for larger volume 
augmentation applications. In particular, previous work from our lab supports that 
seeding the DAT with allogeneic adipose-derived stromal cells (ASCs) enhanced both 
angiogenesis and adipogenesis within DAT implants in an immunocompetent rat 
model169. ASCs are a logical cell source for this application given their relative 
abundance and accessibility70,71, their high tolerance of ischemic conditions such as those 
following implantation411, as well as their enhanced adipogenic potential compared to 
other mesenchymal stromal cell (MSC) sources412. 
In our previous work169, the static seeding methods used resulted in a sparse and 
heterogeneous distribution of ASCs on the DAT scaffolds, which may have restricted 
their capacity to stimulate regeneration. To address this limitation, we recently 
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investigated the effects of culturing human ASCs on the DAT within a scaffold-based 
perfusion bioreactor413. Our findings demonstrated that dynamic culture under 2% O2 
promoted human ASC expansion on the DAT. Further, culturing within the bioreactor 
under 2% O2 for 14 days prior to implantation significantly augmented blood vessel 
infiltration and adipose tissue formation within the DAT scaffolds in a subcutaneous 
implant model in athymic nude (nu/nu) mice in comparison to scaffolds that had been 
cultured within the bioreactor for 14 days under 20% O2, as well as scaffolds that had 
been cultured statically, and freshly-seeded or unseeded controls413.  
Although the delivery of a higher density of ASCs likely contributed to the enhanced 
adipose tissue regeneration observed in the 2% O2 bioreactor group, the dynamic culture 
conditions may have also primed the ASCs to have a more pro-regenerative phenotype. A 
growing body of evidence supports that ASCs delivered within scaffolds primarily 
stimulate regeneration through transient paracrine-mediated effects, rather than through 
long-term engraftment and differentiation101–103. More specifically, ASCs can secrete a 
diverse range of growth factors and cytokines that can promote the recruitment and/or 
modulate the response of host cells, including immune cell populations, endothelial cells 
and adipogenic progenitors that can contribute to implant remodeling, angiogenesis and 
adipogenesis105–107,414. While the stimulatory effects of hypoxia on pro-angiogenic 
factor106,111,263,288 and cytokine secretion283,286 are well documented, the effects of 
dynamic culture on MSC paracrine factor expression remain largely unexplored, with 
most bioreactor studies to date focused on characterizing the effects on proliferation 
and/or differentiation305,313,314,316,325.   
Recognizing that dynamic culture may enhance the pro-regenerative capacity of the 
ASCs, the current study investigated how dynamic culture on the DAT scaffolds within 
the bioreactor modulated human ASC phenotype and paracrine function. To assess the 
effects of shear stress stimulation, the ASCs were cultured on the DAT scaffolds under 
2% O2 either within the perfusion bioreactor or statically for 14 days. As discussed, our 
previous studies clearly demonstrated that adipose tissue regeneration was markedly 
enhanced in the DAT scaffolds in the 2% O2 dynamic group relative to all other groups, 
including the 2% O2 static group, at 8 weeks post-implantation in the nu/nu mouse 
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model413. In vitro analyses were first performed to assess the effects of dynamic culturing 
on the DAT on ASC surface marker expression, phenotype and paracrine factor 
expression. Subsequently, the impact of dynamic culture on the pro-regenerative 
paracrine functionality of the human ASCs cultured and delivered on the DAT scaffolds 
was explored by characterizing the effects on host cell recruitment at 1, 4 and 8 weeks 
post-implantation in the nu/nu mouse model. 
3.3 Methods 
3.3.1 Materials 
Unless otherwise stated, all reagents were purchased from Sigma Aldrich Canada Ltd. 
and used as received (Oakville, Canada).  
3.3.2 Human adipose tissue collection and processing 
Surgically-discarded subcutaneous adipose tissue was collected with informed consent 
from female donors undergoing elective lipo-reduction surgeries at the University 
Hospital or St. Joseph’s Hospital in London, Canada. Human Research Ethics Board 
approval for this study was obtained from Western University (HSREB# 105426). The 
fresh tissues were transported to the lab in sterile phosphate buffered saline (PBS) 
supplemented with 2% bovine serum albumin (BSA) on ice. Within 2 h of collection, the 
adipose tissue was processed for either ASC isolation238 or decellularization253 following 
established protocols. Processed DAT was pooled from multiple tissue donors for all 
subsequent studies.  
The human ASCs were cultured on T75 flasks (Corning, Fisher Scientific, Ottawa, 
Canada) in proliferation medium (DMEM:Ham F12 (Wisent, St. Bruno, Canada) 
supplemented with 10% fetal bovine serum (FBS) (Wisent, St. Bruno, Canada) and 100 
U/mL penicillin and 0.1 mg/mL streptomycin ((1% pen-strep) (ThermoFisher, Waltham, 
USA)).  
To prepare the DAT scaffolds for cell culture, DAT samples were lyophilized and cut 
into individual scaffolds having a mass of 8 ± 1 mg. The scaffolds were rehydrated in 
deionized water, decontaminated through repeated rinsing in 70% ethanol, and finally 
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washed in sterile PBS. Prior to seeding, the scaffolds were equilibrated in fresh 
proliferation medium for 24 h.   
3.3.3 Scaffold seeding and culture 
ASCs were seeded at passage 3 at a density of 1 x 106 cells/scaffold by combining the 
ASCs and individual DAT scaffolds in 3 mL of proliferation medium within a 15 mL 
vented cap conical tube (CellTreat Scientific Products, Pepperell, USA). The samples 
were cultured (37°C, 5% CO2) under agitation at 100 RPM for 24 h on an orbital shaker 
at a 15° incline. Following seeding, the scaffolds were transferred into custom inserts413 
and cultured in proliferation medium for 14 days either statically in vented-cap conical 
tubes or dynamically within a customized perfusion bioreactor system (Tissue Growth 
Technologies, Instron) (Figure 2.1) under a flow rate of 0.5 mL/min. Hypoxic conditions 
(2% O2/93% N2/5% CO2, 37°C) were maintained for all cultures using a tri-gas incubator 
(ThermoFisher Forma Series II 3110). 
3.3.4 ASC immunophenotype 
After 14 days of dynamic or static culture on the DAT, multi-colour flow cytometry was 
performed using a cell surface marker panel including CD90, CD29, CD26, CD34, 
CD146, CD31 and CD45. To isolate the ASCs, 6 replicate scaffolds (n=6 pooled) from 
each condition were pooled, finely minced and digested with Type IV collagenase (4 
mg/mL, Gibco) diluted in sterile PBS at 37°C for 60 min. The scaffold digests were 
filtered through a 40 µm nylon mesh filter and stained with calcein violet-AM 
(BioLegend) for 25 min. The samples were then centrifuged at 500 xg for 7 min at 4°C 
and stained with the antibody cocktail summarized in Table 3.1 (prepared in sterile PBS 
supplemented with 5% FBS) for 30 min at 4°C. All antibodies were purchased from 
BioLegend. Fluorescence minus one (FMO) controls for calcein violet-AM and all 7 
antibodies were included for each cell donor prepared using ASCs cultured on tissue 
culture polystyrene (TCPS). Single stain controls for all antibodies listed in Table 3.1 
were included and performed with UltraComp eBeads (ThermoFisher).  
The samples were analyzed with an LSR II Flow Cytometer (BD Biosciences) at the 
London Regional Flow Cytometry Facility. A total of 1 x 105 events were collected per 
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sample and a total of 3 trials were performed using ASCs from different donors (N=3). 
Sample analysis and colour compensations were performed with FlowJo Software. 
Gating was performed by first selecting single cells based on forward and side scatter. 
Live cells were then selected based on calcein violet-AM staining using the 405 nm laser 
with a 450/50 filter. Additionally, the CD31+ endothelial cell and CD45+ hematopoietic 
cell populations were gated out using the 561 nm laser with the 780/60 filter. The CD31-
CD45- population was then gated for both CD90 and CD29 using the 405 nm and 488 nm 
lasers and the 610/20 and 530/30 filters, respectively. Finally, CD34 expression within 
the CD90+CD29+ ASC population was analyzed with the 561 nm laser with the 610/20 
filter, along with CD26 and CD146 expression using the 640 nm laser with the 670/30 
and 780/60 filters, respectively.  
Table 3.1 Antibody conjugations and dilutions used for the multi-colour flow 
cytometry study. 
Antigen Conjugation Dilution Catalog Number 
CD29 Alexa® Fluor 488 1:100 303015 
CD90 Brilliant Violet 605 1:400 328128 
CD31 PE-Cy7 1:200 303117 
CD45 PE-Cy7 1:100 368531 
CD26 APC 1:50 302709 
CD34 PE-Dazzle 594 1:50 343533 
CD146 APC-Fire750 1:50 361027 
3.3.5 Immunohistochemical assessment of phenotypic markers in 
ASCs cultured on DAT scaffolds in vitro 
Immunohistochemical analysis was performed to assess the expression of inducible nitric 
oxide synthase (iNOS), a marker associated with the immunomodulatory effects of 
MSCs124,133,415, as well as arginase-1 (Arg-1) in the ASCs within the peripheral (< 200 
µm from the scaffold edge) or central (> 200 µm from the scaffold edge) regions of the 
DAT scaffolds cultured either dynamically or statically for 14 days. In addition, triple 
staining was performed for Arg-1 with the pro-regenerative cytokine IL-10 and the pro-
inflammatory cytokine tumour necrosis factor-α (TNFα). Primary and secondary 
antibodies and dilutions used in these studies are summarized in Table 3.2.  
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For both analyses, scaffolds (n=3) were fixed in 4% paraformaldehyde for 24 h at 4°C 
before being embedded in paraffin and sectioned into 7 µm sections. The sections were 
de-waxed in an ethanol series and heat-mediated antigen retrieval was performed with 
Tris-EDTA buffer (10 mM tris base, 1 mM EDTA, 0.05% Tween-20, pH 9.0) for 25 min. 
The sections were cooled for 25 min and then blocked with 5% BSA in PBS-T (0.1% 
Tween 20) for 1 h at room temperature before being incubated with the primary 
antibodies for (i) iNOS in combination with Arg-1 or (ii) Arg-1 in combination with 
TNF-α and IL-10 at 4°C overnight. Next, the sections were washed three times for 5 min 
with PBS, prior to being incubated with the appropriate secondary antibodies for 1 h at 
room temperature. Mouse spleen and liver were used as tissue positive controls, and no 
primary antibody controls were included in all trials.  
Stained cross-sections were mounted in Fluoroshield Mounting Medium with DAPI 
(Abcam, Cambridge, USA) and visualized with an EVOS® FL Cell Imaging System 
(ThermoFisher). Positively-stained cells from 5 non-overlapping fields of view from both 
the central and peripheral regions were quantified using ImageJ Software in 3 non-
adjacent cross-sections taken at least 100 µm apart from each scaffold. A total of 3 trials 
were performed with ASCs from different donors (N=3). 
Table 3.2 Primary and secondary antibodies and dilutions used for immunostaining 
in the in vitro studies. 
Primary antibody  
Primary 
Dilution Secondary antibody 
Secondary 
Dilution 
Arg-1 (Millipore ABS535) 1:100 Goat anti-chicken Alexa® 488 
(Abcam 150169) 
1:200 
iNOS (Abcam AB15323) 1:100 Goat anti-rabbit Alexa® 594 
(Abcam 150080) 
1:200 
TNF-α (Abcam AB6671) 1:200 Goat anti-rabbit Alexa® 594 
(Abcam 150080) 
1:400 
IL-10 (R&D AF519) 1:50 Donkey anti-goat Alexa® 680 
(ThermoFisher 1871998) 
1:100 
3.3.6 Human Angiogenic Growth Factor RT2 Profiler PCR array  
A Human Angiogenic Growth Factor RT2 PCR Profiler Array was performed to screen 
for changes in gene expression of 84 different markers associated with angiogenesis 
between the static and dynamic groups after 14 days of culture. A list of these genes can 
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be found in Appendix Table A.1. For each trial, four replicate scaffolds seeded with 
ASCs from the same donor were pooled, and a total of 4 trials were performed using 
ASCs from different donors (n=4 scaffolds pooled/trial, N=4 trials with different ASC 
donors). The scaffolds were frozen in liquid nitrogen, crushed with a mortar and pestle, 
and resuspended in 1 mL of PureZol® (BioRad) and briefly sonicated 3 times in 4 second 
bursts. mRNA was then isolated with the Aurum® Total RNA Mini kit (BioRad) and the 
yield and purity were measured using a Nanodrop 1000 spectrophotometer 
(ThermoFisher). cDNA was immediately synthesized with 400 ng of input RNA using an 
RT2 First Strand Kit (Qiagen). The Human Angiogenic Growth Factor RT2 PCR Profiler 
Array (Qiagen) was then prepared in accordance with the manufacturer’s protocols, with 
all samples loaded in technical duplicates. Genes without consistent patterns of 
amplification across the 4 ASC donors were excluded from further analysis. The 
expression of the remaining genes of interest was normalized to a panel of housekeeping 
genes (HGPRT, GAPDH, B2M). The 2-ΔCt values were expressed as a ratio 
(dynamic/static) for each of the ASC donors, and the results were compared with a 
multiple t-test, with a False Discovery Rate of 15%. 
3.3.7 Human Magnetic Luminex® Assay 
A Human Magnetic Luminex® Assay was performed to compare the protein expression 
levels of TNF-α, IL-10, interleukin-6 (IL-6), hepatocyte growth factor (HGF), chemokine 
C-X-C motif ligand 2 (CXCL-2) and chemokine C-X-C motif 10 (CXCL-10) between the 
static and dynamic groups at 14 days, selected based on the PCR array data. For this 
assay, 3 replicate scaffolds from each group (n=3) were analyzed with cells from a single 
ASC donor, and a total of 5 trials were performed with different ASC donors (N=5). In 
preparation for the Luminex® assay, the individual scaffolds were frozen in liquid 
nitrogen, crushed with a mortar and pestle, and resuspended in a lysis buffer (50 mM 
Tris-HCl, 100 mM NaCl, 10% glycerol, 1% Triton X-100, pH 7.4). The samples were 
then briefly sonicated with ultrasonic dismembrator (ThermoFisher Model 100) and 
centrifuged at 13,000 xg for 10 min at 4°C. The supernatant from each sample was then 
analyzed with a Human Magnetic Luminex® Assay (R&D Systems), in accordance with 
the manufacturer’s protocols. In brief, the protein samples were diluted 2-fold with the 
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provided diluent solution (buffer RD6-52) before being loaded into a 96-well plate along 
with the provided standards. Pre-mixed magnetic beads were then added and incubated 
for 2 h at room temperature under constant agitation. The diluted biotin-antibody cocktail 
was then added to each sample and incubated for 1 h at room temperature under constant 
agitation before the Streptavidin-PE cocktail was added. The 96-well plate was then 
assayed using a MAGPIX® System (Millipore). Protein concentrations were determined 
based on comparison to the standard curves and normalized to the dsDNA content 
measured in each sample using a PicoGreen® dsDNA Assay413, following the 
manufacturer’s instructions. 
3.3.8 Subcutaneous implantation surgeries 
In vivo studies were performed to compare the effects of culturing the ASCs on the DAT 
scaffolds for 14 days either statically or dynamically on the host cell response. All animal 
studies followed Canadian Council on Animal Care (CCAC) guidelines and the protocols 
were reviewed and approved by the Western University Animal Care Committee 
(Protocol #2015-049). Female athymic nude mice (Nu-Foxn1nu) (Charles River 
Laboratories, Sherbrooke, Canada) of 10 – 13 weeks of age were used for this study (N=6 
mice per scaffold group/timepoint). Subcutaneous implantation surgeries were performed 
in accordance with established protocols413. At 1, 4 and 8 weeks, the mice were sacrificed 
by CO2 overdose and the scaffolds were excised within their surrounding tissues. The 
samples were fixed in 4% paraformaldehyde at 4°C overnight before being embedded in 
paraffin and sectioned (7 µm) for immunohistochemical analysis.  
3.3.9 Immunohistochemical analysis of host cell recruitment 
Immunostaining was performed to assess host cell infiltration into the scaffolds at 1, 4 
and 8 weeks. More specifically, CD31 staining was performed to examine host 
endothelial cell recruitment. In addition, co-staining was performed for CD26, a marker 
that has been associated with highly proliferative multipotent progenitors that give rise to 
preadipocytes in murine subcutaneous adipose tissue416, along with the human cell 
marker Ku80384, to distinguish the host-derived CD26+ population. Finally, host immune 
cell recruitment was characterized through triple staining for the pan-leukocyte marker 
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CD45, the murine macrophage marker F4/80, and the phagocytic macrophage marker 
CD68. The phenotype of the infiltrating macrophages was also probed by co-staining for 
CD45 in combination with the pro-regenerative macrophage marker CD163358. Primary 
and secondary antibodies and dilutions used in these studies are summarized in Table 3.3. 
For each explanted scaffold, 3 non-adjacent cross-sections at least 100 µm apart were 
analyzed.  
Table 3.3 Primary and secondary antibodies and dilutions used for immunostaining 
in the in vivo study. 
Primary antibody  
Primary 
Dilution Secondary antibody 
Secondary 
Dilution 
CD31 (Abcam ab28364) 1:100 Goat anti-rabbit Alexa® 594 
(Abcam 150080) 
1:200 
Ku80 (Cell Signaling 2180) 1:200 Goat anti-rabbit Alexa® 594 
(Abcam 150080) 
1:400 
CD26 (R&D AF954)  1:50 Donkey anti-goat Alexa® 680 
(ThermoFisher 1871998) 
1:100 
CD45 (R&D AF114) 1:100 Donkey anti-goat Alexa® 680 
(ThermoFisher 1871998) 
1:200 
CD68 (BioRad MCA1957) 1:100 Goat anti-rat Alexa® 488 
(ThermoFisher A-11006) 
1:200 
F4/80 (Abcam 111101) 1:50 Goat anti-rabbit Alexa® 594 
(Abcam 150080) 
1:100 
CD163 (Abcam ab182422) 1:200 Goat anti-rabbit Alexa® 594 
(Abcam 150080) 
1:400 
For the staining, the cross-sections were dewaxed via ethanol series and subjected to 
heat-mediated antigen retrieval in Tris-EDTA buffer for 25 min and cooled at room 
temperature for 15 min. Sections were then washed and blocked in 5% BSA in PBS-T 
(0.1% Tween-20) for 1 h at room temperature before being incubated in the appropriate 
primary antibody cocktails (Table 3.3) diluted in the blocking solution at 4°C overnight. 
Next, the sections were incubated with the corresponding secondary antibodies at room 
temperature for 1 h before being mounted in Fluoroshield Mounting Medium with DAPI. 
The stained sections were visualized with the EVOS® FL Cell Imaging System under 
20X magnification. Quantification was performed within 10 randomly selected and non-
overlapping, non-adjacent fields of view in each section using ImageJ analysis software. 
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3.3.10 Statistical analysis 
All numerical values are represented as the mean ± standard deviation. Statistical 
analyses were performed using GraphPad Prism® version 6 by paired t-test or two-way 
ANOVA and followed with a Tukey’s post-hoc test. Differences were considered 
statistically significant at p<0.05. 
3.4 Results 
3.4.1 Dynamic culturing did not affect the immunophenotype of the 
ASCs on the DAT 
Multi-colour flow cytometry was performed to compare the immunophenotype of the 
ASCs that were cultured dynamically versus statically on the DAT scaffolds for 14 days. 
Representative flow plots for a single donor are shown in Appendix Figure A.7. Flow 
analysis of the cells that were enzymatically released from the scaffolds via collagenase 
digestion indicated that there was no significant difference in the percentage of 
CD90+CD29+ cells within the viable CD31-CD45- population between the static and 
dynamic groups (Table 3.4). While donor-to-donor variability was observed, there were 
no significant differences in the average expression levels of CD26, CD34 or CD146 
within the CD90+ CD29+ population between the groups (Table 3.4). In general, these 
findings suggest that dynamic culturing within the perfusion bioreactor did not 
significantly alter the immunophenotype of the ASCs on the DAT.  
Table 3.4 The percentage of live CD90+CD29+CD31-CD45- cells that were positive 
for CD26+, CD34+ and CD146+ (n=6 scaffolds pooled, N=3 ASC donors).  
 Static Dynamic 
CD90+CD29+CD31-CD45- (of viable cells) 77.2 ± 8.0 % 84.0 ± 1.4 % 
CD90+CD29+CD31-CD45-CD26+  76.9 ± 12.4 % 86.9 ± 1.7 % 
CD90+CD29+ CD31-CD45- CD34+  37.4 ± 4.7 % 39.6 ± 9.8 % 
CD90+CD29+ CD31-CD45-CD146+  27.8 ± 18.7 % 27.3 ± 13.9 % 
3.4.2 Dynamic culturing of ASCs upregulated the expression of 
iNOS in the peripheral regions of the DAT scaffolds 
Immunostaining was performed to assess the expression of iNOS and Arg-1 in the ASCs 
that were cultured statically or dynamically on the DAT scaffolds for 14 days. A high 
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density of iNOS+ cells were visualized along the peripheral edges of the scaffolds in the 
dynamic group (Figure 3.1A), with a smaller number throughout the central regions of 
these scaffolds. In contrast, only low levels of iNOS+ cells were visualized in both 
regions of the static culture group. Qualitative analysis of the Arg-1 staining patterns 
showed that Arg-1+ cells were distributed throughout the central and peripheral regions of 
the scaffolds in both the static and dynamic groups. Co-staining results suggested that 
iNOS+Arg+ cells were present in both the static and dynamic groups (Figure 3.1A). While 
relatively few iNOS+Arg+ cells were observed in the statically cultured scaffolds, 
qualitatively more cells were visualized in the dynamic group, particularly along the 
scaffold border (Figure 3.1A). 
Quantification of the iNOS+Arg-1+DAPI+ cells in the central (> 200 µm from scaffold 
edge) and peripheral (< 200 µm from scaffold edge) regions of the scaffolds was 
performed. There was a significantly higher density of iNOS+Arg-1+DAPI+ cells in the 
peripheral region of the dynamic scaffolds as compared to the central region in that 
group, as well as both regions of the static group (Figure 3.1B). Analysis of the number 
of iNOS+Arg-1+DAPI+ cells relative to the total DAPI+ cell population revealed that a 
significantly higher percentage of the ASCs co-expressed iNOS and Arg-1 within the 
peripheral region of the DAT scaffolds in the dynamic group (Figure 3.1C), suggesting 
that culturing within the perfusion bioreactor altered the phenotype of the ASCs within 
the scaffold periphery.              
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Figure 3.1 Dynamic culture on the DAT for 14 days increased the co-expression of 
iNOS and Arg-1 in the ASCs within the peripheral region of the scaffolds. 
A) Representative immunostaining for Arg-1 (green) and iNOS (red) with DAPI (blue) 
for the static and dynamic groups at 14 days. Dashed lines indicate the edge of the DAT 
scaffolds. Scale bars represent 100 µm. B) The density of iNOS+Arg-1+DAPI+ cells and 
C) the percentage of iNOS+Arg-1+DAPI+ cells relative to the total DAPI+ cell population 
in the central and peripheral regions of the scaffolds cultured statically or dynamically. 
Error bars represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with 
different ASC donors). * = significant difference between the peripheral region of 
dynamic group and all other groups (p<0.05).   
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Further probing the expression levels of these functional markers, a significantly greater 
density of iNOS+DAPI+ cells was present in the peripheral regions of the dynamic 
scaffolds as compared to the central region in that group, as well as both the central and 
peripheral regions of the static cultured scaffolds (Appendix Figure A.8A). When 
assessed relative to the total DAPI+ cell population, the percentage of iNOS+DAPI+ cells 
in the peripheral region of the dynamic group (33.2 ± 7.5%) was significantly different 
than the central region of the static group (14.7 ± 7.3%) (Appendix Figure A.8B). Similar 
to iNOS, a significantly greater density of Arg-1+DAPI+ cells was measured in the 
peripheral regions of the dynamic scaffolds (Appendix Figure A.8C). In general, a high 
percentage (>70%) of the ASCs within the DAT scaffolds expressed Arg-1 (Appendix 
Figure A.8D).  
3.4.3 Dynamic culture of ASCs on the DAT scaffolds in the 
perfusion bioreactor altered angiogenic gene expression 
patterns 
To probe whether culturing within the perfusion bioreactor modulated angiogenic gene 
expression in the ASCs cultured on the DAT scaffolds for 14 days, analysis with a 
Human Angiogenic Growth Factor RT2 PCR Profiler Array was performed. Results 
compiled from 4 ASC donors indicated that 33 of the 84 genes analyzed were 
significantly different between the ASCs that were cultured dynamically versus statically 
on the DAT, including a variety of pro-angiogenic cytokines and growth factors, several 
ECM proteins, and a range of other signaling proteins implicated in angiogenesis (Figure 
3.2). Of these genes, 24 were up-regulated and 9 were down-regulated in the dynamic 
group as compared to the static group.  
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Figure 3.2 Dynamic culture alters the angiogenic gene expression profile of ASCs 
cultured on DAT scaffolds for 14 days. Fold regulation (Dynamic/Static) of the 33 
genes on the PCR array that were significantly up- (green) or down- (red) regulated in the 
ASCs cultured dynamically versus statically. Statistical significance was determined via a 
multiple T-test (false discovery rate = 15%). Error bars represent standard deviation (N=4 
trials with different ASC donors). 
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3.4.4 Dynamic culture alters the paracrine factor expression profile 
of the ASCs on the DAT scaffolds 
To further probe whether dynamic culture altered the expression of a range of secreted 
pro-angiogenic and immunomodulatory factors in the ASCs on the DAT scaffolds, a 
custom Luminex® assay was performed to compare the protein expression levels of 
IL-10, TNF-α, HGF, CXCL-10, IL-6 and CXCL-2 in cell lysates from the static and 
dynamic groups after 14 days of culture. These factors were selected based on the PCR 
array results, as well as their known biological functions that may be important in the 
context of adipose tissue regeneration within the DAT. Consistent with the gene 
expression results, the protein expression levels of IL-10, CXCL-10, and HGF were 
significantly higher, and IL-6 expression was significantly lower, in the dynamic group as 
compared to the static group (Figure 3.3A, C, D, F). In contrast to the PCR results, no 
significant differences were observed in the protein expression levels of the 
pro-inflammatory cytokine TNF- (Figure 3.3B) or the pro-inflammatory chemokine 
CXCL-2 (Figure 3.3E) between the groups. 
 
Figure 3.3 Dynamic culture within the perfusion bioreactor alters pro-angiogenic 
and immunomodulatory protein expression in the human ASCs cultured on the 
DAT scaffolds over 14 days. Expression of A) IL-10, B) TNF-α, C) CXCL-10, D) HGF, 
E) CXCL-2 and F) IL-6 as measured by Human Magnetic Luminex® Assay normalized 
to total dsDNA content. Error bars represent standard deviation (n=3 technical replicate 
scaffolds/trial, N=5 trials with different ASC donors). * = significant difference between 
static and dynamic groups (p<0.05; paired t-test).   
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3.4.5 Dynamic culture increased the number of ASCs expressing 
TNF-α and IL-10 in the DAT scaffolds at 14 days 
Immunostaining was performed for Arg-1 in combination with TNF-α and IL-10 to 
assess whether dynamic culture modulated the presence and distribution of ASCs 
expressing these cytokines. A high density of Arg-1+, TNF-α+ and IL-10+ cells were 
observed within the peripheral regions of the DAT scaffolds in the dynamic group 
(Figure 3.4A). A qualitatively smaller number of cells positive for each of these markers 
was observed in the central region of the dynamic group, as well as within both regions 
of the static group.  
Quantification of the TNF-α+DAPI+ and IL-10+DAPI+ cell populations in the central 
(> 200 µm from scaffold edge) and peripheral (< 200 µm from scaffold edge) regions of 
the scaffolds was performed. Similar expression patterns were observed for both TNF-α 
(Figure 3.4B) and IL-10 (Figure 3.4C), with a significantly greater density of positive 
cells in the peripheral region of the scaffolds in the dynamic group as compared to all 
other regions. In addition, the TNF-α+DAPI+ and IL-10+DAPI+ cell densities were 
significantly greater in the central region of the dynamic group as compared to the central 
region of the static group. When expressed as a percentage of the total DAPI+ cell 
population, a higher percentage of cells were TNF-α+ in the peripheral region of the 
scaffolds in the dynamic group versus the static group (Appendix Figure A.9A). In 
contrast, no significant differences were observed in the percentage of IL-10+ cells in 
either group (Appendix Figure A.9B).  
Quantification also revealed that the Arg-1+TNF-α+IL-10+DAPI+ cell density was 
significantly higher in the peripheral region of the dynamic group as compared to all 
other regions (Figure 3.4D). Further, the percentage of TNF-α+IL-10+DAPI+ cells 
(Appendix Figure A.9C) and Arg-1+TNF-α+IL-10+DAPI+ cells (Appendix Figure A.9D) 
relative to the total DAPI+ cell population was significantly higher in the peripheral 
regions of the DAT scaffolds in the dynamic group as compared to the static group, 
suggesting that culturing in the perfusion bioreactor increased the relative number of 
ASCs that were expressing both TNF-α and IL-10, and the majority of these cells were 
also Arg-1+.  
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Figure 3.4 Dynamic culture increased the density of TNF-α+ and IL-10+ human 
ASCs in the peripheral region (< 200 µm from scaffold edge) of the DAT scaffolds 
that were cultured in the perfusion bioreactor for 14 days. A) Representative 
immunostaining showing Arg-1 (green), TNF-α (red) and IL-10 (cyan) expression with 
DAPI counterstaining (blue) for the static and dynamic groups. Dashed lines indicate the 
edge of the DAT scaffolds. Scale bars represent 100 µm. The B) TNF-α+DAPI+, 
C) IL-10+DAPI+ and D) Arg-1+TNF-α+IL-10+DAPI+ cell density in the central and 
peripheral regions of the DAT scaffolds in both the static and dynamic groups. Error bars 
represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with different ASC 
donors). * = significant difference between the peripheral region of the dynamic group 
and all other regions, # = significant difference between the central region of the dynamic 
and static groups (p<0.05).    
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3.4.6 Dynamic culture of ASCs on the DAT enhanced CD31+ 
endothelial cell recruitment into the scaffolds following 
implantation in the nu/nu mouse model 
Following the in vitro characterization, in vivo studies were performed to probe how 
dynamic culture of the ASCs on the DAT modulated their capacity to stimulate the 
recruitment of a range of host cell populations into the DAT scaffolds at 1, 4 and 8 weeks 
post-implantation. Given the importance of angiogenesis in adipose tissue 
regeneration328, the initial characterization focused on immunohistochemical staining to 
assess the presence and distribution of CD31+ endothelial cells within the implants. 
CD31+ vessels were observed within the implants at 1, 4 and 8 weeks in both the static 
and dynamic groups. At the 8-week timepoint, there were qualitatively more CD31+ cells 
within the DAT implants in the dynamic group as compared to the static culture group, 
with some forming larger lumen structures (Figure 3.5A). Quantification of the staining 
confirmed that the CD31+ cell density was significantly greater in the dynamic group as 
compared to the static group at all timepoints (Figure 3.5B).  
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Figure 3.5 Dynamic culture of ASCs on the DAT scaffolds enhanced CD31+ cell 
recruitment following implantation in the nu/nu mouse model. A) Representative 
immunostaining showing CD31 (red) with DAPI counterstaining within the DAT 
implants for both the static and dynamic groups at 1, 4 and 8 weeks. Scale bars represent 
100 µm. B) CD31+DAPI+ endothelial cell density in the implants. Error bars represent the 
standard deviation (n=3 cross-sections/implant, N=6 implants/group). * = significant 
difference relative to the static group at 1, 4 and 8 weeks, # = significant difference 
relative to the static group at 1 and 8 weeks (*=p<0.05). 
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3.4.7 Dynamic culture of ASCs on the DAT scaffolds enhanced 
the recruitment of CD26+ host cells at 1 week 
post-implantation in the nu/nu mouse model 
Co-staining was performed for CD26 with human-specific Ku80 to probe host CD26+ 
cell infiltration into the implants at 1, 4 and 8 weeks, as a potential marker of multipotent 
progenitor cells that can give rise to preadipocytes and adipocytes416. Qualitatively, the 
staining results showed a high density of CD26+ cells in the dynamic group at 1 week 
(Figure 3.6A). The Ku80+ human ASCs were distributed throughout the scaffolds in both 
the static and dynamic groups at all three timepoints, with CD26+Ku80+ cells observed 
(Figure 3.6A). Quantification of the CD26+Ku80-DAPI+ cell population indicated that 
there was a significantly higher density of CD26+ host cells in the DAT implants within 
the dynamic group as compared to the static group at 1 week (Figure 3.6B).  
The Ku80+DAPI+ and CD26+Ku80+DAPI+ human ASC populations were also quantified 
within the implants. Consistent with our previous work that demonstrated that dynamic 
culture under 2% O2 within the perfusion bioreactor promoted human ASC expansion on 
the DAT413, the Ku80+DAPI+ cell density was significantly higher in the dynamic group 
relative to the static group at 1 week (Appendix Figure A.10A). However, the number of 
human ASCs detected in the dynamic group was diminished at the later timepoints, with 
no significant differences observed in the Ku80+DAPI+ cell density between the static 
and dynamic groups at 4 or 8 weeks (Appendix Figure A.10A), similar to our previous 
findings413. The percentage of the human ASCs within the DAT implants that expressed 
CD26 also declined over time, with a significant decrease from 1 to 8 weeks, and no 
significant differences observed between the static and dynamic groups at any of the 
timepoints (Appendix Figure A.10B) 
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Figure 3.6 Dynamic culture of human ASCs on the DAT scaffolds enhanced the 
recruitment of CD26+ host cells at 1 week post-implantation in the nu/nu mouse 
model. A) Representative immunostaining of CD26 (green) in combination with human-
specific Ku80 (red), with DAPI counterstaining (blue) at 1, 4 and 8 weeks. Scale bars 
represent 50 µm. B) CD26+ host cell (CD26+Ku80-DAPI+) density within the DAT 
implants at 1, 4 and 8 weeks. Error bars represent standard deviation (n=3 
cross-sections/implant, N=6 implants/group). * = significant difference between the static 
and dynamic groups at 1 week (p<0.05). 
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3.4.8 Dynamic culture of ASCs on the DAT scaffolds did not alter 
host macrophage recruitment following implantation in the 
nu/nu mouse model 
To probe host macrophage infiltration into the DAT implants over time, immunostaining 
was performed for CD45 as a pan-leukocyte marker in combination with F4/80 as a 
marker of mature murine macrophages and CD68 as a marker of phagocytic macrophages 
(Figure 3.7A). Qualitatively, a high density of CD45+, F4/80+ and CD68+ cells was 
observed within the DAT implants in both the static and dynamic groups at 1 week 
(Figure 3.7A), 4 weeks (Appendix Figure A.11) and 8 weeks (Appendix Figure A.12) 
post-implantation. Furthermore, CD45+, F4/80+ and CD68+ cells were also observed in 
the fibrous capsules surrounding the implanted DAT at all three timepoints. 
Quantification of the CD45+F4/80+CD68+DAPI+ cell density at 1, 4 and 8 weeks 
indicated that there were no significant differences between the static and dynamic 
groups at any of the timepoints (Figure 3.7B).  However, a significant decline was 
observed in the dynamic group from 1 week to 8 weeks. Analysis of the percentage of 
CD45+ cells that co-expressed both F4/80 and CD68 within the total CD45+DAPI+ cell 
population in the DAT implants indicated that the majority (>90%) of the CD45+ cells 
were F4/80+CD68+ at 1 and 4 weeks, but a significant decline in this subpopulation was 
observed for both groups at 8 weeks (Figure 3.7C).  
Individual analysis of the CD45+F4/80+DAPI+ (Appendix Figure A.12A) and 
CD45+CD68+DAPI+ (Appendix Figure A.12B) populations as a percentage of the total 
CD45+DAPI+ population within the implants confirmed that a high percentage (>90%) of 
the CD45+ population expressed these macrophage markers at 1 and 4 weeks. However a 
significant decline in the relative expression of F4/80 was observed in the static group at 
8 weeks as compared to both the dynamic and static groups at 1 and 4 weeks, and a 
significant decline in the relative expression of CD68 was observed in both groups at 8 
weeks as compared to both groups at the earlier timepoints (Appendix Figure A.12).  
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Figure 3.7 The recruitment of CD45+F4/80+CD68+ macrophages was similar in both 
the dynamic and static cultured ASC-seeded DAT scaffolds in the nu/nu mouse 
model. A) Representative images showing CD45 (cyan), F4/80 (red) and CD68 (green) 
expression with DAPI counterstaining (blue) at 1 week. Scale bars represent 100 µm. 
B) CD45+F4/80+CD68+DAPI+ cell density in the static and dynamic groups. C) The 
percentage of CD45+F4/80+CD68+DAPI+ cells relative to the total CD45+DAPI+ cell 
population at 1, 4 and 8 weeks. Error bars represent the standard deviation (n=3 
cross-sections/implant, N=4 implants/group). * = significant difference between the 
dynamic group at 1 and 8 weeks, # = significant difference between the indicated group 
and both the static and dynamic groups at 1 and 4 weeks (p<0.05).  
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3.4.9 Dynamic culture of ASCs on the DAT scaffolds modulated 
macrophage phenotype within the implants in the nu/nu 
mouse model  
To probe the macrophage phenotype within the implants, co-staining was performed for 
the pan-leukocyte marker CD45 with the pro-regenerative macrophage marker CD163. 
CD45+CD163+ cells were observed in the fibrous capsules at the periphery of the 
implants at all three timepoints (Figure 3.8A). Interestingly, while CD45+ cells were 
observed infiltrating the implants at 1, 4 and 8 weeks, very few CD45+CD163+ cells were 
visualized within the scaffolds, with the exception of the dynamic group at 8 weeks, 
which showed a relatively high density of infiltrating CD45+CD163+ cells (Figure 3.8A).  
The density of CD45+CD163+DAPI+ cells was quantified within the implanted scaffolds, 
excluding the fibrous capsule. The analysis confirmed that there were significantly more 
CD45+CD163+DAPI+ cells within the DAT implants in the dynamic group at 8 weeks as 
compared to 1 and 4 weeks, as well as the static group at all three timepoints (Figure 
3.8B). Additionally, the percentage of CD45+DAPI+ cells that were also CD163+ was 
significantly greater in the dynamic group at 8 weeks (47.3 ± 6.5 %) as compared to all 
other conditions, supporting that there was a shift in macrophage phenotype in this group 
over time (Figure 3.8C).  
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Figure 3.8 Dynamic culture of human ASCs on the DAT scaffolds enhanced the 
expression of the pro-regenerative macrophage marker CD163 in the CD45+ host 
cell population at 8 weeks post-implantation in the nu/nu mouse model. 
A) Representative images showing CD45 (green), CD163 (red) and DAPI (blue). Scale 
bars represent 100 µm. White arrowheads showing examples of CD45+CD163+ cells. 
Dashed lines indicate the border between the fibrous capsule (top) and the DAT implant 
(bottom). B) CD45+CD163+DAPI+ cell density within the DAT implants. C) The 
percentage of CD45+CD163+DAPI+ cells relative to the total CD45+DAPI+ population. 
Error bars represent standard deviation (n=3 cross-section/implant, N=6 implants/group). 
* = significant difference between the dynamic group at 8 weeks and all other conditions, 
# = significant difference between the static group at 1 week and the static and dynamic 
groups at both 4 and 8 weeks (p<0.05). 
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3.5 Discussion 
Culturing human ASCs on the DAT scaffolds within the perfusion bioreactor system 
under 2% O2 over 14 days was previously shown to markedly enhance in vivo 
angiogenesis and adipogenesis following subcutaneous implantation in the nu/nu mouse 
model413. The enhanced regeneration of host-derived adipose tissue was likely attributed 
in part to the fact that culturing within the bioreactor promoted the expansion of the 
human ASCs on the DAT, resulting in an estimated 2.2-fold increase in the number of 
ASCs delivered relative to the 2% O2 static culture group that was included in the current 
study413. However, a growing body of evidence suggests that culturing under shear stress 
can also induce functional and phenotypic changes in MSC populations that may 
influence their capacity to stimulate regeneration289–291. As such, the focus of the current 
study was on assessing whether there were differences in the phenotype and paracrine 
function of the ASCs on the DAT following 14 days of culture under 2% O2 within the 
bioreactor or under static conditions.     
Flow cytometry analyses indicated that there were no significant differences in the 
immunophenotype of the ASCs cultured on the DAT in the static and dynamic groups. 
Interestingly, the expression levels of the markers analyzed were more similar to those 
reported for P0 or P1 ASCs as compared to P3 ASCs expanded on 2-D TCPS417, 
suggesting that culturing on the DAT may have modulated ASC surface marker 
expression. In particular, while cell donor variability was observed, an average of ~40% 
of the CD90+CD29+ cell population was CD34+, a marker that has been associated with 
pro-angiogenic functionality in MSC populations418. Previous studies have shown that 
CD34 is expressed on ~25% of the CD45- cells within the stromal vascular fraction 
(SVF) of adipose tissue84, but that its expression rapidly diminishes following in vitro 
culture such that <5% of P3 ASCs are CD34+417. Similarly, the CD146 expression levels 
were more similar to those reported for P0 ASCs than the ~5% reported at passage 3417. 
While CD146 is often regarded as a pericyte marker419, its expression within ASC 
populations in humans has also been associated with enhanced pro-angiogenic 
function420.  
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In addition, Arg-1 was found to be highly expressed in the ASCs cultured on the DAT 
scaffolds in both groups. Arg-1 is an enzyme that is commonly used as a marker of pro-
regenerative macrophage polarization421, which functions in breaking down L-arginine to 
generate urea422. iNOS also utilizes L-arginine as a substrate to generate nitric oxide 
(NO), and as such, Arg-1 can regulate iNOS activity422. In the present study, iNOS 
expression was enhanced in the ASCs within the peripheral region of the DAT scaffolds 
in the dynamic group. While the difference in the iNOS+ cell density can be attributed in 
part to the overall higher density of ASCs in that region of the dynamic group413, the fact 
that a significantly higher fraction of the total cell population was iNOS+Arg-1+ suggests 
that the shear stress stimulation may have altered the ASC phenotype in the dynamic 
group. Interestingly, previous studies have shown that iNOS expression is critical for the 
pro-regenerative immunomodulatory function of MSCs124,133,149.  
As a first step in probing the effects of dynamic culture on ASC function, the qPCR array 
identified 33 genes associated with angiogenesis that were differentially expressed 
between the dynamic and static groups. Mechanical stimulation through intermittent fluid 
flow has been previously reported to increase the production of pro-angiogenic factors 
including VEGFA, HGF, follistatin and leptin in cultured human ASCs423.  Further, shear 
stress has been shown to enhance FGF2 gene expression in human umbilical vein 
endothelial cells424, as well as downregulate VEGF expression in cultured human 
umbilical veins425. In addition to activation of mechanotransduction pathways through 
dynamic culture, other factors that may have influenced the alterations in the gene 
expression patterns between the groups include the cell density, as well as a cascading 
effect of altered levels of other growth factors or cytokines. For example, elevated levels 
of TNF-α have been shown to induce the expression of chemokines including CXCL10 in 
human endothelial and smooth muscle cells426,427. Likewise, the enhanced expression of 
HGF was found to decrease IL-6 and increase IL-10 expression in lipopolysaccaride 
(LPS)-induced macrophages in vitro and in interstitial macrophages in C57BL/6J mice428.  
To further assess whether culturing within the bioreactor modulated the paracrine profile 
of the ASCs on the DAT, a multiplex Luminex assay was performed to characterize the 
expression levels of a subset of factors selected from the PCR array that are known to 
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have the capacity to modulate various processes involved in soft tissue regeneration. 
IL-10 expression, which has been shown to promote a more pro-regenerative macrophage 
phenotype135,429 and downregulate the expression of pro-inflammatory cytokines in 
immune cell populations140,430, was significantly enhanced in the dynamic group, 
consistent with the gene expression results. In addition, the macrophage chemoattractant 
CXCL-10431, as well as the pro-angiogenic factor HGF115, were also detected at 
significantly higher levels in the lysates from the dynamic group. HGF can regulate 
endothelial cell survival, proliferation and migration114, as well as endothelial tube 
formation115. As such, the enhanced expression of this factor may have played a role in 
the increased CD31+ cell recruitment observed in the in vivo model. Further, HGF has 
also been shown to have immunomodulatory effects on monocytes and macrophages, 
promoting a more pro-regenerative response432,433. Also consistent with the gene 
expression results, the expression of IL-6, which is known to promote the pro-
inflammatory polarization of monocytes143,144, was significantly down-regulated in the 
dynamic group. In contrast to the gene array results, no significant differences were 
observed in the protein expression levels of the pro-inflammatory factors CXCL-2 or 
TNF-α within the lysates between the static and dynamic groups.  
In contrast to the Luminex findings, the immunohistochemical analyses demonstrated 
that a significantly higher fraction of the ASCs in the peripheral region of the DAT 
scaffolds in the dynamic group expressed TNF-α relative to this same region in the static 
group, suggesting that the shear stress stimulation may have promoted the localized 
production of this factor. In addition, a significantly higher fraction of the ASCs in the 
peripheral region of the DAT in the dynamic group co-expressed both pro-inflammatory 
TNF-α and pro-regenerative IL-10, consistent with the mixed phenotype observed in the 
analysis of Arg-1 and iNOS expression. Although TNF-α and other pro-inflammatory 
factors are often regarded negatively for their association with chronic inflammation and 
disease434,435, it is becoming increasingly recognized that inflammation plays an 
important role in stimulating angiogenesis and tissue regeneration131,436. As such, the 
locally enhanced expression of TNF-α may have been a mediating factor in the markedly 
increased host-derived adipose tissue regeneration in the dynamic group413. 
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Building from the in vitro findings, in vivo studies were subsequently performed to 
further investigate whether dynamic culture on the DAT altered the capacity of the 
human ASCs to stimulate regeneration via paracrine-mediated mechanisms by assessing 
the effects on host cell recruitment. While there was a significantly higher density of 
human ASCs within the scaffolds in the dynamic group at 1 week post-implantation, 
there was no difference in human cell retention between the groups at either 4 or 8 weeks, 
consistent with our previous findings413. While the higher initial cell dose delivered in the 
dynamic group may have influenced the response, the in vitro characterization studies 
support that there were also differences in the phenotype and secretome of the ASCs 
within the DAT that could have impacted regeneration. 
As a measure of angiogenesis within the implants, CD31+ endothelial cell recruitment 
was significantly enhanced in the dynamic group at 1, 4, and 8 weeks. These findings are 
consistent with previous Masson’s trichrome staining results that showed a significant 
increase in the density of erythrocyte-containing blood vessels in the DAT implants in the 
dynamic group at 4 and 8 weeks413. However, it is also possible that other non-
endothelial CD31+ cell populations, such as certain macrophage subsets437,  could also be 
present in the scaffolds and contributing to the higher density observed in the dynamic 
group.  
The infiltration of host-derived CD26+ cells was also probed. Recent studies have shown 
that CD26, also known as dipeptidylpeptidase IV (DPPIV),  can be associated with an 
adipocyte precursor phenotype375,416. More specifically, a study by Merrick et al. 
demonstrated that a CD26+ interstitial progenitor population within adipose tissue could 
give rise to an intermediate population that was committed to the adipogenic lineage and 
could differentiate into mature adipocytes in vivo416. Notably, CD26 expression was 
down-regulated as the progenitor cells began to differentiate416. In the present study, the 
higher density of host-derived CD26+ cells observed at 1 week post-implantation may 
indicate that there was enhanced adipogenic progenitor cell recruitment in the dynamic 
group, contributing to the previously-characterized increased presence of host-derived 
adipocytes within this implant group at 8 weeks413. However, it is important to note that 
CD26 can also be expressed by other cell populations. For example, CD26 has been 
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associated with a more pro-fibrotic phenotype in fibroblast populations438. In addition, 
CD26 can be expressed on immune cells including dendritic cells439,440, macrophages440, 
and natural killer cells441. As such, further studies are required to more fully characterize 
the CD26+ cells and determine more conclusively whether there is a link between this 
population and the enhanced adipogenesis observed in this group.   
Macrophages have been indicated to play an important role in mediating both 
angiogenesis and adipose tissue regeneration within ECM-derived bioscaffolds169,442,443. 
As such, the effects of dynamic culture on host macrophage recruitment were probed 
through co-staining for CD45, F4/80 and CD68, which showed no significant differences 
in terms of cell densities between the groups at any of the timepoints. These findings are 
similar to previous studies showing that seeding the DAT with allogeneic ASCs did not 
significantly impact the CD68+ macrophage density within the implants in an 
immunocompetent rat model over 12 weeks relative to unseeded controls169. Further, 
similar to the previous results169, a high density of macrophages was observed within the 
DAT implants in both groups at all time points. Interestingly, within the CD45+ cell 
population there was an increased percentage of cells that were F4/80- and CD68- within 
both implant groups at 8 weeks. These cells may be other macrophage subpopulations or 
dendritic cells that do not express these markers444, or potentially natural killer cells445. 
However, further analyses using additional markers would be required to more fully 
characterize the CD45+F4/80-CD68- cell population and assess their potential effects 
within the implants.  
While there was no difference in total macrophage recruitment, analysis of CD163 
expression in the CD45+ cell population suggested that there was a shift in macrophage 
phenotype at 8 weeks in the dynamic group. CD163 is a hemoglobin scavenger receptor 
found on macrophage subpopulations446 that is upregulated by IL-10 and suppressed by 
pro-inflammatory mediators such as TNF-α447,448. The expression of CD163 in 
macrophages has been associated with a more pro-regenerative phenotype that is 
involved in both angiogenesis and ECM remodeling351. In the previous 
immunocompetent rat model, seeding the DAT with allogeneic ASCs was shown to 
enhance the fraction of CD163+ cells within the implants relative to unseeded controls at 
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both 8 and 12 weeks, which also showed significantly greater remodeling into host-
derived adipose tissue169. As such, the infiltrating CD163+ macrophages may have 
contributed to the enhanced adipose tissue regeneration that was previously reported in 
the DAT implants that were cultured for 14 days under 2% O2 prior to implantation413. 
3.6 Conclusions 
The findings of the current study support that in addition to promoting cell expansion, 
dynamic culture of human ASCs on the DAT scaffolds within the perfusion bioreactor 
under 2% O2 altered their phenotype and paracrine profile relative to controls cultured 
under static conditions. Interestingly, a fraction of the ASCs within the peripheral region 
of the DAT implants in the dynamic group were shown to exhibit both pro-inflammatory 
and anti-inflammatory characteristics, co-expressing iNOS and Arg-1, as well as both 
TNF- and IL-10. Moreover, shear stress stimulation was shown to modulate the 
expression of a range of genes and proteins associated with the immunomodulatory and 
pro-angiogenic paracrine functionality of MSCs. These findings suggest that culturing 
within the perfusion bioreactor system may pre-condition the ASCs, altering their 
capacity to stimulate regeneration via paracrine-mediated mechanisms. Analysis in the in 
vivo model indicated that culturing within the bioreactor prior to implantation enhanced 
the recruitment of CD31+ endothelial cells, as well as CD26+ host cells, into the implants, 
which may have contributed to the enhanced angiogenesis and adipogenesis previously 
observed in this group. While there was no significant difference in total macrophage 
recruitment between the groups based on analysis of F4/80 and CD68 expression, greater 
infiltration of CD163+ macrophages was observed in the dynamic group at 8 weeks, 
indicative of a shift towards a more pro-regenerative macrophage response. Future 
studies should focus on de-coupling the effects of increased initial cell density versus 
altered cell function in modulating the host response. Overall, the findings support the 
further investigation of shear stress stimulation as a means to pre-condition ASCs and 
enhance their capacity to stimulate angiogenesis and tissue regeneration through indirect 
mechanisms.   
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Chapter 4  
4 Development of a rocking bioreactor system for the 
dynamic culture of adipose-derived stromal cells on 
decellularized adipose tissue coatings 
4.1 Abstract 
The development of bioreactor systems for promoting the expansion of pro-regenerative 
cell populations is of significant interest in the fields of tissue engineering and 
regenerative medicine. The mechanical stimulation that can be induced by dynamic 
culture can modulate cell phenotype and function, including paracrine factor secretion. 
The focus of this work was on the preliminary exploration of a novel rocking bioreactor 
system that incorporated coatings derived from tissue-specific extracellular matrix 
(ECM) as a dynamic preconditioning strategy for human adipose-derived stromal cells 
(ASCs). More specifically, the studies compared the response of ASCs seeded on fibrous 
coatings fabricated from human decellularized adipose tissue (DAT) or uncoated controls 
and cultured either dynamically on the rocking platform or statically for up to 7 days. 
Analysis of the ASC immunophenotype through multi-colour flow cytometry showed 
that dynamic culture on the DAT coatings significantly enhanced the expression of 
CD146 in the CD90+CD29+ ASC population compared to all other conditions. Further, 
pilot study results indicated that dynamic culture on the DAT coatings stimulated the 
expression of inducible nitric oxide synthase (iNOS) and promoted cell alignment at 7 
days, suggesting that there was a change in cell phenotype in this group. Analysis of the 
expression of a range of pro-regenerative gene markers through a custom qPCR array 
identified no significant differences between the groups, suggesting that the dynamic 
culture conditions require further optimization. Collectively, these studies provide initial 
support for the further exploration of this new rocking bioreactor system incorporating 
the DAT coatings as a potential strategy to modulate the pro-regenerative capacity of 
human ASCs through cell expansion under dynamic conditions.  
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4.2 Introduction  
The repair of damaged and deficient subcutaneous adipose tissue remains a significant 
clinical challenge in the fields of plastic and reconstructive surgery, and there is a clear 
need for new approaches that stimulate the regeneration of healthy host-derived adipose 
tissue and support long-term volume augmentation18,377. Recent advances in adipose 
tissue engineering have shown that combining tissue-specific bioscaffolds with 
regenerative cell populations may be a promising strategy for this clinical 
application169,170,255,258,259,449. 
Research in the Flynn lab has focused on the development of a broad range of bioscaffold 
formats derived from decellularized adipose tissue (DAT), including 3-D scaffolds253, 
foams227, microcarriers257, coatings385 and hydrogels255. These unique adipose-derived 
bioscaffolds have been shown to provide a highly supportive microenvironment for the 
adipogenic differentiation of human adipose-derived stromal cells (ASCs) in culture253–
255,257,260,385. Moreover, DAT scaffolds seeded with allogeneic ASCs stimulated host-
derived adipose tissue regeneration within the implants when delivered subcutaneously in 
immunocompetent Wistar rats169,255.  
Building from this work, a scaffold-based perfusion bioreactor system was developed 
with the goal of promoting human ASC expansion and infiltration on the DAT 
scaffolds413. Dynamic culture of the ASCs on the DAT scaffolds within the perfusion 
bioreactor under 2% O2 for 14 days was shown to enhance ASC proliferation relative to 
bioreactor culture under 20% O2 and static culture controls413. Further, when implanted 
subcutaneously in an athymic mouse (nu/nu) model, angiogenesis and adipogenesis were 
markedly enhanced in the ASC-seeded scaffolds that had been cultured within the 
bioreactor for 14 days under 2% O2 prior to implantation413. Subsequent studies in 
Chapter 3 of this thesis supported that in addition to promoting ASC expansion, dynamic 
culture on the DAT scaffolds within the bioreactor modulated the ASC phenotype and 
paracrine factor secretion profile. 
While the pro-regenerative effects were promising, scaling up the perfusion bioreactor 
system to be able to generate scaffolds of sizes suitable for clinical applications in 
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humans would be a significant challenge. In particular, ASCs cultured within this system 
were found in higher density along the periphery of the DAT scaffolds, suggesting that 
there was limited medium perfusion into the central regions of the DAT scaffolds413. In 
these previous studies, an integrated approach was applied in which the ASCs were 
expanded on the same DAT scaffolds on which they would be delivered. The findings 
suggest that a better strategy may be to develop separate platforms for ASC expansion 
and delivery that would be more readily scalable. Focusing on the ASC expansion 
platform, rocking bioreactor systems are an interesting alternative, as they have been 
successfully applied for the culture of embryonic stem cells (ESCs)450, human bone 
marrow-derived mesenchymal stromal cells (MSCs)451, dermal fibroblasts452 and 
lymphocytes453. These systems leverage gravity to drive an oscillating fluid motion that 
ensures thorough mixing of the media and applies shear stress to the cells in culture451. 
This shear stress stimulation has the potential to promote cell expansion454 and modulate 
cell phenotype including paracrine function451.  
The focus of this study was to perform a preliminary assessment of a novel rocking 
bioreactor system as a new approach for the dynamic preconditioning of human ASCs. 
Recognizing the innate cell-instructive capacity of the extracellular matrix (ECM)256,260, 
the effects of incorporating fibrous DAT coatings (~150 m thick) as a substrate within 
this system were explored. In contrast to conventional culture on tissue culture 
polystyrene (TCPS), the DAT coatings have a complex ECM ultrastructure and 
mechanical properties (Young’s modulus ~40 kPa) more similar to native tissues385. 
Further, culturing human ASCs on the DAT coatings was shown to significantly enhance 
their expansion and adipogenic differentiation under static culture conditions relative to 
similar collagen-based coatings and uncoated TCPS controls385. In the current study, 
human ASCs were seeded onto the DAT coatings or uncoated controls and cultured for 
up to 7 days either dynamically on the rocking platform or statically under 2% O2, 
selected based on the previous perfusion bioreactor studies413. Multi-colour flow 
cytometry was performed to characterize the ASC immunophenotype after 7 days of 
culture. Immunohistochemical analyses assessed the effects of dynamic culture on the 
ASC morphology and expression of inducible nitric oxide synthase (iNOS), a marker 
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associated with immunomodulatory function in MSCs124,133,415. Finally, gene expression 
analyses were conducted using a custom-made qPCR array to probe for changes in the 
expression levels of a range of markers associated with soft tissue regeneration between 
the groups. 
4.3 Methods 
4.3.1 Materials 
Unless otherwise stated, all materials were purchased from Sigma Aldrich Canada Ltd. 
(Oakville, Canada), and all antibodies for immunostaining were purchased from Abcam 
(Cambridge, USA).  
4.3.2 Human ASC isolation and DAT coating fabrication  
Human adipose tissue was processed to either isolate ASCs238 or decellularized253 using 
published methods. In brief, surgically discarded adipose tissue was collected with 
informed consent from the University Hospital and St. Joseph’s Hospital in London, 
Canada and transported to the laboratory in sterile phosphate buffered saline (PBS) with 
2% bovine serum albumin (BSA) on ice. The protocols for this study were reviewed and 
approved by the Human Research Ethics Board at Western University (REB# 105426). 
The ASCs were cultured (37°C, 5% CO2) in proliferation medium comprised of 
DMEM:Ham’s F12 (Wisent, St. Bruno, Canada) supplemented with 10% fetal bovine 
serum (FBS) (Wisent, St. Bruno, Canada) and 100 U/mL penicillin and 0.1 mg/mL 
streptomycin (1% pen-strep) (ThermoFisher, Waltham, USA). The cells were frozen at 
passage 1 (P1) until ready for use. 
Decellularized tissues from multiple donors were pooled and fabricated into DAT 
coatings based on published work385. Briefly, the DAT was finely minced and cryo-
milled prior to decontamination through rinsing in 70% ethanol overnight under constant 
agitation at room temperature. The milled DAT was then rinsed in PBS (3 x 15 min) and 
digested with α-amylase (3% w/v in 0.25 M NaH2PO4) at room temperature under 
constant agitation at 300 RPM for 3 days. The digested samples were then washed in 5% 
NaCl (w/v in deionized H2O) for 10 min, resuspended at a concentration of 25 mg 
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DAT/mL in 0.2 M acetic acid, and homogenized (PowerGen Model 123 homogenizer, 
Fisher Scientific, Ottawa, Canada) to generate a DAT suspension. The DAT suspension 
was plated in 4-well rectangular plates (ThermoFisher) at a volume of 3 mL per well and 
air dried at room temperature within a biological safety cabinet overnight. For 
immunohistochemical characterization studies, rectangular glass coverslips were 
positioned within the wells prior to the coating application. 
4.3.3 ASC seeding 
The DAT coatings were washed twice in sterile PBS immediately prior to seeding. 
Passage 3 (P3) ASCs were seeded on the DAT coatings or uncoated control wells at a 
density of 5,000 cells/cm2 in proliferation medium and incubated overnight (37°C, 5% 
CO2, ~20% O2) to promote cell attachment. Subsequently, the seeded well plates were 
transferred to the rocking platform (Thermo Scientific Compact Digital Rocker) 
(Appendix Figure A.14) and cultured dynamically at a frequency of 30 RPM and a 
rocking angle of 13° under 2% oxygen tension (2% O2/93% N2/5% CO2, 37°C) 
controlled using a tri-gas incubator (ThermoFisher Forma Series II 3110) for up to 7 
days. Static culture controls were also included in all assays, to generate a total of 4 
experimental conditions: (i) static uncoated, (ii) static DAT-coated, (iii) dynamic 
uncoated, and (iv) dynamic DAT-coated.   
4.3.4 Multi-colour flow cytometry 
To explore the effects of dynamic culture on the DAT coatings on the ASC 
immunophenotype, multi-coloured flow cytometry analysis was performed to assess the 
expression levels of the positive ASC markers CD90 and CD29, along with the variable 
markers CD26, CD34 and CD146. Gating was performed to exclude any contaminating 
CD31+ endothelial cells and CD45+ hematopoietic cells. After 7 days of culture under 
static or dynamic conditions, the cells were trypsin-released through incubation in 0.25% 
Trypsin/EDTA (325-043-CL, Wisent, St. Bruno, Canada) for 10 min at 37°C. The 
suspended cells were filtered through a 100 µm nylon mesh and then stained with calcein 
violet-AM (BioLegend) for 25 min. The stained cells were then centrifuged at 500 xg for 
7 min at 4°C prior to antibody staining and flow analysis following the methods 
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described in Section 3.3.4. For the analyses, duplicate wells were pooled per condition 
(n=2 wells pooled) to obtain sufficient cell numbers and the studies were repeated with a 
total of 3 different ASC donors (N=3). 
4.3.5 Immunohistochemical analysis of ASC morphology and 
iNOS expression 
A pilot study was performed to probe the effects of dynamic culture on the DAT coatings 
on the ASC morphology and expression of iNOS as a potential marker of phenotypic 
changes in the ASCs133. Samples prepared with ASCs from one donor (N=1) were 
collected after 1, 3 and 7 days of culture, fixed in 4% paraformaldehyde for 5 min, and 
washed 3 times in PBS. The samples were then stained overnight with a rabbit anti-iNOS 
antibody (ThermoFisher PA1-036, 1:200 dilution) diluted in PBS-T (0.1% Tween-20 
supplemented with 1% BSA) at 4°C before being stained with a goat anti-rabbit antibody 
conjugated with Alexa Fluor® 594 (1:200 dilution) diluted in PBS-T for 1 h at room 
temperature. To visualize the cell morphology, staining with Alexa Fluor® 680 Phalloidin 
(Abcam AB176760) was performed in accordance with the manufacturer’s protocols. 
Finally, the samples were counterstained with Hoechst 33258 (ThermoFisher) to 
visualize the cell nuclei and mounted in Fluoroshield Mounting Medium. The samples 
were visualized with an EVOS® FL Cell Imaging System under 20X magnification. The 
number of iNOS+Hochest+ cells was quantified using ImageJ software in 15 randomly 
selected non-adjacent fields of view per condition per timepoint. 
4.3.6 PrimePCR™ array analysis of gene expression 
To probe whether dynamic culture on the DAT coatings altered the gene expression 
profile of the human ASCs, analysis was performed using a custom-made PrimePCR™ 
Array (BioRad) that included genes associated with (i) angiogenesis, (ii) inflammation, 
(iii) ECM synthesis, and (iv) ECM remodeling. Appendix Table A.2 lists the specifics of 
the 26 genes of interest included in the array. The total cellular RNA from duplicate 
sample wells was extracted and pooled from all four conditions after 7 days of culture 
using PureZol® RNA Isolation Reagent (BioRad) and the Aurum® Total RNA Mini kit 
(BioRad). cDNA was synthesized from 2 µg of input RNA with an iScript® cDNA 
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synthesis kit (BioRad). The PrimePCR™ Array was performed in accordance with the 
manufacturer’s protocols with duplicate samples (n=2) of 25 ng of cDNA per well, and 
repeated with ASCs from a total of three different donors (N=3).  The expression of all 
genes of interest was normalized against the geometric mean of the reference genes UBC, 
GAPDH and RSP18 using BioRad CFX Maestro® Software. Data was normalized against 
the static uncoated group for comparative purposes. 
4.3.7 Statistical analysis 
All numerical values are represented as the mean ± standard deviation. Statistical 
analyses were performed using GraphPad Prism® version 6 by one-way ANOVA and 
followed with a Tukey’s post-hoc test. Differences were considered statistically 
significant at p<0.05. 
4.4 Results 
4.4.1 Dynamic culture of ASCs on the DAT coatings enhanced the 
expression of CD146 within the CD90+CD29+ human ASC 
population 
Multi-colour flow cytometry analysis was performed to assess the effects of dynamic 
culture on the DAT coatings on the immunophenotype of the cultured human ASCs. For 
all groups, CD31+CD45+ cells accounted for <2.5% of all viable cells, and >90% of the 
viable CD31-CD45- population was CD90+CD29+, confirming their stromal origin (Table 
4.1). The CD90+CD29+ human ASCs were also highly positive for CD26 and showed 
donor-dependent variability in terms of CD34 expression, with no significant differences 
between the four culture conditions for either of these markers (Table 4.1). Interestingly, 
a significantly greater percentage of the CD90+CD29+ cell population was CD146+ in the 
dynamic DAT-coated group as compared to all other conditions following 7 days of 
culture (Table 4.1). Representative scatter plots for the CD26 and CD34 analyses are 
shown in Appendix Figure A.15, and for CD146 are shown in Figure 4.1.  
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Table 4.1 The percentage of live CD90+ CD29+CD31-CD45- cells that were positive 
for CD26+, CD34+ and CD146+ (n=2 wells pooled, N=3 trials with different ASC 
donors). 
 Static 
Uncoated 
Static  
DAT-coated 
Dynamic 
Uncoated 
Dynamic 
DAT-coated 
Viable Cells (calcein 
violet-AM+) 94.7 ± 3.7 % 94.4 ± 1.5% 94.4 ± 4.8% 97.2 ± 1.0% 
CD90+CD29+CD31-
CD45- (of viable cells) 89.5 ± 6.7% 89.8 ± 1.6% 82.7 ± 4.8% 87.6 ± 6.8% 
CD90+CD29+CD31-
CD45-CD26+  94.3 ± 5.4% 94.7 ± 6.3% 92.8 ± 4.9% 91.5 ± 7.1% 
CD90+CD29+ CD31-
CD45- CD34+  18.8 ± 25.0% 13.0 ± 18.3% 11.9 ± 15.4% 10.2 ± 12.7% 
CD90+CD29+ CD31-
CD45-CD146+  3.1 ± 1.1% 6.9 ± 4.4% 2.1 ± 0.8% 13.9 ± 3.2% 
 
 
Figure 4.1 Dynamic culture of human ASCs on the DAT coatings for 7 days on the 
rocking platform enhanced the expression of CD146 in the CD90+CD29+ cell 
population. Representative scatter plots showing the fluorescence intensity of CD146 
versus the forward scatter area (FSC-A). 
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4.4.2 Dynamic culture of ASCs on the DAT coatings promoted cell 
alignment and upregulated iNOS expression  
Immunohistochemical analysis was performed to probe the morphology and iNOS 
expression patterns in the human ASCs that were cultured dynamically or statically on 
the DAT coatings or uncoated controls for 1, 3 and 7 days. Notably, there was a 
qualitative reduction in the number of cells visualized in the dynamic DAT-coated group 
from 1 to 3 days, suggesting that the shear stress stimulation may have caused initial cell 
detachment in this group, but higher densities were observed at day 7 (Figure 4.3A). At 
both 3 and 7 days, the ASCs were observed to have a more spindle-like morphology 
when cultured on the DAT coatings, with less cell spreading as compared to the uncoated 
controls. Interestingly, the ASCs in the dynamic DAT-coated group appeared to align 
perpendicular to the direction of the fluid flow at day 7 (Appendix Figure A.17). iNOS+ 
cells were observed in the dynamic DAT-coated group at both 3 and 7 days. 
Quantification of the iNOS+Hoechst+ cell population indicated that there was a marked 
increase in the iNOS+ cell density in the dynamic DAT-coated group as compared to all 
other groups at 7 days in this pilot study (Figure 4.3B).  
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Figure 4.2 Dynamic culture of human ASCs on the DAT coatings promoted iNOS 
expression at 7 days in vitro. A) Representative images showing iNOS (red), F-actin 
(green) and nuclei (blue) at 1, 3 and 7 days of culture. ASCs cultured on the DAT 
coatings showed a more spindle-like morphology at 3 and 7 days, with alignment 
perpendicular to the direction of the fluid flow in the dynamic group at 7 days. Scale bars 
represent 100 µm. B) Quantification of iNOS+Hoechst+ cell density at 1, 3 and 7 days 
(N=1 trial with one ASC donor). A total of 15 non-overlapping images were analyzed in 
each sample. Values represent the mean ± standard deviation. 
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4.4.3 Dynamic culture of the human ASCs on the DAT coatings 
did not significantly alter the gene expression patterns of a 
range of pro-regenerative markers 
The expression of 26 selected genes associated with (i) angiogenesis, (ii) inflammation, 
(iii) ECM synthesis and (iv) ECM remodeling  was assessed through a custom-made PCR 
array to probe the effects of the rocking bioreactor strategy on the expression levels of a 
range of markers associated with soft tissue regeneration (Appendix Table A.2). 
Amplification was observed for all genes with the exception of IL4, which was excluded 
from the analysis. There was donor variability in the response, and no significant 
differences were observed between the various culture conditions for any of the genes 
(Figure 4.3). To aid in visualization of the trends, Appendix Figure A.16 shows the data 
alternatively plotted as a heat map.  While not significant, many of the genes associated 
with angiogenesis and inflammation appeared to be down-regulated in the ASCs cultured 
statically or dynamically on the DAT coatings or dynamically on the uncoated controls 
relative to the static uncoated group. Notably while a number of the ECM synthesis 
markers (i.e. COL3A1, COL4A1, CTGF) were downregulated in the ASCs cultured 
dynamically on the DAT coatings relative to the static uncoated controls, the ECM 
remodeling markers TGFB1, MMP1, and MMP2 were all upregulated, while TIMP1 was 
downregulated (Figure 4.3D).  
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Figure 4.3 Analysis of the effects of the varying culture conditions on the expression 
levels of a range of gene markers associated with soft tissue regeneration in the 
ASCs after 7 days of culture. Relative expression levels normalized to the static 
uncoated group for gene markers associated with A) angiogenesis, B) inflammation, C) 
ECM synthesis and D) ECM remodeling. The data is plotted on a log2 scale and the error 
bars represent the standard deviation (n=2 technical replicate samples/trial, N=3 trials 
with different ASC donors).  
A)
B)
C)
D)
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4.5 Discussion 
Many recent studies have emphasized that ASCs can be harnessed to stimulate 
regeneration within engineered bioscaffolds for a broad range of cell therapy 
applications, including adipose tissue engineering40,449,455–459. From a translational 
perspective, there is a need for improved cell expansion strategies that can be applied to 
obtain large populations of cells with predictable pro-regenerative functionality from 
relatively small tissue biopsies. While adipose tissue is regarded as a rich source of 
MSCs, typical yields of 1 x 105 - 4 x 105 ASCs can be extracted per gram of human 
adipose tissue70,71, while it is estimated that cell doses in the range of 107 - 1010 cells/mL 
would be required for many clinical applications in humans460.  
Although conventional culture on 2-D TCPS remains the standard approach, prolonged 
culture on these rigid substrates is associated with a loss of regenerative potential in 
ASCs257,393, including their capacity to proliferate and differentiate, which may impact 
the overall effectiveness of adipose tissue regeneration strategies applying these cell 
populations. To address this limitation, 3-D culture systems have been explored as an 
alternative expansion strategy257,305,308,325,381,389–391,413. In the context of adipose tissue 
engineering, a perfusion bioreactor system was previously applied to expand human 
ASCs on 3-D DAT scaffolds that could also be used as a cell delivery platform413. In 
addition to promoting ASC expansion, culturing the ASCs on the DAT scaffolds within 
the perfusion bioreactor under 2% O2 for 14 days enhanced their capacity to stimulate in 
vivo adipose tissue regeneration413. However, scaling up this bioreactor system for 
clinical implementation in humans would be technically challenging. As such, an 
alternative, more scalable rocking bioreactor platform was explored in this pilot study.   
Relative to 3-D perfusion bioreactor systems, the rocking bioreactor offers advantages in 
that it can both support cell expansion and act as a preconditioning platform, while 
remain highly scalable, as these systems can easily be stacked to enable mass culturing. 
Fundamentally, a rocking bioreactor platform leverages a back-and-forth rocking motion 
to drive an oscillating fluid flow, which can deliver fluid shear stress and promote the 
efficient distribution of nutrients to the cultured cell populations. Within the system 
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developed in the current study, all of the cells would be subjected to shear stress 
stimulation induced by the flow of the media. In contrast, previous evidence suggested 
that there was limited media perfusion into the central regions of the DAT scaffolds 
cultured within the perfusion bioreactor system, which resulted in heterogeneity in the 
cellular response in terms of both proliferation and phenotype413. 
Recognizing the importance of both the complex ECM composition and mechanical 
properties in directing cell function461, DAT coatings were incorporated as a substrate 
within the new dynamic culture system385. Human DAT was selected as a tissue-specific 
substrate, as it has been shown to support ASC proliferation and adipogenesis255,257,260,385. 
For example, the favorable properties of DAT-based biomaterials in terms of ASC 
proliferation were demonstrated in a study where DAT-derived microcarriers were shown 
to better support the proliferation of human ASCs as compared to commercially-available 
Cultispher-S microcarriers, which are gelatin-based257. More recently, human ASC 
proliferation under static conditions was shown to be enhanced on DAT coatings similar 
to those used in the current study relative to both collagen-derived coatings and uncoated 
TCPS385.  
In addition to supporting cell expansion, there is evidence that culturing on DAT-derived 
biomaterials may be favorable for enhancing the secretion of pro-regenerative paracrine 
factors. More specifically, a recent comparison of human fibroblasts cultured on 
structurally and biomechanically similar DAT-derived and collagen-derived foams 
demonstrated that pro-angiogenic growth factor production was significantly increased in 
the cells cultured on the DAT foams, including hepatocyte growth factor (HGF) and 
vascular endothelial growth factor A (VEGFA)462.  
The findings in Chapter 3 of this thesis support that fluid shear stress stimulation can be 
applied to modulate the phenotype of the human ASCs and potentially enhance their pro-
regenerative paracrine functionality. In the current study, the flow cytometry analyses 
support that fluid shearing can alter the ASC phenotype, with a significantly higher 
percentage of the CD90+CD29+ population expressing CD146 in the ASCs cultured on 
the DAT coatings on the rocking platform. Although CD146 is commonly regarded as a 
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surface marker for pericytes419,420, its expression in ASCs has been associated with an 
increased capacity for proliferation, clonogenicity and trilineage differentiation87. 
Additionally, this surface marker is also strongly associated with an increased capacity to 
support endothelial tube formation, suggesting that this specific subpopulation is more 
pro-angiogenic86,463. While ASCs are known to express CD146, it is typically expressed 
in a small fraction of the overall population at early passages when cultured on TCPS 
(<10%)464,465. The marked enrichment of the CD146+ population in the dynamic DAT 
coated group relative to the more conventional static uncoated group may be a positive 
indicator in terms of the pro-regenerative potential of the cells expanded on the new 
platform, which should be explored further in future work.  
Preliminary evidence also suggests that the shearing forces from the rocking bioreactor 
system also induced iNOS expression in the ASCs that were cultured on the DAT 
coatings, consistent with the findings from the perfusion bioreactor study in Chapter 3. 
These observations are also similar to a study by Bassaneze et al. which demonstrated 
that subjecting ASCs to a shearing stress of 10 dyn/cm2 for 96 h was sufficient to 
upregulate iNOS expression and promote nitric oxide (NO) production289,466. Since iNOS 
expression has been associated with an increase in the pro-regenerative capacity of 
MSCs124,133,415, the pilot data from this study supports the further investigation and 
development of the new rocking bioreactor platform, including confirming the response 
in multiple ASC donors.  
While the immunophenotype and IHC studies were a promising indication that culturing 
the ASCs on the DAT coatings under dynamic conditions on the rocking platform 
modulated the ASC response, the gene expression findings suggest that further 
optimization of the system is required. While no significant differences were observed 
between the groups, the trend towards the reduced levels of expression of a range of pro-
angiogenic and immunomodulatory factors under dynamic conditions relative to the static 
uncoated controls is an indicator that the selected conditions were not favorable for 
stimulating paracrine factor expression in the cultured ASCs. Further, the qualitative 
reduction in the number of cells observed on the DAT coatings in the dynamic group 
from 1 to 3 days suggests that excessive shear forces may have been applied that were 
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disruptive to the cells and potentially the coatings. This interpretation may be supported 
by the qPCR array results that showed a shift towards higher expression of genes 
associated with matrix degradation, combined with reduced expression of a number of 
ECM components, suggestive of a more catabolic response that may be detrimental for 
regeneration467. Within the rocking bioreactor system, a broad range of parameters could 
be refined, including the rocking speed, rotation angle, media volume, and culture 
duration, with the goal of promoting a more desirable response. In addition, the gene 
expression results should be further validated at the protein level in a larger number of 
ASC donors. 
4.6 Conclusions 
The present study provided initial evidence to support the further investigation of this 
new scalable rocking bioreactor system integrating tissue-specific ECM-derived coatings 
to dynamically culture and precondition human ASCs, towards the long-term goal of 
promoting cell expansion and enhancing the pro-regenerative functionality of the cells 
through shear stress stimulation. The system is cost-effective and simple to use and 
appears to stimulate a more homogeneous response across the cultured ASC population 
relative to what was observed in the previous perfusion bioreactor strategy. Another 
advantage to this new approach is that the cells can easily be extracted from the DAT 
coatings through enzymatic digestion, for subsequent incorporation into a range of cell 
delivery platforms. The preliminary findings supported that dynamic culture on the DAT 
coatings modulated the ASC phenotype, enhancing the expression of CD146 and iNOS, 
which may be positive indicators in terms of their pro-angiogenic and 
immunomodulatory functionality. However, the gene expression results suggest that 
optimization is required to assess whether this dynamic culture strategy can be harnessed 
to stimulate ASC paracrine factor production. In addition, further studies are required to 
characterize ASC proliferation over time and the capacity of the expanded cells to 
support in vivo angiogenesis and adipose tissue regeneration.  
  
117 
 
Chapter 5  
5 General discussion and future work 
5.1 General discussion 
To address the clinical need in plastic and reconstructive surgery for a therapeutic 
strategy with the capacity to promote the stable regeneration of subcutaneous soft tissues, 
the Flynn lab pioneered the development of decellularized adipose tissue (DAT) as an 
off-the-shelf adipose tissue substitute253. Over the past 10 years since its initial 
development, the DAT has been fabricated into an array of bioscaffolds that have been 
shown to have adipo-inductive properties229,255,257,385,462. Moreover, the DAT can be 
combined with adipose-derived stromal cells (ASCs), which was previously shown to 
significantly enhance angiogenesis and constructive remodeling of the scaffolds into 
host-derived adipose tissue in an immunocompetent rat model169. This work was crucial 
in highlighting the important role that ASCs can play in mediating key processes 
involved in adipose tissue regeneration. Recognizing both the capacity of the ASCs to 
stimulate regeneration and of the DAT to provide a supportive microenvironment for 
adipogenesis, a perfusion bioreactor strategy was developed with the goals of promoting 
(i) ASC expansion and infiltration on the DAT and (ii) enhancing the pro-regenerative 
function of the ASC-seeded DAT.  
The capacity of the perfusion bioreactor system to support ASC expansion on the DAT 
addressed the limitations that were associated with the static seeding methods that had 
previously been applied, which can lead to low attachment and a heterogeneous 
distribution of ASCs primarily on the surface of the DAT. While it may be possible to 
expand a large number of ASCs on 2-D tissue culture polystyrene (TCPS) before seeding 
on the DAT, prolonged proliferation under these conditions is often associated with a 
decreased potential for the ASCs to promote regeneration257,393. As such, 3-D culture 
systems represent a promising approach to circumvent this challenge by enabling the 
cells to be directly expanded on a bioscaffold that more closely mimics the biochemical, 
biomechanical, and structural properties of the native cellular microenvironment, which 
play important roles in directing cell function247,256,260. In terms of 3-D culture systems, a 
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diverse range of bioreactors257,305,308,325,381,389–391,413, including spinner flasks254,308,388,392 
and rotating wall vessels88,306,307,309 have been explored. However, these bioreactor 
systems are typically designed such that the expanded cells are enzymatically released 
from their 3-D expansion platforms for downstream tissue engineering applications303,394. 
In contrast, the perfusion bioreactor system was designed with the goal of promoting cell 
expansion and in vivo delivery on the same scaffold system.  
While perfusion bioreactor systems have primarily been explored for generating highly 
cellularized bone tissue grafts310,312,314,316,317,319, the studies outlined in Chapter 2 provide 
a strong case for their use in adipose tissue engineering applications. In particular, the 
increased density of ASCs that was found along the periphery of the DAT scaffolds that 
were cultured in the perfusion bioreactor under hypoxic conditions (2% O2) is consistent 
with previous studies316,319. For example, Xie et al. demonstrated that sheep bone 
marrow-derived mesenchymal stromal cells (MSCs) seeded on porous β-tricalcium 
phosphate ceramic bioscaffolds and cultured in a perfusion bioreactor were significantly 
more proliferative than controls cultured under static conditions over 28 days317. 
Furthermore, the perfused regions of the ceramic scaffolds contained a high density of 
MSCs with a homogeneous distribution317. While similar cell expansion effects were 
observed in the present study, the cell distribution patterns also suggest that the central 
regions of the DAT bioscaffolds may have been poorly perfused. The greater density of 
ASCs along the periphery of the scaffold may have been caused by an increased delivery 
of nutrients from the culture medium397,398, which could have also driven the migration of 
cells from the central region to the periphery, in addition to promoting the proliferation of 
cells around the scaffold border. These observations provided a case for developing an 
alternative system where the cells could be in contact with the DAT but receive more 
uniform exposure to the media and shear stress stimulation, which served as the rationale 
for the development of the rocking bioreactor ASC expansion platform incorporating the 
DAT coatings outlined in Chapter 4.  
Increasing the density of the ASCs on the DAT was likely a mechanism through which 
dynamic culturing in the perfusion bioreactor enhanced the capacity of the ASC-seeded 
DAT to promote blood vessel formation and constructive adipose tissue remodeling 
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following implantation in the subcutaneous thymic nude (nu/nu) mouse model in Chapter 
2413. However, shear stress has also been shown to affect the function of MSC 
populations290,291,313,326. For example, Yuan et al. showed that subjecting human bone 
marrow-derived MSCs to 2 Pa of shear could increase vascular endothelial growth factor 
A (VEGFA) expression compared to static controls290. In a more recent study, Bravo et 
al. demonstrated that intermittent fluid flow upregulated the expression of VEGFA, 
hepatocyte growth factor (HGF) and follistatin in human ASCs in vitro423. These studies 
support that shear stress stimulation can be applied as a strategy to precondition MSCs to 
enhance their capacity to stimulate in vivo regeneration.  Their findings contributed to the 
motivation to probe potential changes in the ASC phenotype and paracrine function 
following culture on the DAT within the perfusion bioreactor under 2% O2 in Chapter 3.  
Previous studies have shown that human ASCs that were subjected to 10 dyn/cm2 of 
shear stress upregulated the expression of nitric oxide (NO) through inducible nitric oxide 
synthase (iNOS)289. As such, the increased iNOS expression in the ASCs within the 
peripheral regions of the DAT that were dynamically cultured in the perfusion system not 
only supports that those cells were experiencing fluid shear, but may be phenotypically 
altered. To further compare the ASCs that were cultured dynamically or statically on the 
DAT, the expression of key angiogenic factors and cytokines that were identified to be 
altered in the PCR array was analyzed with a multiplex Luminex Assay. An increase in 
interleukin 10 (IL-10) and C-X-C motif chemokine (CXCL-10) expression in the 
dynamically cultured ASCs suggests that there may be differences in the 
immunomodulatory function of the cells, as these factors have been associated with 
promoting an anti-inflammatory/pro-regenerative macrophage phenotype and 
macrophage recruitment, respectively135,429. Additionally, the increased expression of 
HGF in the dynamically cultured ASCs could correlate with an increased capacity to both 
promote angiogenesis114,115,118 and a more anti-inflammatory/pro-regenerative 
macrophage response433. Further, the down-regulation of interleukin 6 (IL-6) in the 
dynamically cultured ASCs would suggest a decreased capacity to induce a pro-
inflammatory macrophage response143. Together, the in vitro studies from Chapter 3 
suggest that dynamic culturing may enhance the capacity of the ASCs to promote both a 
pro-angiogenic and a pro-regenerative macrophage response. These findings not only 
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align with the results of the in vivo studies, but also provide a strong rationale for 
applying the perfusion bioreactor strategy as a preconditioning system to increase the 
pro-regenerative paracrine capacity of human ASCs through shear stress stimulation.    
ASCs are recognized for their capacity to promote angiogenesis via the secretion of pro-
angiogenic paracrine factors101,265,468,469, which has been leveraged for an array of tissue 
engineering and regenerative applications101,170,470–472. For example, a study by Matsuda 
et al. demonstrated that culturing human ASCs on decellularized cardiac tissue matrix 
(cardiogel) can lead to an increased expression of interleukin 8 (IL-8), basic fibroblast 
growth factor (bFGF) and stromal cell-derived factor 1 (SDF-1) than controls on 
plastic170. Furthermore, these ASCs were shown to better support blood vessel formation 
than cardiogel only control when delivered into the inguinal region of nude rats for 7 
days170. Moreover, a study by Suga et al. demonstrated that the transplantation of 
allogeneic ASCs into the inguinal fat pad in mice promoted blood vessel formation in the 
target tissue at 14 days and this was achieved through the ASC-mediated secretion of 
HGF and VEGF101. In Chapter 3 of this thesis, the qPCR array identified a variety of pro-
angiogenic factors that were up-regulated in the ASCs that were dynamically cultured on 
the DAT, including HGF, TNF, FGF13, AGGF1, and PLG. Follow-up studies to assess 
changes at the protein level confirmed upregulation of HGF using the Luminex® Assay, 
as well as the locally enhanced expression of tumour necrosis factor alpha (TNF-α) in the 
ASCs in the periphery of the DAT scaffolds within the dynamic culture group via 
immunostaining. The increased levels of these pro-angiogenic paracrine factors may have 
contributed to the increased CD31+ endothelial cell recruitment observed starting at 1 
week and the increased density of erythrocyte-containing blood vessels at both 4 and 
weeks in the DAT implants from the 2% O2 dynamic culture group413.  
Previous studies have demonstrated that ASCs can also secrete a wide array of cytokines, 
which can modulate the immune response, including promoting a more pro-regenerative 
macrophage response124,473,474. For example, a study by Anderson et al. demonstrated that 
human ASCs could stimulate the anti-inflammatory polarization of mouse macrophages 
in vitro through the secretion of IL-10475. In a more recent study, human ASCs that were 
seeded on Integra Matrix, a commercially-available wound dressing, were shown to 
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promote macrophage infiltration and a decreased pro-inflammatory macrophage 
response, which led to increased wound closure at 21 days in C57BL/6 mice476. 
Consistent with these studies, the Flynn lab has previously shown that delivering 
allogeneic ASCs on the DAT subcutaneously into Wistar rats promoted a more pro-
regenerative macrophage response associated with enhanced expression of CD163, as 
well as increased blood vessel formation and adipose tissue remodeling of the DAT 
bioscaffolds as compared to unseeded controls169. As previously discussed, the studies in 
the current thesis demonstrated that human ASCs that were dynamically cultured on the 
DAT expressed increased levels of IL-10 in vitro. When delivered in vivo into athymic 
nude mice, a more pro-regenerative macrophage response was observed, with enhanced 
infiltration of CD163+ macrophages into the implants in the dynamic group, coupled with 
an increased angiogenic response and adipose tissue remodeling413. Collectively, the in 
vivo studies in Chapter 3 provided further support that ASCs could modulate the 
macrophage phenotype, which have been an important factor in mediating both 
angiogenesis353 and extracellular matrix remodeling351,447 within the implants.  
In Chapter 2 of this thesis, significantly increased remodeling of the DAT into host-
derived adipose tissue was observed at 8 weeks in the scaffolds that were cultured 
dynamically within the perfusion bioreactor under 2% O2 for 14 days prior to 
implantation, as compared to all other groups. The timeframe in which adipose tissue 
formation was observed in this study was consistent with the previous rat study from the 
Flynn lab, where seeding the DAT with allogeneic ASCs was found to better promote 
adipose tissue remodeling as compared to the DAT scaffold alone at both 8 and 12 
weeks169. Given the highly vascularized nature of mature adipose tissue, it is likely that a 
well-established vasculature and the infiltration of pro-regenerative macrophages with the 
capacity to remodel the DAT would be required before adipose tissue formation could 
occur259,443,477. This interpretation would be consistent with the timing of adipose tissue 
remodeling observed in the in vivo studies from Chapter 2, as well as the reduced 
adipogenic response in the other groups, where there were significantly fewer blood 
vessels infiltrating the implants.  
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Adipogenesis in the context of adipose tissue engineering is an understudied process, and 
little is known about the cell populations that can give rise to mature adipocytes within 
engineered bioscaffolds. However, a study by Rodeheffer et al. identified an adipocyte 
precursor population (CD29+CD34+CD24+stem cell antigen 1+ (SCA-1)) in the stromal 
vascular fraction (SVF) of adipose tissue  that could differentiate into adipocytes in 
vivo374. In a more recent study, a large percentage of this adipocyte precursor cell 
population was also identified as being CD26+375. In Chapter 3 of this thesis, a greater 
host-derived CD26+ cell population was found in the implants in the dynamic group at 1 
week, which could suggest there was enhanced infiltration of adipogenic progenitor cells 
in this group. While CD26 is also expressed on non-adipocyte precursor cells including 
fibroblasts and immune cell populations439–441, the CD26+ cell population may have 
contributed to the increased perilipin+ adipocytes observed at 8 weeks in the implants 
from the 2% O2 dynamic culture group, as shown in Chapter 2.  
5.2 Future directions 
The studies highlighted in this thesis provided important insights into how dynamic 
culture systems could be applied to both expand and precondition ASCs to promote their 
capacity to stimulate adipose tissue regeneration within DAT scaffolds. Based on insights 
acquired from these studies, future work should focus on i) further exploring the effects 
of dynamic culture within the perfusion bioreactor system on modulating ASC function, 
ii) further investigating the mechanisms behind adipose tissue regeneration in vivo and 
iii) further development and optimization of the rocking bioreactor system.  
The perfusion bioreactor was set at a flow rate of 0.5 mL/min in the studies in Chapter 2 
and Chapter 3. While this parameter supported ASC expansion and promoted the 
expression of several key paracrine factors, it is possible that a different flow rate could 
impact the proliferative and secretory behaviour of these cells. For example, a previous 
study has shown that the proliferation capacity of bovine aortic endothelial cells was 
inversely correlated with shear force478. For the perfusion bioreactor used in this study, it 
is possible that the flow rate could be refined to further accelerate ASC expansion on the 
DAT. Moreover, shear stress could also affect the paracrine secretion of the ASCs, as 
shown in Chapter 3 and by Bassazene et al.289. While decreasing the flow rate could be 
123 
 
conducive for ASC expansion, it could also attenuate pro-regenerative paracrine factor 
secretion. Future studies should aim to test a range of flow rates that are both faster and 
slower than the current parameter (e.g. 0.25 mL/min to 1 mL/min). The in vitro studies in 
Chapter 2 could be used as a benchmark to assess proliferation, and the techniques 
developed in Chapter 3 could be adopted as a framework to guide the analysis of 
paracrine factor secretion. Upon in vitro refinement, additional in vivo studies using the 
subcutaneous implantation model in athymic nude mice could be performed for up to 12 
weeks to determine the long-term effects of altering the dynamic culture parameters on 
angiogenesis and adipogenesis within the DAT.  
The in vivo studies highlighted in Chapter 3 indicated that while dynamic culturing of 
ASCs on the DAT did not significantly impact the recruitment of macrophages in the 
nu/nu mouse model, it did result in a more pro-regenerative polarization within the DAT 
implants, with enhanced infiltration of CD163+ macrophages. Given the dynamic nature 
of the immune system, it is possible that the bioreactor cultured implants could have also 
affected the phenotype of macrophages at earlier time points (e.g. 1, 2, 4 and 6 weeks). 
Additionally, dynamic culture was shown to up-regulate IL-10 expression in the human 
ASCs, which can promote a pro-regenerative macrophage phenotype and inhibit pro-
inflammatory macrophage polarization. As such, it is possible that culturing the ASCs on 
the DAT scaffolds under dynamic conditions may have also inhibited the pro-
inflammatory polarization of macrophages at earlier timepoints in vivo. Future studies 
could be performed to further examine the phenotype of macrophages at 1, 2, 4, 6 and 8 
weeks. Potential markers of interest could include CD80, iNOS and Ly6c for pro-
inflammatory macrophage polarization, as well as interleukin 4 (IL4), CD206, CD163 
and Arg-1 for pro-regenerative macrophage polarization. In addition to the 
immunostaining analyses performed in Chapter 3, scaffolds could be digested to isolate 
the infiltrating cells for multi-colour flow cytometry analysis to identify specific 
macrophage populations with distinct functions that may be relevant for regeneration. An 
in-depth understanding of the immune response would provide important insights into the 
role of macrophages in mediating adipose tissue regeneration.  
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The selection of in vivo analyses in both Chapter 2 and Chapter 3 examined the effects of 
dynamic culturing of the ASCs on the DAT prior to implantation on the host response, 
with a particular focus on angiogenesis and the macrophage response. While increased 
angiogenesis and a more pro-regenerative macrophage phenotype are strongly correlated 
with constructive adipose tissue remodeling169,259, how ASCs and/or the DAT promote 
the formation of new host-derived adipose tissue remains poorly understood. Chapter 3 of 
this thesis highlighted the increased infiltration of host-derived CD26+ cells, which may 
have the potential to give rise to adipocytes, within the implants in the dynamic group at 
1 week. However, it remains unclear whether this population contributed to adipogenesis. 
Therefore, further investigation of this cell population could provide greater insight into 
the potential mechanisms behind the observed adipose tissue regeneration within the 
DAT implants. More specifically, implanted DAT scaffolds could be extracted, and 
enzymatically digested to generate cell suspensions that could be analyzed using multi-
colour flow cytometry for the adipocyte precursor markers CD26, CD24, CD34, CD29 
and SCA-1374. Understanding if these cells are present and the role these cells may play 
in mediating adipogenesis would allow for the design of more targeted and efficient 
therapeutic strategies to support adipose tissue regeneration.  
The preliminary development of the rocking bioreactor system described in Chapter 4 
demonstrated initial promise as a dynamic culturing system that could harness the cell-
instructive capacity of the DAT and shear stress stimulation to modulate the pro-
regenerative potential of the ASCs. The PCR Array performed did not indicate significant 
differences in the gene expression levels of a range of pro-regenerative markers, which 
suggests that the parameters used for the rocking system require further refinement. More 
specifically, a combination of different rocking angles, frequencies and medium volumes 
should be tested to first identify the amount of shear (dyn/cm2) the cells are experiencing 
before moving forward to determine parameters that could both promote ASC expansion 
as well as upregulate pro-angiogenic and immunomodulatory gene and protein 
expression. Given the initial cell attachment issues observed in the dynamic DAT-coated 
group, reducing the amount of shear by lowering the frequency from 30 RPM to 15 RPM, 
decreasing the rocking angle from 13° to 10° and increasing the media volume from 3 
mL/well to 4 mL/well could be initially tested. In addition to immunophenotypic 
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analyses, further probing for angiogenic gene expression with qPCR and protein 
expression with Luminex® Assays would help to determine a range of parameters to 
move forward with in vivo assessments.  
For in vivo analysis, the ASCs could be enzymatically released from the DAT coating 
and encapsulated within a previously-developed DAT-methacrylated chondroitin sulfate 
(MCS) composite hydrogel system255. The macrophage, angiogenic and adipogenic 
responses could subsequently be evaluated at 1, 4, 8, 12 and 24 weeks to evaluate both 
the short- and long-term potential of the system to promote angiogenesis and 
adipogenesis, following the methods described in Chapter 3. Overall, the in vitro 
optimization studies and subsequent in vivo validation would be an important next step to 
assess the feasibility of the approach and potential benefits of ASC pre-conditioning 
towards future clinical application.  
5.3 Summary and significance 
The body of work described in this thesis demonstrated that the perfusion bioreactor 
system can be used as both an expansion and preconditioning platform for the human 
ASCs on the DAT. Through dynamic culturing in the perfusion bioreactor system, the 
ASC-seeded DAT scaffolds promoted a more pro-regenerative in vivo response, resulting 
in an increased capacity to support angiogenesis, pro-regenerative macrophage 
polarization and adipogenesis. To the best of my knowledge, this is the first study to 
explore the application of a scaffold-based perfusion bioreactor system for adipose tissue 
engineering. 
The perfusion bioreactor was initially developed as a dynamic culturing platform to 
support ASC expansion on the DAT. The in vivo study clearly demonstrated that the 
ASCs that were cultured on the DAT within this system under 2% O2 exhibited an 
increased capacity to promote both angiogenesis and adipogenesis in 
immunocompromised animals in vivo. Beyond acting as a 3-D expansion platform, the 
perfusion bioreactor altered the ASC phenotype and increased the expression of key 
paracrine factors, which may have contributed to the enhanced infiltration of host-derived 
cell populations and the polarization of host macrophages towards a more 
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pro-regenerative phenotype within the implants. It is postulated that these cell 
populations played an important role in the substantial remodeling of the implants into 
host-derived adipose tissue that was observed in this group at 8 weeks.  
Building on this work, pilot studies were performed to explore an alternative rocking 
bioreactor strategy as a more scalable system that allows for the 3-D culturing of ASCs. 
The preliminary studies performed demonstrated that the rocking bioreactor system 
incorporating the DAT coatings has the potential to alter the ASC phenotype. Overall, 
this work contributes to an emerging body of evidence that dynamic culture under shear 
stress can be applied to modulate the pro-regenerative capacity of MSCs during cell 
expansion.  
127 
 
References 
1. McLafferty, E., Hendry, C. & Alistair, F. The integumentary system: anatomy, 
physiology and function of skin. Nurs. Stand. 27, 35–42 (2012). 
2. Kolarsick, P. A. J., Kolarsick, M. A. & Goodwin, C. Anatomy and Physiology of 
the Skin. J. Dermatol. Nurses. Assoc. 3, 203–213 (2011). 
3. Imanishi, N., Kishi, K., Chang, H., Nakajima, H. & Aiso, S. Three-dimensional 
venous anatomy of the dermis observed using stereography. J. Anat. 212, 669–673 
(2008). 
4. McGrath, J. A. & Uitto, J. Anatomy and Organization of Human Skin. Rook’s 
Textb. Dermatology Eighth Ed. 1, 34–86 (2010). 
5. Lancerotto, L. et al. Layers of the abdominal wall: anatomical investigation of 
subcutaneous tissue and superficial fascia. Surg. Radiol. Anat. 33, 835–842 (2011). 
6. Illouz, Y. G. Study of subcutaneous fat. Aesthetic Plast. Surg. 14, 165–177 (1990). 
7. Trayhurn, P. & Wood, I. S. Signalling role of adipose tissue: adipokines and 
inflammation in obesity. Biochem. Soc. Trans. 33, 1078–1081 (2005). 
8. Wajchenberg, B. L. Subcutaneous and Visceral Adipose Tissue: Their Relation to 
the Metabolic Syndrome. Endocr. Rev. 21, 697–738 (2000). 
9. Wajchenberg, B. L. Subcutaneous and Visceral Adipose Tissue : Endocr. Rev. 21, 
697–738 (2000). 
10. Musi, N. & Guardado-Mendoza, R. Adipose Tissue as an Endocrine Organ. Cell. 
Endocrinol. Heal. Dis. 89, 229–237 (2014). 
11. Patrick, C. W. Tissue engineering strategies for adipose tissue repair. Anat. Rec. 
263, 361–366 (2001). 
12. Statistics, P. American Society of Plastic Surgeons. 2018 Plastic Surgery Statistics 
128 
 
Report. Available at: 
https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-
statistics-full-report-2018.pdf. Accessed Sept 27, 2019. Plast. Surg. 25 (2017). 
13. Pearl, R. A., Leedham, S. J. & Pacifico, M. D. The safety of autologous fat transfer 
in breast cancer: Lessons from stem cell biology. J. Plast. Reconstr. Aesthetic 
Surg. 65, 283–288 (2012). 
14. Serletti, J. M., Man, L. X. & Selber, J. C. Abdominal wall following free TRAM 
or DIEP flap reconstruction: A meta-analysis and critical review. Plast. Reconstr. 
Surg. 124, 752–764 (2009). 
15. Parrett, B. M., Caterson, S. A., Tobias, A. M. & Lee, B. T. DIEP flaps in women 
with abdominal scars: Are complication rates affected? Plast. Reconstr. Surg. 121, 
1527–1531 (2008). 
16. Futter, C. M., Webster, M. H. C., Hagen, S. & Mitchell, S. L. A retrospective 
comparison of abdominal muscle strength following breast reconstruction with a 
free TRAM or DIEP flap. Br. J. Plast. Surg. 53, 578–583 (2000). 
17. Choi, M. et al. The volumetric analysis of fat graft survival in breast 
reconstruction. Plast. Reconstr. Surg. 131, 185–191 (2013). 
18. Kaufman, M. R. et al. Autologous fat transfer for facial recontouring: Is there 
science behind the art? Plast. Reconstr. Surg. 119, 2287–2296 (2007). 
19. Kamakura, T. & Ito, K. Autologous cell-enriched fat grafting for breast 
augmentation. Aesthetic Plast. Surg. 35, 1022–1030 (2011). 
20. Pierre, S., Liew, S. & Bernardin, A. Basics of dermal filler rheology. Dermatologic 
Surg. 41, S120–S126 (2015). 
21. Kim, Z. H. et al. A composite dermal filler comprising cross-linked hyaluronic 
acid and human collagen for tissue reconstructions. J. Microbiol. Biotechnol. 25, 
399–406 (2014). 
129 
 
22. Mochizuki, M., Aoi, N., Gonda, K., Hirabayashi, S. & Komuro, Y. Evaluation of 
the in vivo kinetics and biostimulatory effects of subcutaneously injected 
hyaluronic acid filler. Plast. Reconstr. Surg. 142, 112–121 (2018). 
23. Cohen, J. L. Understanding, avoiding, and managing dermal filler complications. 
Dermatologic Surg. 34, 92–99 (2008). 
24. Hoeller, U. et al. Cosmesis from the patient’s and the doctor’s view. Int. J. Radiat. 
Oncol. 57, 345–354 (2003). 
25. Glynn, S. M. et al. Chronic Posttraumatic Stress Disorder After Facial Injury: A 1-
year Prospective Cohort Study. J. Trauma Inj. Infect. Crit. Care 62, 410–418 
(2007). 
26. Flynn, L., Prestwich, G. D., Semple, J. L. & Woodhouse, K. A. Adipose tissue 
engineering in vivo with adipose-derived stem cells on naturally derived scaffolds. 
J. Biomed. Mater. Res. - Part A 89, 929–941 (2009). 
27. Choi, J. H. et al. Adipose tissue engineering for soft tissue regeneration. Tissue 
Eng. - Part B Rev. 16, 413–426 (2010). 
28. McCarthy, M. E. et al. Therapeutic Applications for Adipose-Derived Stem Cells 
in Wound Healing and Tissue Engineering. Curr. Stem Cell Reports 4, 127–137 
(2018). 
29. Saha, K. et al. Substrate modulus directs neural stem cell behavior. Biophys. J. 95, 
4426–38 (2008). 
30. Xu, R., Boudreau, A. & Bissell, M. J. Tissue architecture and function: dynamic 
reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev. 28, 167–
76 (2009). 
31. Frantz, C., Stewart, K. M. & Weaver, V. M. The extracellular matrix at a glance. J. 
Cell Sci. 123, 4195–4200 (2010). 
130 
 
32. Karamichos, D., Brown, R. A. & Mudera, V. Collagen stiffness regulates cellular 
contraction and matrix remodeling gene expression. J. Biomed. Mater. Res. Part A 
83A, 887–894 (2007). 
33. Li, Q. et al. Photocrosslinkable polysaccharides based on chondroitin sulfate. J. 
Biomed. Mater. Res. A 68, 28–33 (2004). 
34. Ni, H.-C., Tseng, T.-C., Chen, J.-R., Hsu, S.-H. & Chiu, I.-M. Fabrication of 
bioactive conduits containing the fibroblast growth factor 1 and neural stem cells 
for peripheral nerve regeneration across a 15 mm critical gap. Biofabrication 5, 
035010 (2013). 
35. Lutolf, M. P. et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the 
conduction of tissue regeneration: engineering cell-invasion characteristics. Proc 
Natl Acad Sci U S A 100, 5413–5418 (2003). 
36. Hemmrich, K. et al. Autologous In Vivo Adipose Tissue Engineering in 
Hyaluronan-Based Gels-A Pilot Study. J. Surg. Res. 144, 82–88 (2008). 
37. Gilbert, T. W., Sellaro, T. L. & Badylak, S. F. Decellularization of tissues and 
organs. Biomaterials 27, 3675–3683 (2006). 
38. Huber, B., Borchers, K., Tovar, G. E. M. & Kluger, P. J. Methacrylated gelatin and 
mature adipocytes are promising components for adipose tissue engineering. J. 
Biomater. Appl. 30, 699–710 (2016). 
39. Zhou, Q., Li, L. & Li, J. Stem cells with decellularized liver scaffolds in liver 
regeneration and their potential clinical applications. Liver Int. 35, 687–694 
(2015). 
40. Russo, V., Young, S., Hamilton, A., Amsden, B. G. & Flynn, L. E. Mesenchymal 
stem cell delivery strategies to promote cardiac regeneration following ischemic 
injury. Biomaterials 35, 3956–3974 (2014). 
41. Li, J. et al. Iota -carrageenan/chitosan/gelatin scaffold for the osteogenic 
131 
 
differentiation of adipose-derived MSCs in vitro. J. Biomed. Mater. Res. Part B 
Appl. Biomater. 103, 1498–1510 (2015). 
42. Heathman, T. R. et al. The translation of cell-based therapies: Clinical landscape 
and manufacturing challenges. Regen. Med. 10, 49–64 (2015). 
43. Hillel, A. T., Varghese, S., Petsche, J., Shamblott, M. J. & Elisseeff, J. H. 
Embryonic germ cells are capable of adipogenic differentiation in vitro and in 
vivo. Tissue Eng. - Part A 15, 479–486 (2009). 
44. Mauney, J. R. et al. Engineering adipose-like tissue in vitro and in vivo utilizing 
human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 
3D scaffolds. Biomaterials 28, 5280–5290 (2007). 
45. Vashi, A. V. et al. Adipose differentiation of bone marrow-derived mesenchymal 
stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 29, 573–579 
(2008). 
46. Stosich, M. S. et al. Vascularized adipose tissue grafts from human mesenchymal 
stem cells with bioactive cues and microchannel conduits. Tissue Eng. 13, 2881–
2890 (2007). 
47. Fernyhough, M. E. et al. Mature adipocytes may be a source of stem cells for 
tissue engineering. Biochem. Biophys. Res. Commun. 368, 455–457 (2008). 
48. Eto, H. et al. The fate of adipocytes after nonvascularized fat grafting: Evidence of 
early death and replacement of adipocytes. Plast. Reconstr. Surg. 129, 1081–1092 
(2012). 
49. Eto, H. et al. Characterization of structure and cellular components of aspirated 
and excised adipose tissue. Plast. Reconstr. Surg. 124, 1087–1097 (2009). 
50. Condé-Green, A., Gontijo De Amorim, N. F. & Pitanguy, I. Influence of 
decantation, washing and centrifugation on adipocyte and mesenchymal stem cell 
content of aspirated adipose tissue: A comparative study. J. Plast. Reconstr. 
132 
 
Aesthetic Surg. 63, 1375–1381 (2010). 
51. Cowan, C. A. et al. Derivation of Embryonic Stem-Cell Lines from Human 
Blastocysts. N. Engl. J. Med. 350, 1353–1356 (2004). 
52. Vats, A., Tolley, N. S., Bishop, A. E. & Polak, J. M. Embryonic stem cells and 
tissue engineering: Delivering stem cells to the clinic. J. R. Soc. Med. 98, 346–350 
(2005). 
53. Kubo, A. et al. Development of definitive endoderm from embryonic stem cells in 
culture. Development 131, 1651–1662 (2004). 
54. D’Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to 
definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005). 
55. Tran, T. H. et al. Wnt3a-induced mesoderm formation and cardiomyogenesis in 
human embryonic stem cells. Stem Cells 27, 1869–1878 (2009). 
56. Zhang, P. et al. Short-term BMP-4 treatment initiates mesoderm induction in 
human embryonic stem cells. Blood 111, 1933–1941 (2008). 
57. Roche, E., Sepulcre, P., Reig, J. A., Santana, A. & Soria, B. Ectodermal 
commitment of insulin-producing cells derived from mouse embryonic stem cells. 
FASEB J. 19, 1341–1343 (2005). 
58. Rieske, P., Krynska, B. & Azizi, S. A. Human fibroblast-derived cell lines have 
characteristics of embryonic stem cells and cells of neuro-ectodermal origin. 
Differentiation 73, 474–483 (2005). 
59. Nussbaum, J. et al. Transplantation of undifferentiated murine embryonic stem 
cells in the heart: teratoma formation and immune response. FASEB J. 21, 1345–
1357 (2007). 
60. Ilic, D. & Ogilvie, C. Concise Review: Human Embryonic Stem Cells-What Have 
We Done? What Are We Doing? Where Are We Going? Stem Cells 35, 17–25 
133 
 
(2017). 
61. Knoepfler, P. S. Deconstructing stem cell tumorigenicity: A roadmap to safe 
regenerative medicine. Stem Cells 27, 1050–1056 (2009). 
62. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem 
cells. Science 284, 143–7 (1999). 
63. Zuk, P. Adipose-Derived Stem Cells in Tissue Regeneration: A Review. ISRN 
Stem Cells 2013, 1–35 (2013). 
64. De Sousa, E. B., Casado, P. L., Neto, V. M., Duarte, M. E. L. & Aguiar, D. P. 
Synovial fluid and synovial membrane mesenchymal stem cells: Latest discoveries 
and therapeutic perspectives. Stem Cell Res. Ther. 5, 1–6 (2014). 
65. Romanov, Y. A. Searching for Alternative Sources of Postnatal Human 
Mesenchymal Stem Cells: Candidate MSC-Like Cells from Umbilical Cord. Stem 
Cells 21, 105–110 (2003). 
66. Hass, R., Kasper, C., Böhm, S. & Jacobs, R. Different populations and sources of 
human mesenchymal stem cells (MSC): A comparison of adult and neonatal 
tissue-derived MSC. Cell Commun. Signal. 9, 12 (2011). 
67. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal 
cells. The International Society for Cellular Therapy position statement. 
Cytotherapy 8, 315–317 (2006). 
68. Pak, J. et al. Current use of autologous adipose tissue-derived stromal vascular 
fraction cells for orthopedic applications. J. Biomed. Sci. 24, 1–12 (2017). 
69. Locke, M., Windsor, J. & Dunbar, P. R. Human adipose-derived stem cells: 
Isolation, characterization and applications in surgery. ANZ J. Surg. 79, 235–244 
(2009). 
70. Bourin, P. et al. Stromal cells from the adipose tissue-derived stromal vascular 
134 
 
fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint 
statement of the International Federation for Adipose Therapeutics and Science 
(IFATS) and the International So. Cytotherapy 15, 641–648 (2013). 
71. Strem, B. M. et al. Multipotential differentiation of adipose tissue-derived stem 
cells. Keio J. Med. 54, 132–41 (2005). 
72. Zuk, P. A. et al. Multilineage cells from human adipose tissue: Implications for 
cell-based therapies. Tissue Eng. 7, 211–228 (2001). 
73. Haniffa, M. A. et al. Adult Human Fibroblasts Are Potent Immunoregulatory Cells 
and Functionally Equivalent to Mesenchymal Stem Cells. J. Immunol. 179, 1595–
1604 (2007). 
74. Oliferenko, S., Kaverina, I., Small, J. V. & Huber, L. A. Hyaluronic acid (HA) 
binding to CD44 activates Rac1 and induces lamellipodia outgrowth. J. Cell Biol. 
148, 1159–1164 (2000). 
75. Isacke, C. M. & Yarwood, H. The hyaluronan receptor, CD44. Int. J. Biochem. 
Cell Biol. 34, 718–721 (2002). 
76. Regateiro, F. S., Cobbold, S. P. & Waldmann, H. CD73 and adenosine generation 
in the creation of regulatory microenvironments. Clin. Exp. Immunol. 171, 1–7 
(2013). 
77. Chung, M. T. et al. CD90 (Thy-1)-positive selection enhances osteogenic capacity 
of human adipose-derived stromal cells. Tissue Eng. - Part A 19, 989–997 (2013). 
78. Torsney, E., Charlton, R., Parums, D., Collis, M. & Arthur, H. M. Inducible 
expression of human endoglin during inflammation and wound healing in vivo. 
Inflamm. Res. 51, 464–470 (2002). 
79. Ilan, N., Mahooti, S., Rimm, D. L. & Madri, J. A. PECAM-1 (CD31) functions as 
a reservoir for and a modulator of tyrosine-phosphorylated β-catenin. J. Cell Sci. 
112, 3005–3014 (1999). 
135 
 
80. Nakano, A., Harada, T., Morikawa, S. & Kato, Y. Expression of Leukocyte 
Common Antigen (CD45) on Various Human Leukemia/Lymphoma Cell Lines. 
Pathol. Int. 40, 107–115 (1990). 
81. Christopherson, K. W., Hangoc, G. & Broxmeyer, H. E.  Cell Surface Peptidase 
CD26/Dipeptidylpeptidase IV Regulates CXCL12/Stromal Cell-Derived Factor-
1α-Mediated Chemotaxis of Human Cord Blood CD34 + Progenitor Cells . J. 
Immunol. 169, 7000–7008 (2002). 
82. Christopherson, K. W. Modulation of Hematopoietic Stem Cell Homing and 
Engraftment by CD26. Science 305, 1000–1003 (2004). 
83. Rinkevich, Y. et al. Identification and isolation of a dermal lineage with intrinsic 
fibrogenic potential. Science 348, aaa2151–aaa2151 (2015). 
84. Suga, H. et al. Functional implications of CD34 expression in human adipose-
derived stem/progenitor cells. Stem Cells Dev. 18, 1201–1209 (2009). 
85. Traktuev, D. O. et al. A population of multipotent CD34-positive adipose stromal 
cells share pericyte and mesenchymal surface markers, reside in a periendothelial 
location, and stabilize endothelial networks. Circ. Res. 102, 77–85 (2008). 
86. Zheng, C. et al. Endothelial CD146 is required for in vitro tumor-induced 
angiogenesis: The role of a disulfide bond in signaling and dimerization. Int. J. 
Biochem. Cell Biol. 41, 2163–2172 (2009). 
87. Russell, K. C. et al. In vitro high-capacity assay to quantify the clonal 
heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex 
hierarchy of lineage commitment. Stem Cells 28, 788–798 (2010). 
88. Fomby, P. et al. Stem cells and cell therapies in lung biology and diseases: 
Conference report. Ann. Am. Thorac. Soc. 12, 181–204 (2010). 
89. Gierloff, M. et al. Adipogenic differentiation potential of rat adipose tissue-derived 
subpopulations of stromal cells. J. Plast. Reconstr. Aesthetic Surg. 67, 1427–1435 
136 
 
(2014). 
90. Choy, L. & Derynck, R. Transforming Growth Factor-β Inhibits Adipocyte 
Differentiation by Smad3 Interacting with CCAAT/Enhancer-binding Protein 
(C/EBP) and Repressing C/EBP Transactivation Function. J. Biol. Chem. 278, 
9609–9619 (2003). 
91. Brun, R. P. et al. Differential activation of adipogenesis by multiple PPAR 
isoforms. Genes Dev. 10, 974–984 (1996). 
92. Gregoire, F. M., Smas, C. M. & Sul, H. S. Understanding adipocyte 
differentiation. Physiol. Rev. 78, 783–809 (1998). 
93. Mehlhorn, A. T. et al. Differential effects of BMP-2 and TGF-β1 on chondrogenic 
differentiation of adipose derived stem cells. Cell Prolif. 40, 809–823 (2007). 
94. Langenbach, F. & Handschel, J. Effects of dexamethasone, ascorbic acid and β-
glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell 
Res. Ther. 4, 117 (2013). 
95. Rodbell, M. & Jones, A. Metabolism of isolated fat cells. J. Biol. Chem. 241, 140–
142 (1966). 
96. Bunnell, B. A., Flaat, M., Gagliardi, C., Patel, B. & Ripoll, C. Adipose-derived 
stem cells: Isolation, expansion and differentiation. Methods 45, 115–120 (2008). 
97. Markarian, C. F. et al. Isolation of adipose-derived stem cells: A comparison 
among different methods. Biotechnol. Lett. 36, 693–702 (2014). 
98. Priya, N., Sarcar, S., Majumdar, A. Sen & SundarRaj, S. Explant culture: a simple, 
reproducible, efficient and economic technique for isolation of mesenchymal 
stromal cells from human adipose tissue and lipoaspirate. J. Tissue Eng. Regen. 
Med. 8, 706–716 (2014). 
99. Brunet, S. et al. Characterization of the TPX2 Domains Involved in Microtubule 
137 
 
Nucleation and Spindle Assembly in Xenopus nucleation around chromatin and 
functions in a network of other molecules , some of which also are regulated by. 
Mol Biol Cell 15, 5318–5328 (2004). 
100. Wosnitza, M., Hemmrich, K., Groger, A., Gräber, S. & Pallua, N. Plasticity of 
human adipose stem cells to perform adipogenic and endothelial differentiation. 
Differentiation 75, 12–23 (2007). 
101. Suga, H., Glotzbach, J. P., Sorkin, M., Longaker, M. T. & Gurtner, G. C. Paracrine 
Mechanism of Angiogenesis in Adipose-Derived Stem Cell Transplantation. Ann. 
Plast. Surg. 72, 234–241 (2014). 
102. Chazenbalk, G. et al. Novel pathway of adipogenesis through cross-talk between 
adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell 
plasticity. PLoS One 6, e17834 (2011). 
103. Kang, S., Kim, S.-M. & Sung, J.-H. Cellular and molecular stimulation of adipose-
derived stem cells under hypoxia. Cell Biol. Int. 38, 553–562 (2014). 
104. Tsuji, W. Adipose-derived stem cells: Implications in tissue regeneration. World J. 
Stem Cells 6, 312 (2014). 
105. Frazier, T. P., Gimble, J. M., Kheterpal, I. & Rowan, B. G. Impact of low oxygen 
on the secretome of human adipose-derived stromal/stem cell primary cultures. 
Biochimie 95, 2286–2296 (2013). 
106. Thangarajah, H. et al. IFATS Collection: Adipose Stromal Cells Adopt a 
Proangiogenic Phenotype Under the Influence of Hypoxia. Stem Cells 27, 266–274 
(2009). 
107. Kapur, S. K. & Katz, A. J. Biochimie Review of the adipose derived stem cell 
secretome. Biochimie 95, 2222–2228 (2013). 
108. Chung, A. S., Waldeck, H., Schmidt, D. R. & Kao, W. J. Monocyte inflammatory 
and matrix remodeling response modulated by grafted ECM-derived ligand 
138 
 
concentration. J. Biomed. Mater. Res. - Part A 91, 741–752 (2009). 
109. Khan, T. et al. Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of 
Collagen VI. Mol. Cell. Biol. 29, 1575–1591 (2009). 
110. Sillat, T. et al. Basement membrane collagen type IV expression by human 
mesenchymal stem cells during adipogenic differentiation. J. Cell. Mol. Med. 16, 
1485–1495 (2012). 
111. Hsiao, S. T. et al. Hypoxic conditioning enhances the angiogenic paracrine activity 
of human adipose-derived stem cells. Stem Cells Dev. 22, 1614–1623 (2013). 
112. Cross, M. J. & Claesson-Welsh, L. FGF and VEGF function in angiogenesis: 
Signalling pathways, biological responses and therapeutic inhibition. Trends 
Pharmacol. Sci. 22, 201–207 (2001). 
113. Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R. & Link, D. C. Expression 
of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic 
progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251–260 (2011). 
114. Kawaguchi, M. & Kataoka, H. Mechanisms of hepatocyte growth factor activation 
in cancer tissues. Cancers (Basel). 6, 1890–1904 (2014). 
115. Beilmann, M., Birk, G. & Lenter, M. C. Human primary co-culture angiogenesis 
assay reveals additive stimulation and different angiogenic properties of VEGF 
and HGF. Cytokine 26, 178–185 (2004). 
116. Kiec-Wilk, B. et al. The MAPK-dependent regulation of the Jagged/Notch gene 
expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC. 
J. Physiol. Pharmacol. 61, 217–225 (2010). 
117. Natori, T. et al. G-CSF stimulates angiogenesis and promotes tumor growth: 
Potential contribution of bone marrow-derived endothelial progenitor cells. 
Biochem. Biophys. Res. Commun. 297, 1058–1061 (2002). 
139 
 
118. Shojaei, S., Tafazzoli-Shahdpour, M., Shokrgozar, M. A. & Haghighipour, N. 
Effects of mechanical and chemical stimuli on differentiation of human adipose-
derived stem cells into endothelial cells. Int. J. Artif. Organs 36, 663–673 (2013). 
119. Chen, R. R., Silva, E. A., Yuen, W. W. & Mooney, D. J. Spatio-temporal VEGF 
and PDGF delivery patterns blood vessel formation and maturation. Pharm. Res. 
24, 258–264 (2007). 
120. Lopatina, T. et al. Platelet-derived growth factor regulates the secretion of 
extracellular vesicles by adipose mesenchymal stem cells and enhances their 
angiogenic potential. Cell Commun. Signal. 12, 1–12 (2014). 
121. Rajkumar, V. S. et al. Platelet-derived growth factor-β receptor activation is 
essential for fibroblast and pericyte recruitment during cutaneous wound healing. 
Am. J. Pathol. 169, 2254–2265 (2006). 
122. Chislock, E. M., Ring, C. & Pendergast, A. M. Abl kinases are required for 
vascular function, Tie2 expression, and angiopoietin-1-mediated survival. Proc. 
Natl. Acad. Sci. U. S. A. 110, 12432–12437 (2013). 
123. Caplan, A. I. & Sorrell, J. M. The MSC curtain that stops the immune system. 
Immunol. Lett. 168, 136–139 (2015). 
124. Ren, G. et al. Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via 
Concerted Action of Chemokines and Nitric Oxide. Cell Stem Cell 2, 141–150 
(2008). 
125. Zhang, S. et al. Interleukin 6 Mediates the Therapeutic Effects of Adipose-Derived 
Stromal/Stem Cells in Lipopolysaccharide-Induced Acute Lung Injury. Stem Cells 
32, 1616–1628 (2014). 
126. Huh, J. E. & Lee, S. Y. IL-6 is produced by adipose-derived stromal cells and 
promotes osteogenesis. Biochim. Biophys. Acta - Mol. Cell Res. 1833, 2608–2616 
(2013). 
140 
 
127. Hutton, D. L. et al. Tumor necrosis factor improves vascularization in osteogenic 
grafts engineered with human adipose-derived stem/stromal cells. PLoS One 9, 
(2014). 
128. Lee, M. J. et al. Proteomic analysis of tumor necrosis factor-α-induced secretome 
of human adipose tissue-derived mesenchymal stem cells. J. Proteome Res. 9, 
1754–1762 (2010). 
129. Ogami, K. et al. Computational gene network analysis reveals TNF-induced 
angiogenesis. BMC Syst. Biol. 6, 3–8 (2012). 
130. Yuan, J., Fang, W., Lin, A., Ni, Z. & Qian, J. Angiopoietin-2/Tie2 Signaling 
Involved in TNF-α Induced Peritoneal Angiogenesis. Int. J. Artif. Organs 35, 655–
662 (2012). 
131. Sainson, R. C. A. et al. TNF primes endothelial cells for angiogenic sprouting by 
inducing a tip cell phenotype. Blood 111, 4997–5007 (2008). 
132. English, K., Barry, F. P., Field-Corbett, C. P. & Mahon, B. P. IFN-γ and TNF-α 
differentially regulate immunomodulation by murine mesenchymal stem cells. 
Immunol. Lett. 110, 91–100 (2007). 
133. Maria, A. T. J. et al. iNOS Activity Is Required for the Therapeutic Effect of 
Mesenchymal Stem Cells in Experimental Systemic Sclerosis. Front. Immunol. 9, 
3056 (2018). 
134. Manferdini, C. et al. Adipose stromal cells mediated switching of the pro-
inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro 
evaluation. Osteoarthr. Cartil. 25, 1161–1171 (2017). 
135. Mocellin, S., Panelli, M. C., Wang, E., Nagorsen, D. & Marincola, F. M. The dual 
role of IL-10. Trends Immunol. 24, 36–43 (2003). 
136. Deng, B., Wehling-Henricks, M., Villalta, S. A., Wang, Y. & Tidball, J. G. IL-10 
Triggers Changes in Macrophage Phenotype That Promote Muscle Growth and 
141 
 
Regeneration. J. Immunol. 189, 3669–3680 (2012). 
137. Liu, Z. G. Molecular mechanism of TNF signaling and beyond. Cell Res. 15, 24–
27 (2005). 
138. Schwabe, R. F. & Brenner, D. A. Mechanisms of liver injury. I. TNF-α-induced 
liver injury: Role of IKK, JNK, and ROS pathways. Am. J. Physiol. - Gastrointest. 
Liver Physiol. 290, 583–589 (2006). 
139. Böcker, W. et al. IKK-2 is required for TNF-α-induced invasion and proliferation 
of human mesenchymal stem cells. Journal of Molecular Medicine vol. 86 1183–
1192 (2008). 
140. Martínez-Chaćon, G. et al. IL-10 suppresses TNF-A-induced expression of human 
aromatase gene in mammary adipose tissue. FASEB J. 32, 3361–3370 (2018). 
141. Akira, S., Hirano, T., Taga, T. & Kishimoto, T. Biology of multifunctional 
cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4, 2860–2867 
(1990). 
142. Díaz, L. et al. Calcitriol inhibits TNF-α-induced inflammatory cytokines in human 
trophoblasts. J. Reprod. Immunol. 81, 17–24 (2009). 
143. Mori, T. et al. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in 
mediating inflammatory cytokines and RANKL expression in inflammatory 
arthritis. Int. Immunol. 23, 701–712 (2011). 
144. Wang, L. et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling 
pathway. J. Exp. Med. 206, 1457–1464 (2009). 
145. Baluk, P. et al. TNF-α drives remodeling of blood vessels and lymphatics in 
sustained airway inflammation in mice. J. Clin. Invest. 119, (2009). 
146. Rehman, J. et al. Secretion of angiogenic and antiapoptotic factors by human 
adipose stromal cells. Circulation 109, 1292–8 (2004). 
142 
 
147. Kronsteiner, B. et al. Human mesenchymal stem cells and renal tubular epithelial 
cells differentially influence monocyte-derived dendritic cell differentiation and 
maturation. Cell. Immunol. 267, 30–38 (2011). 
148. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23–35 
(2003). 
149. Song, J. young et al. Umbilical cord-derived mesenchymal stem cell extracts 
ameliorate atopic dermatitis in mice by reducing the T cell responses. Sci. Rep. 9, 
1–9 (2019). 
150. He, Y. & Lu, F. Development of Synthetic and Natural Materials for Tissue 
Engineering Applications Using Adipose Stem Cells. Stem Cells Int. 2016, (2016). 
151. Weiser, B. et al. In vivo development and long-term survival of engineered 
adipose tissue depend on in vitro precultivation strategy. Tissue Eng. - Part A. 14, 
275–284 (2008). 
152. Kang, S. W., Seo, S. W., Choi, C. Y. & Kim, B. S. Porous poly(lactic-co-glycolic 
acid) microsphere as cell culture substrate and cell transplantation vehicle for 
adipose tissue engineering. Tissue Eng. - Part C Methods 14, 25–34 (2008). 
153. Salick, D. A., Kretsinger, J. K., Pochan, D. J. & Schneider, J. P. Inherent 
antibacterial activity of a peptide-based β-hairpin hydrogel. J. Am. Chem. Soc. 129, 
14793–14799 (2007). 
154. Cronin, K. J. et al. New murine model of spontaneous autologous tissue 
engineering, combining an arteriovenous pedicle with matrix materials. Plast. 
Reconstr. Surg. 113, 260–269 (2004). 
155. Choi, Y. S. et al. Adipogenic differentiation of adipose tissue derived adult stem 
cells in nude mouse. Biochem. Biophys. Res. Commun. 345, 631–637 (2006). 
156. Marra, K. G. et al. FGF-2 enhances vascularization for adipose tissue engineering. 
Plast. Reconstr. Surg. 121, 1153–1164 (2008). 
143 
 
157. Cho, S. W. et al. Engineered adipose tissue formation enhanced by basic fibroblast 
growth factor and a mechanically stable environment. Cell Transplant. 16, 421–
434 (2007). 
158. Patrick, C. W. W., Chauvin, P. B. B., Hobley, J. & Reece, G. P. P. Preadipocyte 
Seeded PLGA Scaffolds for Adipose Tissue Engineering. Tissue Eng. 5, 139–151 
(1999). 
159. Yu, S. C., Park, S. N. & Suh, H. Adipose tissue engineering using mesenchymal 
stem cells attached to injectable PLGA spheres. Biomaterials 26, 5855–5863 
(2005). 
160. Kimura, Y., Ozeki, M., Inamoto, T. & Tabata, Y. Adipose tissue engineering based 
on human preadipocytes combined with gelatin microspheres containing basic 
fibroblast growth factor. Biomaterials 24, 2513–2521 (2003). 
161. Neuss, S. et al. Long-term survival and bipotent terminal differentiation of human 
mesenchymal stem cells (hMSC) in combination with a commercially available 
three-dimensional collagen scaffold. Cell Transplant. 17, 977–986 (2008). 
162. Von Heimburg, D. et al. Preadipocyte-loaded collagen scaffolds with enlarged 
pore size for improved soft-tissue engineering. Int. J. Artif. Organs 26, 1064–1076 
(2003). 
163. Tan, H. et al. Thermosensitive injectable hyaluronic acid hydrogel for adipose 
tissue engineering. Biomaterials 30, 6844–6853 (2009). 
164. Borzacchiello, A. et al. Structural and rheological characterization of hyaluronic 
acid-based scaffolds for adipose tissue engineering. Biomaterials 28, 4399–4408 
(2007). 
165. Chang, K. H., Liao, H. T. & Chen, J. P. Preparation and characterization of 
gelatin/hyaluronic acid cryogels for adipose tissue engineering: In vitro and in vivo 
studies. Acta Biomater. 9, 9012–9026 (2013). 
144 
 
166. Choi, J. S. et al. Decellularized extracellular matrix derived from human adipose 
tissue as a potential scaffold for allograft tissue engineering. J. Biomed. Mater. 
Res. - Part A 97 A, 292–299 (2011). 
167. Choi, Y. C. et al. Decellularized Extracellular Matrix Derived from Porcine 
Adipose Tissue as a Xenogeneic Biomaterial for Tissue Engineering. Tissue Eng. 
Part C Methods 18, 866–876 (2012). 
168. Zhang, Q. et al. Decellularized skin/adipose tissue flap matrix for engineering 
vascularized composite soft tissue flaps. Acta Biomater. 35, 166–184 (2016). 
169. Han, T. T. Y., Toutounji, S., Amsden, B. G. & Flynn, L. E. Adipose-derived 
stromal cells mediate in vivo adipogenesis, angiogenesis and inflammation in 
decellularized adipose tissue bioscaffolds. Biomaterials 72, 125–137 (2015). 
170. Matsuda, K. et al. Adipose-derived stem cells promote angiogenesis and tissue 
formation for in vivo tissue engineering. Tissue Eng. - Part A 19, 1327–1335 
(2013). 
171. Chircov, C., Grumezescu, A. M. & Bejenaru, L. E. Hyaluronic acid-based 
scaffolds for tissue engineering. Rom. J. Morphol. Embryol. 59, 71–76 (2018). 
172. Collins, M. N. & Birkinshaw, C. Hyaluronic acid based scaffolds for tissue 
engineering - A review. Carbohydr. Polym. 92, 1262–1279 (2013). 
173. Collins, M. N. & Birkinshaw, C. Hyaluronic acid based scaffolds for tissue 
engineering--a review. Carbohydr. Polym. 92, 1262–1279 (2013). 
174. Burdick, J. A. & Prestwich, G. D. Hyaluronic acid hydrogels for biomedical 
applications. Adv. Mater. 23, H41–H56 (2011). 
175. Halbleib, M., Skurk, T., de Luca, C., von Heimburg, D. & Hauner, H. Tissue 
engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in 
vitro differentiation of human adipocyte precursor cells on scaffolds. Biomaterials 
24, 3125–3132 (2003). 
145 
 
176. Hemmrich, K. et al. Implantation of preadipocyte-loaded hyaluronic acid-based 
scaffolds into nude mice to evaluate potential for soft tissue engineering. 
Biomaterials 26, 7025–7037 (2005). 
177. Tan, H., Chu, C. R., Payne, K. a. & Marra, K. G. Injectable in situ forming 
biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue 
engineering. Biomaterials vol. 30 2499–2506 (2009). 
178. Kirk, J. F. et al. Mechanical and biocompatible characterization of a cross-linked 
collagen-hyaluronic acid wound dressing. Biomatter 3, e25633 (2013). 
179. Lee, Y. et al. Thermo-sensitive, injectable, and tissue adhesive sol–gel transition 
hyaluronic acid/pluronic composite hydrogels prepared from bio-inspired catechol-
thiol reaction. Soft Matter 6, 977 (2010). 
180. Chen, J.-P. & Cheng, T.-H. Preparation and evaluation of thermo-reversible 
copolymer hydrogels containing chitosan and hyaluronic acid as injectable cell 
carriers. Polymer 50, 107–116 (2009). 
181. Roth, C. C. et al. Bladder regeneration in a canine model using hyaluronic acid-
poly(lactic-co-glycolic-acid) nanoparticle modified porcine small intestinal 
submucosa. BJU Int. 108, 148–155 (2011). 
182. Davidenko, N., Campbell, J. J., Thian, E. S., Watson, C. J. & Cameron, R. E. 
Collagen-hyaluronic acid scaffolds for adipose tissue engineering. Acta Biomater. 
6, 3957–3968 (2010). 
183. Keck, M. et al. Adipose tissue engineering: Three different approaches to seed 
preadipocytes on a collagen-elastin matrix. Ann. Plast. Surg. 67, 484–488 (2011). 
184. Wu, X., Black, L., Santacana-Laffitte, G. & Patrick, C. W. Preparation and 
assessment of glutaraldehyde-crosslinked collagen–chitosan hydrogels for adipose 
tissue engineering. J. Biomed. Mater. Res. Part A 81A, 59–65 (2007). 
185. Yao, R., Zhang, R., Lin, F. & Luan, J. Biomimetic injectable HUVEC-
146 
 
adipocytes/collagen/alginate microsphere co-cultures for adipose tissue 
engineering. Biotechnol. Bioeng. 110, 1430–1443 (2013). 
186. Heino, J. The collagen family members as cell adhesion proteins. BioEssays 29, 
1001–1010 (2007). 
187. Kühn, K. Basement membrane (type IV) collagen. Matrix Biol. 14, 439–45 (1995). 
188. Dehsorkhi, A., Castelletto, V., Hamley, I. W., Adamcik, J. & Mezzenga, R. The 
effect of pH on the self-assembly of a collagen derived peptide amphiphile. Soft 
Matter 9, 6033 (2013). 
189. Choi, J. S. et al. Human extracellular matrix (ECM) powders for injectable cell 
delivery and adipose tissue engineering. J. Control. Release 139, 2–7 (2009). 
190. Vashi, A. V. et al. Adipose tissue engineering based on the controlled release of 
fibroblast growth factor-2 in a collagen matrix. Tissue Eng. 12, 3035–3043 (2006). 
191. Hiraoka, Y. et al. In situ regeneration of adipose tissue in rat fat pad by combining 
a collagen scaffold with gelatin microspheres containing basic fibroblast growth 
factor. Tissue Eng. 12, 1475–1487 (2006). 
192. Song, K. et al. Preparation, fabrication and biocompatibility of novel injectable 
temperature-sensitive chitosan/glycerophosphate/collagen hydrogels. J. Mater. Sci. 
Mater. Med. 21, 2835–2842 (2010). 
193. Zhang, Q. et al. Engineering vascularized soft tissue flaps in an animal model 
using human adipose-derived stem cells and VEGF+PLGA/PEG microspheres on 
a collagen-chitosan scaffold with a flow-through vascular pedicle. Biomaterials 
73, 198–213 (2015). 
194. Hynes, R. O. The Extracellular Matrix: Not Just Pretty Fibrils. Science 326, 1216–
1219 (2009). 
195. Badylak, S. F. The extracellular matrix as a biologic scaffold material. 
147 
 
Biomaterials 28, 3587–3593 (2007). 
196. Nagase, H., Visse, R. & Murphy, G. Structure and function of matrix 
metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562–573 (2006). 
197. Mesenchymal, H. et al. Tailored Integrin – Extracellular Matrix Interactions to 
Direct. 21, 2442–2456 (2012). 
198. Page-McCaw, A., Ewald, A. J. & Werb, Z. Matrix metalloproteinases and the 
regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221–33 (2007). 
199. Mariman, E. C. M. M. & Wang, P. Adipocyte extracellular matrix composition, 
dynamics and role in obesity. Cell. Mol. Life Sci. 67, 1277–1292 (2010). 
200. Knight, C. G. et al. The collagen-binding a-domains of integrins α1/β1 and α2/β1 
recognize the same specific amino acid sequence, GFOGER, in native (triple- 
helical) collagens. J. Biol. Chem. 275, 35–40 (2000). 
201. Lahti, M., Heino, J. & Käpylä, J. Leukocyte integrins αlβ2, αmβ2 and αxβ2 as 
collagen receptors - Receptor activation and recognition of GFOGER motif. Int. J. 
Biochem. Cell Biol. 45, 1204–1211 (2013). 
202. Lee, S. H. et al. Fibronectin gene expression in human adipose tissue and its 
associations with obesity-related genes and metabolic parameters. Obes. Surg. 23, 
554–560 (2013). 
203. Halliday, N. L. & Tomasek, J. J. Mechanical properties of the extracellular matrix 
influence fibronectin fibril assembly in vitro. Experimental cell research vol. 217 
109–117 (1995). 
204. Kapp, T. G. et al. A comprehensive evaluation of the activity and selectivity 
profile of ligands for RGD-binding integrins. Sci. Rep. 7, 1–13 (2017). 
205. Laterra, J., Silbert, J. E. & Culp, L. A. Cell surface heparan sulfate mediates some 
adhesive responses to glycosaminoglycan binding matrices, including fibronectin. 
148 
 
J. Cell Biol. 96, 112–123 (1983). 
206. Stamatoglou, S. C. & Keller, J. M. Correlation between cell substrate attachment 
in vitro and cell surface heparan sulfate affinity for fibronectin and collagen. J. 
Cell Biol. 96, 1820–1823 (1983). 
207. Wang, Y., Zhao, L., Smas, C. & Sul, H. S. Pref-1 interacts with fibronectin to 
inhibit adipocyte differentiation. Mol. Cell. Biol. 30, 3480–92 (2010). 
208. Smas, C. M., Chen, L. & Sul, H. S. Cleavage of membrane-associated pref-1 
generates a soluble inhibitor of adipocyte differentiation. Mol. Cell. Biol. 17, 977–
88 (1997). 
209. Durbeej, M. Laminins. Cell Tissue Res. 339, 259–268 (2010). 
210. Theocharis, A. D., Skandalis, S. S., Gialeli, C. & Karamanos, N. K. Extracellular 
matrix structure. Adv. Drug Deliv. Rev. 97, 4–27 (2016). 
211. van Dijk,  a, Niessen, H. W. M., Zandieh Doulabi, B., Visser, F. C. & van 
Milligen, F. J. Differentiation of human adipose-derived stem cells towards 
cardiomyocytes is facilitated by laminin. Cell Tissue Res. 334, 457–67 (2008). 
212. Sur, S. et al. Synergistic regulation of cerebellar Purkinje neuron development by 
laminin epitopes and collagen on an artificial hybrid matrix construct  . Biomater. 
Sci. 2, 903–914 (2014). 
213. Chen, S. et al. A laminin mimetic peptide SIKVAV-conjugated chitosan hydrogel 
promoting wound healing by enhancing angiogenesis, re-epithelialization and 
collagen deposition. J. Mater. Chem. B 3, 6798–6804 (2015). 
214. Ruoslahti, E. & Yamaguchi, Y. Proteoglycans as modulators of growth factor 
activities. Cell 64, 867–869 (1991). 
215. Dreyfuss, J. L. et al. Heparan sulfate proteoglycans: Structure, protein interactions 
and cell signaling. An. Acad. Bras. Cienc. 81, 409–429 (2009). 
149 
 
216. Wang, Q. G., Hughes, N., Cartmell, S. H. & Kuiper, N. J. The composition of 
hydrogels for cartilage tissue engineering can influence glycosaminoglycan 
profiles. Eur. Cells Mater. 19, 86–95 (2010). 
217. Zhu, Y., Crewe, C. & Scherer, P. E. Hyaluronan in adipose tissue: Beyond dermal 
filler and therapeutic carrier. Sci. Transl. Med. 8, (2016). 
218. Liang, J., Jiang, D. & Noble, P. W. Hyaluronan as a therapeutic target in human 
diseases. Adv. Drug Deliv. Rev. 97, 186–203 (2016). 
219. Kang, L. et al. Hyaluronan accumulates with high-fat feeding and contributes to 
insulin resistance. Diabetes 62, 1888–1896 (2013). 
220. Ji, E. et al. Inhibition of adipogenesis in 3T3-L1 cells and suppression of 
abdominal fat accumulation in high-fat diet-feeding C57BL/6J mice after 
downregulation of hyaluronic acid. Int. J. Obes. 38, 1035–1043 (2014). 
221. Lu, P., Takai, K., Weaver, V. M. & Werb, Z. Extracellular matrix degradation and 
remodeling in development and disease. Cold Spring Harb Perspect Biol 3, 
(2011). 
222. Lin, D., Chun, T. & Kang, L. Adipose extracellular matrix remodelling in obesity 
and insulin. Biochem. Pharmacol. 1–9 (2016) doi:10.1016/j.bcp.2016.05.005. 
223. Chavey, C. et al. Matrix metalloproteinases are differentially expressed in adipose 
tissue during obesity and modulate adipocyte differentiation. J. Biol. Chem. 278, 
11888–96 (2003). 
224. Lin, D., Chun, T.-H. & Kang, L. Adipose extracellular matrix remodelling in 
obesity and insulin resistance. Biochem. Pharmacol. 119, 8–16 (2016). 
225. Kubota, S. & Takigawa, M. Cellular and molecular actions of CCN2/CTGF and its 
role under physiological and pathological conditions. Clin Sci 128, 181–196 
(2015). 
150 
 
226. Rosso, F. et al. Smart materials as scaffolds for tissue engineering. J. Cell. Physiol. 
203, 465–470 (2005). 
227. Yu, C. et al. Porous decellularized adipose tissue foams for soft tissue 
regeneration. Biomaterials 34, 3290–3302 (2013). 
228. Hoshiba, T., Lu, H., Kawazoe, N. & Chen, G. Decellularized matrices for tissue 
engineering. Expert Opin. Biol. Ther. 10, 1717–1728 (2010). 
229. Turner, A. E. B., Yu, C., Bianco, J., Watkins, J. F. & Flynn, L. E. The performance 
of decellularized adipose tissue microcarriers as an inductive substrate for human 
adipose-derived stem cells. Biomaterials 33, 4490–4499 (2012). 
230. Voytik-Harbin, S. L. et al. Small intestinal submucosa: A tissue-derived 
extracellular matrix that promotes tissue-specific growth and differentiation of 
cells in vitro. Tissue Eng. 4, 157–174 (1998). 
231. Cheng, N.-C., Estes, B. T., Awad, H. A. & Guilak, F. Chondrogenic differentiation 
of adipose-derived adult stem cells by a porous scaffold derived from native 
articular cartilage extracellular matrix. Tissue Eng. Part A 15, 231–241 (2009). 
232. Wang, R. M. & Christman, K. L. Decellularized myocardial matrix hydrogels: In 
basic research and preclinical studies. Adv. Drug Deliv. Rev. 96, 77–82 (2016). 
233. Kleinman, H. K. et al. Basement Membrane Complexes with Biological Activity. 
Biochemistry 25, 312–318 (1986). 
234. Stillaert, F. et al. Host rather than graft origin of Matrigel-induced adipose tissue in 
the murine tissue-engineering chamber. Tissue Eng. 13, 2291–2300 (2007). 
235. Polykandriotis, E., Arkudas, A., Horch, R. E. & Kneser, U. To Matrigel or not to 
Matrigel. Am. J. Pathol. 172, 1441–1442 (2008). 
236. Badylak, S. F., Taylor, D. & Uygun, K. Whole-Organ Tissue Engineering: 
Decellularization and Recellularization of Three-Dimensional Matrix Scaffolds. 
151 
 
Annu. Rev. Biomed. Eng. 13, 27–53 (2011). 
237. Badylak, S. F., Weiss, D. J., Caplan, A. & MacChiarini, P. Engineered whole 
organs and complex tissues. Lancet 379, 943–952 (2012). 
238. Flynn, L., Semple, J. L. & Woodhouse, K. A. Decellularized placental matrices for 
adipose tissue engineering. J. Biomed. Mater. Res. - Part A 79, 359–369 (2006). 
239. Flynn, L., Prestwich, G. D., Semple, J. L. & Woodhouse, K. a. Adipose tissue 
engineering with naturally derived scaffolds and adipose-derived stem cells. 
Biomaterials 28, 3834–42 (2007). 
240. Gude, N. M., Roberts, C. T., Kalionis, B. & King, R. G. Growth and function of 
the normal human placenta. Thromb. Res. 114, 397–407 (2004). 
241. Altman, A. M. et al. Human adipose-derived stem cells adhere to acellular dermal 
matrix. Aesthetic Plast. Surg. 32, 698–699 (2008). 
242. Wolf, M. T. et al. A hydrogel derived from decellularized dermal extracellular 
matrix. Biomaterials 33, 7028–7038 (2012). 
243. Altman, A. M. et al. Dermal matrix as a carrier for in vivo delivery of human 
adipose-derived stem cells. Biomaterials 29, 1431–1442 (2008). 
244. Ting, A. C. H. et al. The adipogenic potential of various extracellular matrices 
under the influence of an angiogenic growth factor combination in a mouse tissue 
engineering chamber. Acta Biomater. 10, 1907–1918 (2014). 
245. Young, D. A., Choi, Y. S., Engler, A. J. & Christman, K. L. Stimulation of 
adipogenesis of adult adipose-derived stem cells using substrates that mimic the 
stiffness of adipose tissue. Biomaterials 34, 8581–8588 (2013). 
246. Haddad, S. M. H., Omidi, E., Flynn, L. E. & Samani, A. Comparative 
biomechanical study of using decellularized human adipose tissues for post-
mastectomy and post-lumpectomy breast reconstruction. J. Mech. Behav. Biomed. 
152 
 
Mater. 57, 235–245 (2016). 
247. Omidi, E. et al. Characterization and assessment of hyperelastic and elastic 
properties of decellularized human adipose tissues. J. Biomech. 47, 3657–3663 
(2014). 
248. Lago, F., Gómez, R., Gómez-Reino, J. J., Dieguez, C. & Gualillo, O. Adipokines 
as novel modulators of lipid metabolism. Trends Biochem. Sci. 34, 500–510 
(2009). 
249. Pasarica, M. et al. Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. 
Metab. 94, 5155–5162 (2009). 
250. Martinez-Santibañez, G. & Nien-Kai Lumeng, C. Macrophages and the Regulation 
of Adipose Tissue Remodeling. Annu. Rev. Nutr. 34, 57–76 (2014). 
251. Chun, T.-H. Peri-adipocyte ECM remodeling in obesity and adipose tissue fibrosis. 
Adipocyte 1, 89–95 (2012). 
252. Sun, K., Tordjman, J., Clément, K. & Scherer, P. E. Fibrosis and Adipose Tissue 
Dysfunction. Cell Metab. 18, 470–477 (2013). 
253. Flynn, L. E. The use of decellularized adipose tissue to provide an inductive 
microenvironment for the adipogenic differentiation of human adipose-derived 
stem cells. Biomaterials 31, 4715–24 (2010). 
254. Turner, A. E. B. & Flynn, L. E. Design and characterization of tissue-specific 
extracellular matrix-derived microcarriers. Tissue Eng. - Part C Methods 18, 186–
197 (2012). 
255. Cheung, H. K. et al. Composite hydrogel scaffolds incorporating decellularized 
adipose tissue for soft tissue engineering with adipose-derived stem cells. 
Biomaterials 35, 1914–1923 (2014). 
256. Kuljanin, M., Brown, C. F. C., Raleigh, M. J., Lajoie, G. A. & Flynn, L. E. 
153 
 
Collagenase treatment enhances proteomic coverage of low-abundance proteins in 
decellularized matrix bioscaffolds. Biomaterials 144, 130–143 (2017). 
257. Yu, C., Kornmuller, A., Brown, C., Hoare, T. & Flynn, L. E. Decellularized 
adipose tissue microcarriers as a dynamic culture platform for human adipose-
derived stem/stromal cell expansion. Biomaterials 120, 66–80 (2017). 
258. Wang, L., Johnson, J. A., Zhang, Q. & Beahm, E. K. Combining decellularized 
human adipose tissue extracellular matrix and adipose-derived stem cells for 
adipose tissue engineering. Acta Biomater. 9, 8921–8931 (2013). 
259. Young, D. ., Bajaj, V. & Christman, K. L. Award winner for outstanding research 
in the PhD category, 2014 society for biomaterials annual meeting and exposition, 
denver, colorado, april 16-19, 2014: Decellularized adipose matrix hydrogels 
stimulate in vivo neovascularization and adipose formation. J. Biomed. Mater. Res. 
Part A 102, 1641–1651 (2014). 
260. Brown, C. F. C. et al. Effect of decellularized adipose tissue particle size and cell 
density on adipose-derived stem cell proliferation and adipogenic differentiation in 
composite methacrylated chondroitin sulphate hydrogels. Biomed. Mater. 10, 
045010 (2015). 
261. Baer, P. C. et al. Effect of different preconditioning regimens on the expression 
profile of murine adipose-derived stromal/stem cells. Int. J. Mol. Sci. 19, (2018). 
262. Herrmann, J. L. et al. Preconditioning mesenchymal stem cells with transforming 
growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. 
Shock 33, 24–30 (2010). 
263. Bader, A. M. et al. Hypoxic preconditioning increases survival and pro-
Angiogenic capacity of human cord blood mesenchymal stromal cells in vitro. 
PLoS One 10, (2015). 
264. Shafiq, M., Jung, Y. & Kim, S. H. Insight on stem cell preconditioning and 
instructive biomaterials to enhance cell adhesion, retention, and engraftment for 
154 
 
tissue repair. Biomaterials 90, 85–115 (2016). 
265. Liu, L. et al. Hypoxia preconditioned human adipose derived mesenchymal stem 
cells enhance angiogenic potential via secretion of increased VEGF and bFGF. 
Cell Biol. Int. 37, 551–560 (2013). 
266. Zhang, W., Liu, L., Huo, Y., Yang, Y. & Wang, Y. Hypoxia-Pretreated Human 
MSCs Attenuate Acute Kidney Injury through Enhanced Angiogenic and 
Antioxidative Capacities. Biomed Res. Int. 2014, (2014). 
267. Ferreira, J. R. et al. Mesenchymal Stromal Cell Secretome: Influencing 
Therapeutic Potential by Cellular Pre-conditioning. Front. Immunol. 9, 2837 
(2018). 
268. Lu, Z. et al. Activation and promotion of adipose stem cells by tumour necrosis 
factor-alpha preconditioning for bone regeneration. J. Cell. Physiol. 228, 1737–
1744 (2013). 
269. Kong, P., Xie, X., Li, F., Liu, Y. & Lu, Y. Placenta mesenchymal stem cell 
accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki 
(GK) rats. Biochem. Biophys. Res. Commun. 438, 410–419 (2013). 
270. Zimna, A. & Kurpisz, M. Hypoxia-Inducible Factor-1 in Physiological and 
Pathophysiological Angiogenesis: Applications and Therapies. Biomed Res. Int. 
2015, 1–13 (2015). 
271. Abdollahi, H. et al. The role of hypoxia in stem cell differentiation and 
therapeutics. J. Surg. Res. 165, 112–117 (2011). 
272. J. A. Hudson and D. B. Cater. An analysis of factors affecting tissue oxygen 
tension. Proc. R. Soc. London. Ser. B. Biol. Sci. 161, 247–274 (1964). 
273. Hodson, L. Adipose tissue oxygenation. Adipocyte 3, 75–80 (2014). 
274. Pasarica, M. et al. Reduced adipose tissue oxygenation in human obesity. Diabetes 
155 
 
58, 718–725 (2009). 
275. Ivan, M. et al. HIFα targeted for VHL-mediated destruction by proline 
hydroxylation: Implications for O2 sensing. Science 292, 464–468 (2001). 
276. Jaakkola, P. et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation 
complex by O 2 -regulated prolyl hydroxylation. Science 292, 468–472 (2001). 
277. Ratcliffe, P. J., O’Rourke, J. F., Maxwell, P. H. & Pugh, C. W. Oxygen sensing, 
hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. 
Exp. Biol. 201, 1153–1162 (1998). 
278. Kanichai, M., Ferguson, D., Prendergast, P. J. & Campbell, V. A. Hypoxia 
promotes chondrogenesis in rat mesenchymal stem cells: A role for AKT and 
hypoxia-inducible factor (HIF)-1α. J. Cell. Physiol. 216, 708–715 (2008). 
279. Yun, S. P., Lee, M. Y., Ryu, J. M., Song, C. H. & Han, H. J. Role of HIF-1α and 
VEGF in human mesenchymal stem cell proliferation by 17β-estradiol: 
Involvement of PKC, PI3K/Akt, and MAPKs. Am. J. Physiol. - Cell Physiol. 296, 
317–326 (2009). 
280. Berniakovich, I. & Giorgio, M. Low oxygen tension maintains multipotency, 
whereas normoxia increases differentiation of mouse bone marrow stromal cells. 
Int. J. Mol. Sci. 14, 2119–2134 (2013). 
281. Choi, J. R. et al. Impact of low oxygen tension on stemness, proliferation and 
differentiation potential of human adipose-derived stem cells. Biochem. Biophys. 
Res. Commun. 448, 218–224 (2014). 
282. Kakudo, N., Morimoto, N., Ogawa, T., Taketani, S. & Kusumoto, K. Hypoxia 
Enhances Proliferation of Human Adipose-Derived Stem Cells via HIF-1ɑ 
Activation. PLoS One 10, e0139890 (2015). 
283. Chen, L. et al. Conditioned medium from hypoxic bone marrow-derived 
mesenchymal stem cells enhances wound healing in mice. PLoS One 9, (2014). 
156 
 
284. Liu, J. et al. Hypoxia Pretreatment of Bone Marrow Mesenchymal Stem Cells 
Facilitates Angiogenesis by Improving the Function of Endothelial Cells in 
Diabetic Rats with Lower Ischemia. PLoS One 10, e0126715 (2015). 
285. Gnecchi, M. et al. Evidence supporting paracrine hypothesis for Akt-modified 
mesenchymal stem cell-mediated cardiac protection and functional improvement. 
FASEB J. 20, 661–669 (2006). 
286. Mojsilovic-Petrovic, J. et al. Hypoxia-inducible factor-1 (HIF-1) is involved in the 
regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-
1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J. Neuroinflammation 4, 1–15 
(2007). 
287. Stubbs, S. L. et al. Hypoxic Preconditioning Enhances Survival of Human 
Adipose-Derived Stem Cells and Conditions Endothelial Cells In Vitro. Stem Cells 
Dev. 21, 1887–1896 (2012). 
288. Hollenbeck, S. T. et al. Tissue engraftment of hypoxic-preconditioned adipose-
derived stem cells improves flap viability. Wound Repair Regen. 20, 872–878 
(2012). 
289. Bassaneze, V. et al. Shear stress induces nitric oxide-mediated vascular endothelial 
growth factor production in Human adipose tissue mesenchymal stem cells. Stem 
Cells Dev. 19, 371–378 (2010). 
290. Yuan, L., Sakamoto, N., Song, G. & Sato, M. High-level shear stress stimulates 
endothelial differentiation and VEGF secretion by human mesenchymal stem cells. 
Cell. Mol. Bioeng. 6, 220–229 (2013). 
291. Becquart, P. et al. Human mesenchymal stem cell responses to hydrostatic 
pressure and shear stress. Eur. Cells Mater. 31, 160–173 (2016). 
292. Stolberg, S. & McCloskey, K. E. Can shear stress direct stem cell fate? Biotechnol. 
Prog. 25, 10–19 (2009). 
157 
 
293. Dalby, M. J. Topographically induced direct cell mechanotransduction. Med. Eng. 
Phys. 27, 730–742 (2005). 
294. Katsumi, A., Orr, A. W., Tzima, E. & Schwartz, M. A. Integrins in 
Mechanotransduction. J. Biol. Chem. 279, 12001–12004 (2004). 
295. Yeatts, A. B., Choquette, D. T. & Fisher, J. P. Bioreactors to influence stem cell 
fate: Augmentation of mesenchymal stem cell signaling pathways via dynamic 
culture systems. Biochim. Biophys. Acta - Gen. Subj. 1830, 2470–2480 (2013). 
296. Yuan, L., Sakamoto, N., Song, G. & Sato, M. Migration of human mesenchymal 
stem cells under low shear stress mediated by mitogen-activated protein kinase 
signaling. Stem Cells Dev. 21, 2520–2530 (2012). 
297. Scott, B. B. et al. TNF-α modulates angiopoietin-1 expression in rheumatoid 
synovial fibroblasts via the NF-κB signalling pathway. Biochem. Biophys. Res. 
Commun. 328, 409–414 (2005). 
298. Sunters, A. et al. Paclitaxel-induced nuclear translocation of FOXO3a in breast 
cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res. 66, 
212–220 (2006). 
299. McIlhenny, S. E. et al. Linear shear conditioning improves vascular graft retention 
of adipose-derived stem cells by upregulation of the α5β 1 integrin. Tissue Eng. - 
Part A 16, 245–255 (2010). 
300. Martin, I., Wendt, D. & Heberer, M. The role of bioreactors in tissue engineering. 
Trends Biotechnol. 22, 80–86 (2004). 
301. Lin, C. Y., Huang, C. H., Wu, Y. K., Cheng, N. C. & Yu, J. Maintenance of human 
adipose derived stem cell (hASC) differentiation capabilities using a 3D culture. 
Biotechnol. Lett. 36, 1529–1537 (2014). 
302. Kassem, M., Mygind, T., Bjerre, L. & Bu, C. E. Biomaterials Flow perfusion 
culture of human mesenchymal stem cells on silicate-substituted tricalcium 
158 
 
phosphate scaffolds. 29, 2616–2627 (2008). 
303. Nieponice, A. et al. In Vivo assessment of a tissue-engineered vascular graft 
combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a 
rat model. Tissue Eng. - Part A 16, 1215–1223 (2010). 
304. Vunjak-Novakovic, G., Freed, L. E., Biron, R. J. & Langer, R. Effects of Mixing 
on the Composition and Morphology of Tissue-Engineered Cartilage. AIChE J. 42, 
850–860 (1996). 
305. Dos Santos, F. et al. A xenogeneic-free bioreactor system for the clinical-scale 
expansion of human mesenchymal stem/stromal cells. Biotechnol. Bioeng. 111, 
1116–1127 (2014). 
306. Bunpetch, V. et al. Strategies for MSC expansion and MSC-based microtissue for 
bone regeneration. Biomaterials 196, 67–79 (2019). 
307. Skardal, A., Sarker, S. F., Crabbé, A., Nickerson, C. A. & Prestwich, G. D. The 
generation of 3-D tissue models based on hyaluronan hydrogel-coated 
microcarriers within a rotating wall vessel bioreactor. Biomaterials 31, 8426–8435 
(2010). 
308. Zhang, Z. Y. et al. A comparison of bioreactors for culture of fetal mesenchymal 
stem cells for bone tissue engineering. Biomaterials 31, 8684–8695 (2010). 
309. Nishi, M., Matsumoto, R., Dong, J. & Uemura, T. Engineered bone tissue 
associated with vascularization utilizing a rotating wall vessel bioreactor. J. 
Biomed. Mater. Res. - Part A 101 A, 421–427 (2013). 
310. Chen, X., Xu, H., Wan, C., McCaigue, M. & Li, G. Bioreactor Expansion of 
Human Adult Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells 24, 
2052–2059 (2006). 
311. Grayson, W. L. et al. Optimizing the medium perfusion rate in bone tissue 
engineering bioreactors. Biotechnol. Bioeng. 108, 1159–1170 (2011). 
159 
 
312. Papadimitropoulos, A. et al. Expansion of Human Mesenchymal Stromal Cells 
from Fresh Bone Marrow in a 3D Scaffold-Based System under Direct Perfusion. 
PLoS One 9, e102359 (2014). 
313. Alvarez-Barreto, J. F. et al. Enhanced osteoblastic differentiation of mesenchymal 
stem cells seeded in RGD-functionalized PLLA scaffolds and cultured in a flow 
perfusion bioreactor. J. Tissue Eng. Regen. Med. 5, 464–475 (2011). 
314. Ouyang, A. & Yang, S. T. A two-stage perfusion fibrous bed bioreactor system for 
mass production of embryonic stem cells. Expert Opin. Biol. Ther. 8, 895–909 
(2008). 
315. Alvarez-Barreto, J. F., Linehan, S. M., Shambaugh, R. L. & Sikavitsas, V. I. Flow 
perfusion improves seeding of tissue engineering scaffolds with different 
architectures. Ann. Biomed. Eng. 35, 429–442 (2007). 
316. Sailon, A. M. et al. A Novel Flow-Perfusion Bioreactor Supports 3D Dynamic 
Cell Culture. J. Biomed. Biotechnol. 2009, 1–7 (2009). 
317. Xie, Y. et al. Three-dimensional flow perfusion culture system for stem cell 
proliferation inside the critical-size beta-tricalcium phosphate scaffold. Tissue Eng. 
12, 3535–3543 (2006). 
318. Zhao, F. et al. Effects of Oxygen Transport on 3-D Human Mesenchymal Stem 
Cell Metabolic Activity in Perfusion and Static Cultures: Experiments and 
Mathematical Model. Biotechnol. Prog. 21, 1269–1280 (2008). 
319. Kim, J. & Ma, T. Perfusion regulation of hMSC microenvironment and osteogenic 
differentiation in 3D scaffold. Biotechnol. Bioeng. 109, 252–261 (2012). 
320. Gomes, M. E., Sikavitsas, V. I., Behravesh, E., Reis, R. L. & Mikos, A. G. Effect 
of flow perfusion on the osteogenic differentiation of bone marrow stromal cells 
cultured on starch-based three-dimensional scaffolds. J. Biomed. Mater. Res. - 
Part A 67, 87–95 (2003). 
160 
 
321. Mitra, D., Whitehead, J., Yasui, O. W. & Leach, J. K. Bioreactor culture duration 
of engineered constructs influences bone formation by mesenchymal stem cells. 
Biomaterials 146, 29–39 (2017). 
322. Bjerre, L., Bünger, C. E., Kassem, M. & Mygind, T. Flow perfusion culture of 
human mesenchymal stem cells on silicate-substituted tricalcium phosphate 
scaffolds. Biomaterials 29, 2616–2627 (2008). 
323. Xie, L. et al. In vitro mesenchymal trilineage differentiation and extracellular 
matrix production by adipose and bone marrow derived adult equine multipotent 
stromal cells on a collagen scaffold. Stem Cell Rev. Reports 9, 858–872 (2013). 
324. Weyand, B. et al. A Differential Pressure Laminar Flow Reactor Supports 
Osteogenic Differentiation and Extracellular Matrix Formation from Adipose 
Mesenchymal Stem Cells in a Macroporous Ceramic Scaffold. Biores. Open 
Access 1, 145–156 (2012). 
325. Zhao, F. & Ma, T. Perfusion bioreactor system for human mesenchymal stem cell 
tissue engineering: Dynamic cell seeding and construct development. Biotechnol. 
Bioeng. 91, 482–493 (2005). 
326. Moser, C. et al. A Perfusion Culture System for Assessing Bone Marrow Stromal 
Cell Differentiation on PLGA Scaffolds for Bone Repair. Front. Bioeng. 
Biotechnol. 6, (2018). 
327. Gerlach, J. C. et al. Adipogenesis of human adipose-derived stem cells within 
three-dimensional hollow fiber-based bioreactors. Tissue Eng. - Part C Methods 
18, 54–61 (2012). 
328. Laschke, M. W. et al. Angiogenesis in tissue engineering: Breathing life into 
constructed tissue substitutes. Tissue Eng. 12, 2093–2104 (2006). 
329. Madeddu, P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. 
Exp. Physiol. 90, 315–326 (2005). 
161 
 
330. Li, W. W., Talcott, K. E., Zhai, A. W., Kruger, E. A. & Li, V. W. The role of 
therapeutic angiogenesis in tissue repair and regeneration. Adv. Skin Wound Care 
18, 491–500 (2005). 
331. Betz, C., Lenard, A., Belting, H. G. & Affolter, M. Cell behaviors and dynamics 
during angiogenesis. Dev. 143, 2249–2260 (2016). 
332. Gerhardt, H. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell 
filopodia. J. Cell Biol. 161, 1163–1177 (2003). 
333. Logsdon, E. A., Finley, S. D., Popel, A. S. & MacGabhann, F. A systems biology 
view of blood vessel growth and remodelling. J. Cell. Mol. Med. 18, 1491–1508 
(2014). 
334. Fantin, A. et al. Tissue macrophages act as cellular chaperones for vascular 
anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 
116, 829–840 (2010). 
335. Ausprunk, D. H. & Folkman, J. Migration and proliferation of endothelial cells in 
preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. 
Res. 14, 53–65 (1977). 
336. Wacker, A. & Gerhardt, H. Endothelial development taking shape. Curr. Opin. 
Cell Biol. 23, 676–685 (2011). 
337. Ribatti, D. The discovery of the fundamental role of VEGF in the development of 
the vascular system. Mech. Dev. 160, 103579 (2019). 
338. Brudno, Y., Ennett-Shepard, A. B., Chen, R. R., Aizenberg, M. & Mooney, D. J. 
Enhancing microvascular formation and vessel maturation through temporal 
control over multiple pro-angiogenic and pro-maturation factors. Biomaterials 34, 
9201–9209 (2013). 
339. Chen, W. et al. The endothelial tip-stalk cell selection and shuffling during 
angiogenesis. J. Cell Commun. Signal. 13, 291–301 (2019). 
162 
 
340. Gebala, V., Collins, R., Geudens, I., Phng, L. K. & Gerhardt, H. Blood flow drives 
lumen formation by inverse membrane blebbing during angiogenesis in vivo. Nat. 
Cell Biol. 18, 443–450 (2016). 
341. Lenard, A. et al. In vivo analysis reveals a highly stereotypic morphogenetic 
pathway of vascular anastomosis. Dev. Cell 25, 492–506 (2013). 
342. Wakui, S. et al. Localization of Ang-1, -2, Tie-2, and VEGF expression at 
endothelial-pericyte interdigitation in rat angiogenesis. Lab. Investig. 86, 1172–
1184 (2006). 
343. Vujasinovic, T., Buta, M., Markicevic, M. & Nikolic-Vukosavljevic, D. 
Angiogenesis: bFGF and VEGF in breast carcinoma. Arch. Oncol. 14, 126–130 
(2006). 
344. Stratman, A. N., Schwindt, A. E., Malotte, K. M. & Davis, G. E. Endothelial-
derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during 
vasculogenic tube assembly and stabilization. Blood 116, 4720–4730 (2010). 
345. Guo, P. et al. Platelet-derived growth factor-B enhances glioma angiogenesis by 
stimulating vascular endothelial growth factor expression in tumor endothelia and 
by promoting pericyte recruitment. Am. J. Pathol. 162, 1083–1093 (2003). 
346. Raza, A., Franklin, M. J. & Dudek, A. Z. Pericytes and vessel maturation during 
tumor angiogenesis and metastasis. Am. J. Hematol. 85, 593–598 (2010). 
347. Erber, R. et al. Combined inhibition of VEGF and PDGF signaling enforces tumor 
vessel regression by interfering with pericyte-mediated endothelial cell survival 
mechanisms. FASEB J. 18, 338–340 (2004). 
348. Sounni, N. E., Paye, A., Host, L. & Noël, A. MT-MMPS as Regulators of Vessel 
Stability Associated with Angiogenesis. Front. Pharmacol. 2, 1–11 (2011). 
349. Saunders, W. B. et al. Coregulation of vascular tube stabilization by endothelial 
cell TIMP-2 and pericyte TIMP-3. J. Cell Biol. 175, 179–191 (2006). 
163 
 
350. Peiser, L., Mukhopadhyay, S. & Gordon, S. Scavenger receptors in innate 
immunity. Curr. Opin. Immunol. 14, 123–128 (2002). 
351. Spiller, K. L. et al. The role of macrophage phenotype in vascularization of tissue 
engineering scaffolds. Biomaterials 35, 4477–4488 (2014). 
352. Badylak, S. F., Valentin, J. E., Ravindra, A. K., McCabe, G. P. & Stewart-Akers, 
A. M. Macrophage phenotype as a determinant of biologic scaffold remodeling. 
Tissue Eng. Part A 14, 1835–1842 (2008). 
353. Spiller, K. L., Freytes, D. O. & Vunjak-Novakovic, G. Macrophages Modulate 
Engineered Human Tissues for Enhanced Vascularization and Healing. Ann. 
Biomed. Eng. 43, 616–627 (2015). 
354. Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and 
polarization. Front. Biosci. 13, 453–61 (2008). 
355. Murray, P. J. et al. Macrophage Activation and Polarization: Nomenclature and 
Experimental Guidelines. Immunity 41, 14–20 (2014). 
356. Hirano, R. et al. Human thymic stromal lymphopoietin enhances expression of 
CD80 in human CD14 + monocytes/macrophages. Inflamm. Res. 60, 605–610 
(2011). 
357. Rutkowski, R. et al. CD80 and CD86 Expression on LPS-Stimulated Monocytes 
and the Effect of CD80 and CD86 Blockade on IL-4 and IFN-γ Production in 
Nonatopic Bronchial Asthma. Arch. Immunol. Ther. Exp. (Warsz). 51, 421–428 
(2003). 
358. Buechler, C. et al. Regulation of scavenger receptor CD163 expression in human 
monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. 
Biol. 67, 97–103 (2000). 
359. Das, A. et al. Monocyte and Macrophage Plasticity in Tissue Repair and 
Regeneration. Am. J. Pathol. 185, 2596–2606 (2015). 
164 
 
360. Zhang, M. Z. et al. CSF-1 signaling mediates recovery from acute kidney injury. J. 
Clin. Invest. 122, 4519–4532 (2012). 
361. Reefman, E. et al. Cytokine Secretion Is Distinct from Secretion of Cytotoxic 
Granules in NK Cells. J. Immunol. 184, 4852–4862 (2010). 
362. Wynn, T. A. & Vannella, K. M. Macrophages in Tissue Repair, Regeneration, and 
Fibrosis. Immunity 44, 450–462 (2016). 
363. Lukacs, N. W., Strieter, R. M., Chensue, S. W., Widmer, M. & Kunkel, S. L. TNF-
alpha mediates recruitment of neutrophils and eosinophils during airway 
inflammation. J. Immunol. 154, 5411–7 (1995). 
364. Novak, M. L. & Koh, T. J. Phenotypic transitions of macrophages orchestrate 
tissue repair. Am. J. Pathol. 183, 1352–1363 (2013). 
365. Arras, M. et al. Monocyte activation in angiogenesis and collateral growth in the 
rabbit hindlimb. J. Clin. Invest. 101, 40–50 (1998). 
366. Dal-Secco, D. et al. A dynamic spectrum of monocytes arising from the in situ 
reprogramming of CCR2+ monocytes at a site of sterile injury. J. Exp. Med. 212, 
447–456 (2015). 
367. Pradere, J. P. et al. Hepatic macrophages but not dendritic cells contribute to liver 
fibrosis by promoting the survival of activated hepatic stellate cells in mice. 
Hepatology 58, 1461–1473 (2013). 
368. Pellicoro, A. et al. Elastin accumulation is regulated at the level of degradation by 
macrophage metalloelastase (MMP-12) during experimental liver fibrosis. 
Hepatology 55, 1965–1975 (2012). 
369. Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. 
J. Clin. Invest. 122, 787–795 (2012). 
370. Salans, L. B., Cushman, S. W. & Weismann, R. E. Studies of human adipose 
165 
 
tissue. Adipose cell size and number in nonobese and obese patients. J. Clin. 
Invest. 52, 929–941 (1973). 
371. Spiegelman, B. M. & Flier, J. S. Obesity and the regulation of energy balance. Cell 
104, 531–543 (2001). 
372. Arner, E. et al. Adipocyte Turnover : Relevance to Human Adipose Tissue. 
Diabetes 59, 105–109 (2010). 
373. Jeffery, E. et al. The Adipose Tissue Microenvironment Regulates Depot-Specific 
Adipogenesis in Obesity. Cell Metab. 24, 142–150 (2016). 
374. Rodeheffer, M. S., Birsoy, K. & Friedman, J. M. Identification of White Adipocyte 
Progenitor Cells In Vivo. Cell 135, 240–249 (2008). 
375. Shook, B. A. et al. Myofibroblast proliferation and heterogeneity are supported by 
macrophages during skin repair. Science 362, (2018). 
376. Shenaq, S. M. & Yuksel, E. New research in breast reconstruction: Adipose tissue 
engineering. Clin. Plast. Surg. 29, 111–125 (2002). 
377. Šmahel, J. Experimental implantation of adipose tissue fragments. Br. J. Plast. 
Surg. 42, 207–211 (1989). 
378. Gomillion, C. T. & Burg, K. J. L. Stem cells and adipose tissue engineering. 
Biomaterials 27, 6052–6063 (2006). 
379. Zhao, J., Hu, L., Liu, J., Gong, N. & Chen, L. The effects of cytokines in adipose 
stem cell-conditioned medium on the migration and proliferation of skin 
fibroblasts in vitro. Biomed Res. Int. 2013, (2013). 
380. Pathi, P., Ma, T. & Locke, B. R. Role of nutrient supply on cell growth in 
bioreactor design for tissue engineering of hematopoietic cells. Biotechnol. Bioeng. 
89, 743–758 (2005). 
381. Gomes, M. E., Bossano, C. M., Johnston, C. M., Reis, R. L. & Mikos, A. G. In 
166 
 
vitro localization of bone growth factors in constructs of biodegradable scaffolds 
seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. 
Tissue Eng. 12, 177–188 (2006). 
382. Oswald, J. et al. Mesenchymal Stem Cells Can Be Differentiated Into Endothelial 
Cells In Vitro. Stem Cells 22, 377–384 (2004). 
383. Lee, E. Y. et al. Hypoxia-enhanced wound-healing function of adipose-derived 
stem cells: Increase in stem cell proliferation and up-regulation of VEGF and 
bFGF. Wound Repair Regen. 17, 540–547 (2009). 
384. Allard, J. et al. Immunohistochemical toolkit for tracking and quantifying 
xenotransplanted human stem cells. Regen. Med. 9, 437–452 (2014). 
385. Shridhar, A. et al. Culture on Tissue‐Specific Coatings Derived from α‐Amylase‐
Digested Decellularized Adipose Tissue Enhances the Proliferation and 
Adipogenic Differentiation of Human Adipose‐Derived Stromal Cells. Biotechnol. 
J. 15, 1900118 (2020). 
386. Wendt, D., Marsano, A., Jakob, M., Heberer, M. & Martin, I. Oscillating perfusion 
of cell suspensions through three-dimensional scaffolds enhances cell seeding 
efficiency and uniformity. Biotechnol. Bioeng. 84, 205–214 (2003). 
387. Grayson, W. L. et al. Effects of initial seeding density and fluid perfusion rate on 
formation of tissue-engineered bone. Tissue Eng. - Part A. 14, 1809–1820 (2008). 
388. Hewitt, C. J. et al. Expansion of human mesenchymal stem cells on microcarriers. 
Biotechnol. Lett. 33, 2325–2335 (2011). 
389. Teixeira, G. Q., Barrias, C. C., Lourenço, A. H. & Gonçalves, R. M. A 
multicompartment holder for spinner flasks improves expansion and osteogenic 
differentiation of mesenchymal stem cells in three-dimensional scaffolds. Tissue 
Eng. - Part C Methods 20, 984–993 (2014). 
390. Zhu, Y. et al. Ex vivo expansion of adipose tissue-derived stem cells in spinner 
167 
 
flasks. Biotechnol. J. 4, 1198–1209 (2009). 
391. Gadelorge, M. et al. Clinical-scale expansion of adipose-derived stromal cells 
starting from stromal vascular fraction in a single-use bioreactor: proof of concept 
for autologous applications. J. Tissue Eng. Regen. Med. 12, 129–141 (2018). 
392. Carmelo, J. G., Fernandes-Platzgummer, A., Diogo, M. M., da Silva, C. L. & 
Cabral, J. M. S. A xeno-free microcarrier-based stirred culture system for the 
scalable expansion of human mesenchymal stem/stromal cells isolated from bone 
marrow and adipose tissue. Biotechnol. J. 10, 1235–1247 (2015). 
393. Banfi, A. et al. Proliferation kinetics and differentiation potential of ex vivo 
expanded human bone marrow stromal cells. Exp. Hematol. 28, 707–715 (2000). 
394. Haskett, D. G. et al. An exploratory study on the preparation and evaluation of a 
“same-day” adipose stem cell–based tissue-engineered vascular graft. J. Thorac. 
Cardiovasc. Surg. 156, 1814-1822.e3 (2018). 
395. Haykal, S. et al. Double-chamber rotating bioreactor for dynamic perfusion cell 
seeding of large-segment tracheal allografts: Comparison to conventional static 
methods. Tissue Eng. - Part C Methods 20, 681–692 (2014). 
396. Frohlich, M., Cells, S., Culture, B., Gimble, J. M. & Ph, D. Bone Grafts 
Engineered from Human Adipose-Derived. Tissue Eng. Part A 16, 179–189 
(2010). 
397. Bieback, K. et al. Altered gene expression in human adipose stem cells cultured 
with fetal bovine serum compared to human supplements. Tissue Eng. - Part A 16, 
3467–3484 (2010). 
398. Lindroos, B. et al. Differential gene expression in adipose stem cells cultured in 
allogeneic human serum versus fetal bovine serum. Tissue Eng. - Part A 16, 2281–
2294 (2010). 
399. Ciria, M. et al. Mesenchymal Stem Cell Migration and Proliferation Are Mediated 
168 
 
by Hypoxia-Inducible Factor-1α Upstream of Notch and SUMO Pathways. Stem 
Cells Dev. 26, 973–985 (2017). 
400. Pugh, C. W. & Ratcliffe, P. J. Regulation of angiogenesis by hypoxia: role of the 
HIF system. Nat. Med. 9, 677–684 (2003). 
401. Dong, Z., Peng, Z., Chang, Q. & Lu, F. The survival condition and 
immunoregulatory function of adipose stromal vascular fraction (SVF) in the early 
stage of nonvascularized adipose transplantation. PLoS One 8, 1–11 (2013). 
402. Noguchi, M. et al. In vitro characterization and engraftment of adipocytes derived 
from human induced pluripotent stem cells and embryonic stem cells. Stem Cells 
Dev. 22, 2895–2905 (2013). 
403. Torio-Padron, N., Baerlecken, N., Momeni, A., Stark, G. B. & Borges, J. 
Engineering of adipose tissue by injection of human preadipocytes in fibrin. 
Aesthetic Plast. Surg. 31, 285–293 (2007). 
404. Al-Khaldi, A. et al. Postnatal bone marrow stromal cells elicit a potent VEGF-
dependent neoangiogenic response in vivo. Gene Ther. 10, 621–629 (2003). 
405. Nishimura, S. et al. Adipogenesis in Obesity Requires Close Interplay Between 
Differentiating Adipocytes, Stromal Cells, and Blood Vessels. Diabetes 56, 1517–
1526 (2007). 
406. Fukumura, D. et al. Paracrine Regulation of Angiogenesis and Adipocyte 
Differentiation During In Vivo Adipogenesis. Circ. Res. 93, e88–e97 (2003). 
407. Parisi-Amon, A., Mulyasasmita, W., Chung, C. & Heilshorn, S. C. Protein-
Engineered Injectable Hydrogel to Improve Retention of Transplanted Adipose-
Derived Stem Cells. Adv. Healthc. Mater. 2, 428–432 (2013). 
408. Cai, L., Dewi, R. E. & Heilshorn, S. C. Injectable hydrogels with in situ double 
network formation enhance retention of transplanted stem cells. Adv. Funct. Mater. 
25, 1344–1351 (2015). 
169 
 
409. Brett, E. et al. A review of cell-based strategies for soft tissue reconstruction. 
Tissue Eng. - Part B Rev. 23, 336–346 (2017). 
410. Choi, J. S. et al. Fabrication of porous extracellular matrix scaffolds from human 
adipose tissue. Tissue Eng. Part C. Methods 16, 387–396 (2010). 
411. Suga, H. et al. Adipose tissue remodeling under ischemia: Death of adipocytes and 
activation of stem/ progenitor cells. Plast. Reconstr. Surg. 126, 1911–1923 (2010). 
412. Pizzute, T., Lynch, K. & Pei, M. Impact of Tissue-Specific Stem Cells on Lineage-
Specific Differentiation: A Focus on the Musculoskeletal System. Stem Cell Rev. 
Reports 11, 119–132 (2015). 
413. Han, T. T. Y. & Flynn, L. E. Perfusion bioreactor culture of adipose-derived 
stromal cells on decellularized adipose tissue scaffolds enhances in vivo 
regeneration. bioRxiv 2020.04.10.036194 (2020) doi:10.1101/2020.04.10.036194. 
414. Prichard, H. L., Reichert, W. & Klitzman, B. IFATS Collection: Adipose-Derived 
Stromal Cells Improve the Foreign Body Response. Stem Cells 26, 2691–2695 
(2008). 
415. Li, W. et al. Mesenchymal stem cells: A double-edged sword in regulating 
immune responses. Cell Death Differ. 19, 1505–1513 (2012). 
416. Merrick, D. et al. Identification of a mesenchymal progenitor cell hierarchy in 
adipose tissue. Science 364, eaav2501 (2019). 
417. Mitchell, J. B. et al. Immunophenotype of human adipose-derived cells: temporal 
changes in stromal-associated and stem cell-associated markers. Stem Cells 24, 
376–385 (2006). 
418. Scheubel, R. J. et al. Paracrine effects of CD34 progenitor cells on angiogenic 
endothelial sprouting. Int. J. Cardiol. 139, 134–141 (2010). 
419. Li, H. et al. Adipogenic potential of adipose stem cell subpopulations. Plast. 
170 
 
Reconstr. Surg. 128, 663–672 (2011). 
420. Wang, Y. et al. Relative contributions of adipose-resident CD146+ pericytes and 
CD34+ adventitial progenitor cells in bone tissue engineering. npj Regen. Med. 4, 
(2019). 
421. Yang, Z. & Ming, X. F. Functions of arginase isoforms in macrophage 
inflammatory responses: Impact on cardiovascular diseases and metabolic 
disorders. Front. Immunol. 5, 1–10 (2014). 
422. Santhanam, L. et al. Inducible NO synthase-dependent S-nitrosylation and 
activation of arginase1 contribute to age-related endothelial dysfunction. Circ. Res. 
101, 692–702 (2007). 
423. Bravo, B. et al. Opposite Effects of Mechanical Action of Fluid Flow on 
Proangiogenic Factor Secretion From Human Adipose-Derived Stem Cells With 
and Without Oxidative Stress. J. Cell. Physiol. 232, 2158–2167 (2017). 
424. Passerini, A. G., Milsted, A. & Rittgers, S. E. Shear stress magnitude and 
directionality modulate growth factor gene expression in preconditioned vascular 
endothelial cells. J. Vasc. Surg. 37, 182–190 (2003). 
425. Gan, L. M., Miocic, M., Doroudi, R., Selin-Sjoögren, L. & Jern, S. Distinct 
regulation of vascular endothelial growth factor in intact human conduit vessels 
exposed to laminar fluid shear stress and pressure. Biochem. Biophys. Res. 
Commun. 272, 490–496 (2000). 
426. Harris, D. P., Bandyopadhyay, S., Maxwell, T. J., Willard, B. & DiCorleto, P. E. 
Tumor necrosis factor (TNF)-α induction of CXCL10 in endothelial cells requires 
protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB 
p65 Methylation. J. Biol. Chem. 289, 15328–15339 (2014). 
427. Hardaker, E. L. et al. Regulation of TNF‐α and IFN‐γ induced CXCL10 
expression: participation of the airway smooth muscle in the pulmonary 
inflammatory response in chronic obstructive pulmonary disease. FASEB J. 18, 
171 
 
191–193 (2004). 
428. Kamimoto, M., Mizuno, S. & Nakamura, T. Reciprocal regulation of IL-6 and IL-
10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for 
attenuation of liver injury in a mouse model of endotoxemia. Int. J. Mol. Med. 24, 
837–43 (2009). 
429. Boehler, R. M. et al. Lentivirus delivery of IL-10 to promote and sustain 
macrophage polarization towards an anti-inflammatory phenotype. Biotechnol. 
Bioeng. 111, 1210–1221 (2014). 
430. Peranteau, W. H. et al. IL-10 overexpression decreases inflammatory mediators 
and promotes regenerative healing in an adult model of scar formation. J. Invest. 
Dermatol. 128, 1852–1860 (2008). 
431. Petrovic-Djergovic, D. et al. CXCL10 induces the recruitment of monocyte-
derived macrophages into kidney, which aggravate puromycin aminonucleoside 
nephrosis. Clin. Exp. Immunol. 180, 305–315 (2015). 
432. Chen, P.-M. et al. Induction of immunomodulatory monocytes by human 
mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. J. 
Leukoc. Biol. 96, 295–303 (2014). 
433. Choi, W., Lee, J., Lee, J., Lee, S. H. & Kim, S. Hepatocyte growth factor regulates 
macrophage transition to the M2 phenotype and promotes murine skeletal muscle 
regeneration. Front. Physiol. 10, (2019). 
434. Maachi, M. et al. Systemic low-grade inflammation is related to both circulating 
and adipose tissue TNFα, leptin and IL-6 levels in obese women. Int. J. Obes. 28, 
993–997 (2004). 
435. Bulló, M., García-Lorda, P., Megias, I. & Salas-Salvadó, J. Systemic 
inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes. 
Res. 11, 525–531 (2003). 
172 
 
436. Kwon, Y. W. et al. Tumor necrosis factor-α-activated mesenchymal stem cells 
promote endothelial progenitor cell homing and angiogenesis. Biochim. Biophys. 
Acta - Mol. Basis Dis. 1832, 2136–2144 (2013). 
437. McKenney, J. K., Weiss, S. W. & Folpe, A. L. CD31 expression in intratumoral 
macrophages: A potential diagnostic pitfall. Am. J. Surg. Pathol. 25, 1167–1173 
(2001). 
438. Mah, W. et al. Elevated CD26 Expression by Skin Fibroblasts Distinguishes a 
Profibrotic Phenotype Involved in Scar Formation Compared to Gingival 
Fibroblasts. Am. J. Pathol. 187, 1717–1735 (2017). 
439. Gliddon, D. R. & Howard, C. J. CD26 is expressed on a restricted subpopulation 
of dendritic cells in vivo. Eur. J. Immunol. 32, 1472–1481 (2002). 
440. Zhong, J. et al. A potential role for dendritic cell/macrophage-expressing DPP4 in 
obesity-induced visceral inflammation. Diabetes 62, 149–157 (2013). 
441. Mantovani, A., Gray, P. A., Van Damme, J. & Sozzani, S. Macrophage-derived 
chemokine (MDC). J. Leukoc. Biol. 68, 400–4 (2000). 
442. Lilja, H. E. et al. An adipoinductive role of inflammation in adipose tissue 
engineering: key factors in the early development of engineered soft tissues. Stem 
Cells Dev. 22, 1602–13 (2013). 
443. Debels, H. et al. Macrophages play a key role in angiogenesis and adipogenesis in 
a mouse tissue engineering model. Tissue Eng. 19, 2615–2625 (2013). 
444. Sun, X., Jones, H. P., Dobbs, N., Bodhankar, S. & Simecka, J. W. Dendritic Cells 
Are the Major Antigen Presenting Cells in Inflammatory Lesions of Murine 
Mycoplasma Respiratory Disease. PLoS One 8, e55984 (2013). 
445. Krzywinska, E. et al. CD45 Isoform Profile Identifies Natural Killer (NK) Subsets 
with Differential Activity. PLoS One 11, e0150434 (2016). 
173 
 
446. Fabriek, B. O., Dijkstra, C. D. & van den Berg, T. K. The macrophage scavenger 
receptor CD163. Immunobiology 210, 153–160 (2005). 
447. Lurier, E. B. et al. Transcriptome analysis of IL-10-stimulated (M2c) macrophages 
by next-generation sequencing. Immunobiology 222, 847–856 (2017). 
448. Buechler, C. et al. Regulation of scavenger receptor CD163 expression in human 
monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. 
Biol. 67, 97–103 (2000). 
449. Storck, K., Fischer, R., Buchberger, M., Haller, B. & Regn, S. Delivered adipose-
derived stromal cells improve host-derived adipose tissue formation in composite 
constructs in vivo. Laryngoscope 127, E428–E436 (2017). 
450. Davis, B. M., Loghin, E. R., Conway, K. R. & Zhang, X. Automated Closed-
System Expansion of Pluripotent Stem Cell Aggregates in a Rocking-Motion 
Bioreactor. SLAS Technol. 23, 364–373 (2018). 
451. Tsai, A. C., Liu, Y., Yuan, X., Chella, R. & Ma, T. Aggregation kinetics of human 
mesenchymal stem cells under wave motion. Biotechnol. J. 12, 1–13 (2017). 
452. Fortier, G. M., Gauvin, R., Proulx, M., Vallée, M. & Fradette, J. Dynamic culture 
induces a cell type-dependent response impacting on the thickness of engineered 
connective tissues. J. Tissue Eng. Regen. Med. 7, 292–301 (2013). 
453. Sadeghi, A. et al. Large-scale bioreactor expansion of tumor-infiltrating 
lymphocytes. J. Immunol. Methods 364, 94–100 (2011). 
454. Clincke, M. F. et al. Very high density of Chinese hamster ovary cells in perfusion 
by alternating tangential flow or tangential flow filtration in WAVE bioreactorTM-
part II: Applications for antibody production and cryopreservation. Biotechnol. 
Prog. 29, 768–777 (2013). 
455. Amos, P. J. et al. Human Adipose-Derived Stromal Cells Accelerate Diabetic 
Wound Healing: Impact of Cell Formulation and Delivery. Tissue Eng. Part A 16, 
174 
 
1595–606 (2010). 
456. Agrawal, H. et al. Human adipose-derived stromal/stem cells demonstrate short-
lived persistence after implantation in both an immunocompetent and an 
immunocompromised murine model. Stem Cell Res. Ther. 5, 142 (2014). 
457. Song, Y. H., Shon, S. H., Shan, M., Stroock, A. D. & Fischbach, C. Adipose-
derived stem cells increase angiogenesis through matrix metalloproteinase-
dependent collagen remodeling. Integr. Biol. (United Kingdom) 8, 205–215 
(2016). 
458. Pers, Y.-M. et al. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe 
Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial. Stem Cells Transl. 
Med. 5, 847–856 (2016). 
459. Young, S. A., Flynn, L. E. & Amsden, B. G. Adipose-derived stem cells in a 
resilient in situ forming hydrogel modulate macrophage phenotype. Tissue Eng. - 
Part A 24, 1784–1797 (2018). 
460. Kirouac, D. C. & Zandstra, P. W. The Systematic Production of Cells for Cell 
Therapies. Cell Stem Cell 3, 369–381 (2008). 
461. Robb, K. P., Shridhar, A. & Flynn, L. E. Decellularized Matrices As Cell-
Instructive Scaffolds to Guide Tissue-Specific Regeneration. ACS Biomater. Sci. 
Eng. 4, 3627–3643 (2018). 
462. Morissette Martin, P., Grant, A., Hamilton, D. W. & Flynn, L. E. Matrix 
composition in 3-D collagenous bioscaffolds modulates the survival and 
angiogenic phenotype of human chronic wound dermal fibroblasts. Acta Biomater. 
83, 199–210 (2019). 
463. Lin, Y. et al. A novel antibody AA98 VH/L directed against CD146 efficiently 
inhibits angiogenesis. Anticancer Res. 27, 4219–4224 (2007). 
464. Baer, P. C. Adipose-derived mesenchymal stromal/stem cells: An update on their 
175 
 
phenotype in vivo and in vitro. World J. Stem Cells 6, 256 (2014). 
465. Varma, M. J. O. et al. Phenotypical and functional characterization of freshly 
isolated adipose tissue-derived stem cells. Stem Cells Dev. 16, 91–104 (2007). 
466. Malek, A. & Izumo, S. Physiological fluid shear stress causes downregulation of 
endothelin-1 mRNA in bovine aortic endothelium. Am. J. Physiol. Physiol. 263, 
C389–C396 (1992). 
467. Kim, U. J., Park, J., Joo Kim, H., Wada, M. & Kaplan, D. L. Three-dimensional 
aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26, 2775–
2785 (2005). 
468. Rehman, J. et al. Secretion of Angiogenic and Antiapoptotic Factors by Human 
Adipose Stromal Cells. Circulation 109, 1292–1298 (2004). 
469. Rehman, J. et al. Secretion of Angiogenic and Antiapoptotic Factors by Human 
Adipose Stromal Cells. Circulation 109, 1292–1298 (2004). 
470. Park, I. S., Chung, P. S. & Ahn, J. C. Adipose-derived stem cell spheroid treated 
with low-level light irradiation accelerates spontaneous angiogenesis in mouse 
model of hindlimb ischemia. Cytotherapy 19, 1070–1078 (2017). 
471. Lopatina, T. et al. PDGF enhances the protective effect of adipose stem cell-
derived extracellular vesicles in a model of acute hindlimb ischemia. Sci. Rep. 8, 
1–12 (2018). 
472. Huang, H. et al. Preferred M2 Polarization by ASC-Based Hydrogel Accelerated 
Angiogenesis and Myogenesis in Volumetric Muscle Loss Rats. Stem Cells Int. 
2017, 1–13 (2017). 
473. Melief, S. M., Geutskens, S. B., Fibbe, W. E. & Roelofs, H. Multipotent stromal 
cells skew monocytes towards an anti-inflammatory interleukin-10-producing 
phenotype by production of interleukin-6. Haematologica 98, 888–895 (2013). 
176 
 
474. Razmkhah, M. et al. Adipose derived stem cells (ASCs) isolated from breast 
cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of 
regulatory molecules on T cells: Do they protect breast cancer cells from the 
immune response? Cell. Immunol. 266, 116–122 (2011). 
475. Anderson, P. et al. Adipose-derived mesenchymal stromal cells induce 
immunomodulatory macrophages which protect from experimental colitis and 
sepsis. Gut 62, 1131–1141 (2013). 
476. Zomer, H. D., Jeremias, T. da S., Ratner, B. & Trentin, A. G. Mesenchymal 
stromal cells from dermal and adipose tissues induce macrophage polarization to a 
pro-repair phenotype and improve skin wound healing. Cytotherapy 000, 1–14 
(2020). 
477. Brown, B. N. et al. Macrophage phenotype as a predictor of constructive 
remodeling following the implantation of biologically derived surgical mesh 
materials. Acta Biomater. 8, 978–987 (2012). 
478. Levesque, M. J., Nerem, R. M. & Sprague, E. A. Vascular endottielial cell 
proliferation in culture and the influence of flow. Biomaterials 11, 702–707 
(1990). 
 
177 
 
Appendix A: Supplemental Figures and Tables 
 
Figure A.1 Schematic of the perfusion bioreactor system. A) Culture media is pumped 
unidirectionally via the peristaltic pump through the sample chamber before being 
recycled back into the media reservoir. B-C) The components of the sample chamber (B) 
and culture inserts (C).  
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Figure A.2 Representative Ki-67 staining in the central regions of the ASC-seeded 
DAT scaffolds cultured under static or dynamic conditions within the bioreactor for 
14 days. Ki-67 expression is shown in red and DAPI counterstaining in blue. Scale bars 
represent 100 µm. 
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Figure A.3 Representative HIF-1α staining in the central regions of the ASC-seeded 
DAT scaffolds cultured under static or dynamic conditions within the bioreactor for 
14 days. HIF-1α+ cells are shown in green and DAPI counterstaining in blue. Scale bars 
represent 100 µm. 
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Figure A.4 The average erythrocyte-containing blood vessel A) diameter and B) 
depth of infiltration in the DAT scaffolds following subcutaneous implantation in 
the nu/nu mouse model for 4 and 8 weeks. Error bars represent standard deviation (n=3 
cross-sections/implant, N=6 implants/group). *=significant difference in the 2% O2 
dynamic group as compared to the unseeded, freshly-seeded and 2% O2 static groups at 8 
weeks (p<0.05). 
 
 
181 
 
 
Figure A.5 Representative images showing perilipin staining (brown) in the DAT 
scaffolds implanted subcutaneously in the nu/nu mouse model for 4 weeks. Scale 
bars represent 100 µm. 
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Figure A.6 Representative immunostaining showing Ku80+ (red) human ASCs 
counterstained with DAPI (blue) in the DAT scaffolds that implanted 
subcutaneously in the nu/nu mouse model for 4 weeks. Scale bars represent 100 µm. 
 
 
 
183 
 
 
Figure A.7 Representative scatter plots showing that dynamic culture did not 
significantly alter the immunophenotype of the ASCs on the DAT scaffolds. The 
ASCs were enzymatically-released from the DAT for flow analysis. A) Representative 
scatter plots for one ASC donor showing the percentage of CD90+CD29+ cells in the 
calcein violet-AM+CD31-CD45- subset. Representative scatter plots showing the 
percentage of this population that also expressed B) CD26, C) CD34 or D) CD146.  
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Figure A.8 Analysis of iNOS and Arg-1 expression in the ASC-seeded DAT scaffolds 
cultured in vitro statically or dynamically for 14 days. A) The density of iNOS+DAPI+ 
cells and B) iNOS+DAPI+ cells as a percentage of the total DAPI+ cell population, and 
C) the density of Arg-1+DAPI+ cells and D) Arg-1+DAPI+ cells as a percentage of the 
total DAPI+ cell population in both the central (> 200 µm from scaffold border) and 
peripheral (< 200 µm from scaffold border) regions of the DAT scaffolds. Error bars 
represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with different ASC 
donors). * = significant difference between the peripheral region of the dynamic group 
and all other groups, # = significant difference between the peripheral region of the 
dynamic group and the central region of the static group (p<0.05). 
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Figure A.9 Analysis of TNF-α and IL-10 expression in the ASCs cultured statically 
or dynamically on the DAT for 14 days. The percentage of the total DAPI+ human ASC 
population that was A) TNF-α+DAPI+, B) IL-10+DAPI+, C) TNF-α+IL-10+DAPI+ and D) 
Arg-1+TNF-α+IL-10+ DAPI+ in both the central (> 200 µm from scaffold border) and 
peripheral (< 200 µm from scaffold border) regions of the DAT scaffolds. Error bars 
represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with different ASC 
donors). * = significant difference between indicated groups (p<0.05). 
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Figure A.10 The A) density of Ku80+DAPI+ human ASCs within the DAT implants 
and B) the CD26+ human ASCs as a percentage of the total Ku80+DAPI+ human 
ASC population in the DAT implants at 1, 4 and 8 weeks. Error bars represent 
standard deviation (n=3 cross-sections/implant, N=6 implants/group). * = significant 
difference between the dynamic group at 1 week and all other groups, # = significant 
difference between the indicated group and both the static and dynamic groups at 1 week, 
as well as the dynamic group at 4 weeks (p<0.05).  
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Figure A.11 Representative immunostaining for CD45 (cyan), F4/80 (red) and CD68 
(green) with DAPI counterstaining (blue) in the static and dynamic implants at 4 
weeks. Scale bars represent 100 µm.  
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Figure A.12 Representative immunostaining for CD45 (cyan), F4/80 (red) and CD68 
(green) with DAPI counterstaining (blue) in the static and dynamic implants at 8 
weeks. Scale bars represent 100 µm. 
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Figure A.13 The percentage of A) CD45+F4/80+DAPI+ cells and 
B) CD45+CD68+DAPI+ relative to the total CD45+DAPI+ cell population in the DAT 
implants at 1, 4 and 8 weeks. Error bars represent standard deviation (n=3 cross-
sections/implant, N=4 implants/group). * = significant difference between the indicated 
group and both the static and dynamic groups at 1 and 4 weeks (p<0.05). 
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Figure A.14. Images of the rocking bioreactor platform. 
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Figure A.15 Representative scatter plots showing the fluorescence intensity of CD90 
versus CD29 in the calcein violet+CD31-CD45- cell population, and the fluorescence 
intensity of CD26 or CD34 versus FSC-A in the viable CD90+CD29+ subpopulation 
following 7 days of culture.    
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Figure A.16. Heatmap showing the relative expression levels for each gene of 
interest in the various culture conditions after 7 days of culture. Data shown was 
normalized against the geometric mean of the housekeeping genes in each respective 
sample. Genes with low average expression are indicated in blue and high expression in 
red on a log2 scale.  
 
 
 
Figure A.17 ASCs appeared to align perpendicular to the direction of the fluid flow 
in the dynamic DAT-coated group at 7 days. Representative images taken from various 
regions on the DAT coating showing iNOS (red), F-actin (green) and nuclei (blue). Scale 
bars represent 100 µm.  
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Table A.1 A list of genes assessed in the Human Angiogenic Growth Factor PCR 
Array 
Gene Symbol Gene Name 
AGGF1 Angiogenic factor with G patch and FHA domains 1 
AMOT Angiomotin 
ANG Angiogenin, ribonuclease, RNase A family, 5 
ANGPT1 Angiopoietin 1 
ANGPT2 Angiopoietin 2 
ANGPTL1 Angiopoietin-like 1 
ADGRB1 Brain-specific angiogenesis inhibitor 1 
BMP2 Bone morphogenetic protein 2 
BTG1 B-cell translocation gene 1, anti-proliferative 
CCL15 Chemokine (C-C motif) ligand 15 
CCL2 Chemokine (C-C motif) ligand 2 
CD55 
CD55 molecule, decay accelerating factor for complement (Cromer 
blood group) 
CD59 CD59 molecule, complement regulatory protein 
CHGA Chromogranin A (parathyroid secretory protein 1) 
COL18A1 Collagen, type XVIII, alpha 1 
COL4A3 Collagen, type IV, alpha 3 (Goodpasture antigen) 
CSF3 Colony stimulating factor 3 (granulocyte) 
CXCL10 Chemokine (C-X-C motif) ligand 10 
CXCL11 Chemokine (C-X-C motif) ligand 11 
CXCL12 Chemokine (C-X-C motif) ligand 12 
CXCL13 Chemokine (C-X-C motif) ligand 13 
CXCL14 Chemokine (C-X-C motif) ligand 14 
CXCL2 Chemokine (C-X-C motif) ligand 2 
CXCL3 Chemokine (C-X-C motif) ligand 3 
CXCL5 Chemokine (C-X-C motif) ligand 5 
CXCL6 
Chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 
2) 
CXCL9 Chemokine (C-X-C motif) ligand 9 
EDIL3 EGF-like repeats and discoidin I-like domains 3 
EREG Epiregulin 
FGF1 Fibroblast growth factor 1 (acidic) 
FGF13 Fibroblast growth factor 13 
FGF2 Fibroblast growth factor 2 (basic) 
FGFBP1 Fibroblast growth factor binding protein 1 
FIGF C-fos induced growth factor (vascular endothelial growth factor D) 
FN1 Fibronectin 1 
FOXO4 Forkhead box O4 
FST Follistatin 
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GRN Granulin 
GRP Gastrin-releasing peptide 
HGF Hepatocyte growth factor (hepapoietin A; scatter factor) 
IFNA1 Interferon, alpha 1 
IFNB1 Interferon, beta 1, fibroblast 
IFNG Interferon, gamma 
IL10 Interleukin 10 
IL12A 
Interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic 
lymphocyte maturation factor 1, p35) 
IL12B 
Interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic 
lymphocyte maturation factor 2, p40) 
IL17F Interleukin 17F 
IL6 Interleukin 6 (interferon, beta 2) 
CXCL8 Interleukin 8 
KITLG KIT ligand 
KLK3 Kallikrein-related peptidase 3 
LEP Leptin 
MDK Midkine (neurite growth-promoting factor 2) 
NPPB Natriuretic peptide B 
NPR1 
Natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic 
peptide receptor A) 
PDGFB Platelet-derived growth factor beta polypeptide 
PDGFD Platelet derived growth factor D 
PF4 Platelet factor 4 
PGF Placental growth factor 
PLG Plasminogen 
PPBP Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) 
PRL Prolactin 
PROK1 Prokineticin 1 
PTN Pleiotrophin 
RHOB Ras homolog gene family, member B 
RNH1 Ribonuclease/angiogenin inhibitor 1 
RUNX1 Runt-related transcription factor 1 
SERPINC1 Serpin peptidase inhibitor, clade C (antithrombin), member 1 
SERPINE1 
Serpin peptidase inhibitor, clade E (nexin, plasminogen activator 
inhibitor type 1), member 1 
SERPINF1 
Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment 
epithelium derived factor), member 1 
SPINK5 Serine peptidase inhibitor, Kazal type 5 
STAB1 Stabilin 1 
TGFA Transforming growth factor, alpha 
TGFB1 Transforming growth factor, beta 1 
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THBS1 Thrombospondin 1 
TIE1 Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 
TIMP1 TIMP metallopeptidase inhibitor 1 
TIMP2 TIMP metallopeptidase inhibitor 2 
TIMP3 TIMP metallopeptidase inhibitor 3 
TNF Tumor necrosis factor 
TNNI2 Troponin I type 2 (skeletal, fast) 
TNNI3 Troponin I type 3 (cardiac) 
TYMP Thymidine phosphorylase 
VEGFA Vascular endothelial growth factor A 
  
196 
 
Table A.2 List of genes included in the PrimePCRTM array analysis. 
Angiogenesis 
Gene Symbol Gene Name 
ANGPT1 Angiopoietin-1 
FGF2 Basic fibroblast growth factor 
HGF Hepatocyte growth factor 
IGF1 Insulin like growth factor-1 
SERPINE1 Serpin family E member-1 
VEGFA Vascular endothelial growth factor A 
Inflammation 
Gene Symbol Gene Name 
CCL2 C-C motif chemokine ligand 2 
CSF2 Colony stimulating factor 2 
IL1B Interleukin-1 beta 
IL4 Interleukin-4 
IL10 Interleukin-10 
TNF Tumor necrosis factor 
CXCL10 C-X-C motif chemokine ligand-10 
ECM synthesis 
Gene Symbol Gene Name 
ACAN Aggrecan 
ACTA2 Smooth muscle actin alpha 2 
BGN Biglycan 
COL1A1 Collagen type 1 alpha 1 chain 
COL3A1 Collagen type III alpha 1 chain 
COL4A1 Collagen type IV alpha 1 chain 
CTGF Connective tissue growth factor 
DCN Decorin 
VCAN Versican 
ECM remodeling 
Gene Symbol Gene Name 
MMP1 Matrix metalloproteinase-1 
MMP2 Matrix metalloproteinase-2 
TGFB1 Transforming growth factor-beta 1 
TIMP1 Tissue inhibitor of metalloproteinases-1 
Housekeeping 
Gene Symbol Gene Name 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
RPS18 Ribosomal protein S18 
UBC Ubiquitin C 
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